<SEC-DOCUMENT>0001047469-19-001531.txt : 20190322
<SEC-HEADER>0001047469-19-001531.hdr.sgml : 20190322
<ACCEPTANCE-DATETIME>20190322120322
ACCESSION NUMBER:		0001047469-19-001531
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20190501
FILED AS OF DATE:		20190322
DATE AS OF CHANGE:		20190322
EFFECTIVENESS DATE:		20190322

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			USANA HEALTH SCIENCES INC
		CENTRAL INDEX KEY:			0000896264
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				870500306
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1229

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35024
		FILM NUMBER:		19699009

	BUSINESS ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336
		BUSINESS PHONE:		8019547100

	MAIL ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		STREET 2:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	USANA INC
		DATE OF NAME CHANGE:	19930125
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a2238104zdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<P><FONT SIZE=3 >
Use these links to rapidly review the document<BR>
<A HREF="#bg15301_table_of_contents">  TABLE OF CONTENTS</A><BR></font>
</P>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B> SCHEDULE 14A</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Proxy
Statement Pursuant to Section 14(a) of<BR>
the Securities Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2> Filed by the Registrant <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Filed by a Party other than the Registrant <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><BR>
Check the appropriate box:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Preliminary Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Additional Materials</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Soliciting Material under &sect;240.14a-12<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> USANA Health Sciences,&nbsp;Inc.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Registrant as Specified In Its Charter)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><BR>
Payment of Filing Fee (Check the appropriate box):</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>No fee required.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and&nbsp;0-11.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Title of each class of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Aggregate number of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Proposed maximum aggregate value of transaction:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(5)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Total fee paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee paid previously with preliminary materials.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><BR><FONT SIZE=2>Amount Previously Paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Form, Schedule or Registration Statement No.:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Filing Party:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Date Filed:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.<BR> </B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=179725,FOLIO='blank',FILE='DISK126:[19ZAE1.19ZAE15301]BA15301A.;8',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g769934.jpg" ALT="LOGO" WIDTH="102" HEIGHT="135">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>3838 West Parkway Boulevard<BR>
Salt Lake City, Utah 84120-6336<BR>
(801)&nbsp;954-7100  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>March&nbsp;22, 2019 </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>Dear
USANA Shareholders, </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are excited to invite you to attend the Annual Meeting of Shareholders of USANA Health Sciences,&nbsp;Inc. on Wednesday, May&nbsp;1, 2019 at 11:00&nbsp;a.m., Mountain Daylight
Time. We will conduct the Annual Meeting via a live webcast. You will be able to attend the annual meeting and vote your shares electronically during the live webcast of the meeting by visiting </FONT> <FONT
SIZE=2><I>www.virtualshareholdermeeting.com/USNA2019</I></FONT><FONT SIZE=2> and entering the 16-digit control number provided in your proxy materials. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are pleased to provide access to our proxy materials over the Internet under the U.S. Securities and Exchange Commission's "notice and access" rules. As a result, we are mailing to
many of our shareholders a Notice of Internet Availability of Proxy Materials, instead of a paper copy of the Proxy Statement and our 2018 Annual Report. The notice contains instructions on how to
access those documents over the Internet as well as how to receive a paper copy of our proxy materials. All shareholders who do not receive a notice will receive a paper copy by mail unless they have
previously requested delivery of proxy materials electronically. Continuing to employ this distribution process will conserve natural resources and reduce the costs of printing and distributing our
proxy materials. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
may vote your shares at the Annual Meeting, or by proxy over the Internet or by telephone, or, if you received paper copies of the proxy materials, by mail. You also may vote by mail
by following the instructions on the proxy card or voting instruction card. Submitting your vote in any of these authorized ways will ensure your representation at the Annual Meeting regardless of
whether you participate virtually in the Annual Meeting online over the Internet. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
vote is important to us and I do hope you will vote as soon as possible. Thank you for your continued support of USANA. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="50%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Sincerely,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B>
<IMG SRC="g263414.jpg" ALT="GRAPHIC" WIDTH="162" HEIGHT="58">
 </B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Kevin Guest</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><I> Chief Executive Officer</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=912838,FOLIO='blank',FILE='DISK126:[19ZAE1.19ZAE15301]BC15301A.;10',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="be15301_notice_of_2019_annual_meeting___not02436"> </A>
<A NAME="toc_be15301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  NOTICE OF&nbsp;2019 ANNUAL MEETING OF SHAREHOLDERS<BR>  AND PROXY STATEMENT    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g769934.jpg" ALT="LOGO" WIDTH="102" HEIGHT="135">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>Annual Meeting of Shareholders<BR>
May&nbsp;1, 2019<BR>
11:00&nbsp;a.m. Mountain Time<BR>
Online at </B></FONT><FONT SIZE=2><B><I>www.virtualshareholdermeeting.com/USNA2019</I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>To
the Shareholders of USANA Health Sciences,&nbsp;Inc.: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
2019 Annual Meeting of Shareholders of USANA Health Sciences,&nbsp;Inc. will be held on May&nbsp;1, 2019, at 11:00&nbsp;a.m. Mountain Time. Our Annual Meeting will be a virtual
meeting conducted entirely via live webcast over the Internet. You will be able to attend the Annual Meeting online and vote your shares electronically during the live webcast of the meeting by
visiting </FONT><FONT SIZE=2><I>www.virtualshareholdermeeting.com/USNA2019</I></FONT><FONT SIZE=2> and entering your 16-digit control number included in the notice containing instructions on how to
access Annual Meeting materials, your proxy card, or the voting instructions that accompanied your proxy materials. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Items of Business</B></FONT><FONT SIZE=2>&#151;At the meeting, we will conduct the following business, as more fully described in the Proxy Statement accompanying this Notice of
Annual Meeting: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>1.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Elect
the seven directors named in the Proxy Statement;
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>2.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Ratify
the selection of KPMG&nbsp;LLP as our independent registered public accounting firm for the Fiscal Year 2019;
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>3.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Conduct
an advisory vote on our named executive officer compensation, as described in these proxy materials; and
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>4.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Such
other business as may properly come before the meeting or at any postponement or adjournment thereof. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
foregoing items of business are more fully described in the Proxy Statement accompanying this Notice of Annual Meeting. You are entitled to notice of, and eligible to vote at, this
year's Annual Meeting if you were a shareholder of record as of the close of business on March&nbsp;1, 2019. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
accordance with Securities and Exchange Commission rules, we are furnishing these proxy materials and our Annual Report on Form&nbsp;10-K for fiscal 2018 via the Internet. On
March&nbsp;22, 2019, we mailed to shareholders as of the record date a notice with instructions on how to access our Annual Meeting materials and vote via the Internet, or by mail or telephone. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
action on the items of business described above may be considered at the Annual Meeting at the time and on the date specified above or at any time and date to which the Annual
Meeting may be properly adjourned or postponed. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
vote is important to us. Whether or not you plan to participate in the Annual Meeting, we encourage you to review the accompanying proxy statement for information relating to each
of the proposals and to cast your vote promptly. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="50%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>By Order of the Board of Directors,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B>
<IMG SRC="g189424.jpg" ALT="GRAPHIC" WIDTH="123" HEIGHT="52">
 </B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Joshua Foukas<BR></FONT> <FONT SIZE=2><I>Chief Legal Officer, General Counsel<BR>
and Corporate Secretary</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>Salt
Lake City, Utah<BR>
March&nbsp;22, 2019 </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=120929,FOLIO='blank',FILE='DISK126:[19ZAE1.19ZAE15301]BE15301A.;9',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_bg15301_1_2"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A NAME="BG15301A_main_toc"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bg15301_usana_health_sciences,_inc._an__usa02900"> </A>
<BR></FONT><FONT SIZE=2><B>  USANA HEALTH SCIENCES,&nbsp;INC.<BR>  ANNUAL MEETING OF SHAREHOLDERS<BR>  PROXY STATEMENT    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bg15301_table_of_contents"> </A></FONT> <FONT SIZE=2><B>  TABLE OF CONTENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
<A NAME="BG15301_TOC"></A> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#be15301_notice_of_2019_annual_meeting___not02436"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND PROXY STATEMENT</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#be15301_notice_of_2019_annual_meeting___not02436"><FONT SIZE=2>i</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#bg15301_usana_health_sciences,_inc._an__usa02900"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PROXY STATEMENT</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#bg15301_usana_health_sciences,_inc._an__usa02900"><FONT SIZE=2>1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#da15301_summary"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Summary</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da15301_summary"><FONT SIZE=2>1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#da15301_internet_availability_of_proxy_materials"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Internet Availability of Proxy Materials</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da15301_internet_availability_of_proxy_materials"><FONT SIZE=2>1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#da15301_voting_and_quorum,_abstentions_and_broker_non-votes"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Voting and Quorum, Abstentions and Broker
Non-Votes</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da15301_voting_and_quorum,_abstentions_and_broker_non-votes"><FONT SIZE=2>1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#da15301_shareholder_of_record."><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Shareholder of Record</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da15301_shareholder_of_record."><FONT SIZE=2>1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#da15301_beneficial_owner."><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Beneficial Owner</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da15301_beneficial_owner."><FONT SIZE=2>2</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#da15301_quorum."><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Quorum</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da15301_quorum."><FONT SIZE=2>2</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#da15301_broker_non-votes"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Broker Non-Votes</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da15301_broker_non-votes"><FONT SIZE=2>2</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#da15301_shares_held_in_multiple_accounts."><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Shares Held in Multiple Accounts</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da15301_shares_held_in_multiple_accounts."><FONT SIZE=2>2</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#da15301_election_of_directors."><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Election of Directors</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da15301_election_of_directors."><FONT SIZE=2>2</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#Rat"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Ratification of Selection of Independent Registered Public Accounting Firm</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#Rat"><FONT SIZE=2>3</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#App"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Approval of Executive Compensation</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#App"><FONT SIZE=2>3</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DA1"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Revocation and Voting of Proxies</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DA1"><FONT SIZE=2>3</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DA2"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Proxy Solicitations</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DA2"><FONT SIZE=2>4</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DA3"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Attending the Virtual Annual Meeting</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DA3"><FONT SIZE=2>4</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DA4"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Voting Results</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DA4"><FONT SIZE=2>4</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DA5"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PROPOSAL #1&#151;ELECTION OF DIRECTORS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DA5"><FONT SIZE=2>4</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DA6"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Director Nominees</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DA6"><FONT SIZE=2>5</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#REC"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>RECOMMENDATION OF THE BOARD OF DIRECTORS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#REC"><FONT SIZE=2>7</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DA7"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DA7"><FONT SIZE=2>7</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DA8"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Independent Directors</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DA8"><FONT SIZE=2>7</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC1"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Communicating with the Board of Directors</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC1"><FONT SIZE=2>8</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC2"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Principles of Corporate Governance</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC2"><FONT SIZE=2>8</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC3"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Stock Ownership Requirements</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC3"><FONT SIZE=2>8</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC4"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Lead Independent Director</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC4"><FONT SIZE=2>8</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC5"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Separation of Chairman and Chief Executive Officer Roles</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC5"><FONT SIZE=2>9</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC6"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Executive Sessions of Independent Directors</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC6"><FONT SIZE=2>9</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC7"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Prohibition Against Pledging USANA Securities and Hedging Transactions</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC7"><FONT SIZE=2>9</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC8"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Code of Ethics</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC8"><FONT SIZE=2>9</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC9"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Corporate Governance Guidelines</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC9"><FONT SIZE=2>10</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC10"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Committees of the Board of Directors</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC10"><FONT SIZE=2>10</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC11"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Annual Assessment of Board Effectiveness</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC11"><FONT SIZE=2>10</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC12"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Plurality Plus Voting for Directors; Director Resignation Policy</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC12"><FONT SIZE=2>10</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC13"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Term Limits and Mandatory Retirement Age</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC13"><FONT SIZE=2>10</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC14"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Risk Oversight and Management</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC14"><FONT SIZE=2>11</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC15"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Audit Committee</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC15"><FONT SIZE=2>11</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC16"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Committee</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC16"><FONT SIZE=2>11</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC17"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Governance, Risk&nbsp;&amp; Nominating Committee</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC17"><FONT SIZE=2>12</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC18"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Composition and Meetings of the Board of Directors and its Committees</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC18"><FONT SIZE=2>12</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC19"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Audit Committee</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC19"><FONT SIZE=2>12</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC20"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Governance, Risk&nbsp;&amp; Nominating Committee</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC20"><FONT SIZE=2>13</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC21"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Committee</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC21"><FONT SIZE=2>13</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC22"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC22"><FONT SIZE=2>14</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC23"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DIRECTOR COMPENSATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC23"><FONT SIZE=2>14</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC24"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Fiscal Year 2018 Director Compensation</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC24"><FONT SIZE=2>14</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC25"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Cash Compensation</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC25"><FONT SIZE=2>15</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>ii</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=4,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=384675,FOLIO='ii',FILE='DISK126:[19ZAE1.19ZAE15301]BG15301A.;18',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_bg15301_1_3"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC26"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Equity Compensation</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC26"><FONT SIZE=2>15</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DC27"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Director Compensation Table</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DC27"><FONT SIZE=2>15</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#Pr2"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PROPOSAL #2&#151;RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#Pr2"><FONT SIZE=2>16</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc15301_independence"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Independence</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc15301_independence"><FONT SIZE=2>16</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc15301_audit_fees"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Audit Fees</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc15301_audit_fees"><FONT SIZE=2>17</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc15301_policy_on_pre-approval_of_audi__pol02605"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Policy on Pre-Approval of Audit and Permissible Non-Audit
Services</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc15301_policy_on_pre-approval_of_audi__pol02605"><FONT SIZE=2>17</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc15301_recommendation_of_the_board_of_directors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>RECOMMENDATION OF THE BOARD OF DIRECTORS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc15301_recommendation_of_the_board_of_directors"><FONT SIZE=2>18</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_report_of_the_audit_committee"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>REPORT OF THE AUDIT COMMITTEE</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_report_of_the_audit_committee"><FONT SIZE=2>19</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_security_ownership_of_certain___sec02525"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_security_ownership_of_certain___sec02525"><FONT SIZE=2>20</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_section_16(a)_benefici__de102018"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SECTION&nbsp;16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_section_16(a)_benefici__de102018"><FONT SIZE=2>22</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_certain_relationships_and_related_party_transactions"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_certain_relationships_and_related_party_transactions"><FONT SIZE=2>22</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_policies_and_procedure__de102492"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Policies and Procedures Regarding Related Party Transactions</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_policies_and_procedure__de102492"><FONT SIZE=2>22</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_related_party_transactions"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Related Party Transactions</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_related_party_transactions"><FONT SIZE=2>23</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_executive_officers"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXECUTIVE OFFICERS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_executive_officers"><FONT SIZE=2>24</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_executive_compensation"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXECUTIVE COMPENSATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_executive_compensation"><FONT SIZE=2>26</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_compensation_discussion_and_analysis"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Discussion and Analysis</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_compensation_discussion_and_analysis"><FONT SIZE=2>26</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_introduction_and_executive_summary"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Introduction and Executive Summary</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_introduction_and_executive_summary"><FONT SIZE=2>26</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_executive_summary"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Executive Summary</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_executive_summary"><FONT SIZE=2>26</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_summary_of_2018_accomplishments"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Summary of 2018 Accomplishments</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_summary_of_2018_accomplishments"><FONT SIZE=2>26</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_compensation_philosophy_and_objectives"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Philosophy and Objectives</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_compensation_philosophy_and_objectives"><FONT SIZE=2>27</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de15301_overview_of_components__de102397"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Overview of Components of Executive Compensation Program</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de15301_overview_of_components__de102397"><FONT SIZE=2>27</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_role_of_compensation_committee"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Role of Compensation Committee</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_role_of_compensation_committee"><FONT SIZE=2>28</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_role_of_corporate_management_i__rol02639"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Role of Corporate Management in Assisting Compensation
Committee</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_role_of_corporate_management_i__rol02639"><FONT SIZE=2>28</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_compensation_consultant"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Consultant</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_compensation_consultant"><FONT SIZE=2>28</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_peer_group"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Peer Group</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_peer_group"><FONT SIZE=2>29</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_compensation_risk_assessment"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Risk Assessment</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_compensation_risk_assessment"><FONT SIZE=2>29</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_components_of_compensation"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Components of Compensation</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_components_of_compensation"><FONT SIZE=2>30</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_base_salary"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Base Salary</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_base_salary"><FONT SIZE=2>30</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_short-term_cash_incentive_(non__sho02523"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Short-Term Cash Incentive (Non-Equity Incentive Plan Compensation)
</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_short-term_cash_incentive_(non__sho02523"><FONT SIZE=2>30</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_equity_compensation"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Equity Compensation</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_equity_compensation"><FONT SIZE=2>31</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_other_compensation"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Other Compensation</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_other_compensation"><FONT SIZE=2>32</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_accounting_considerations_and___acc03014"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Accounting Considerations and Tax Deductibility of Executive
Compensation</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_accounting_considerations_and___acc03014"><FONT SIZE=2>33</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg15301_report_of_the_compensation_committee"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>REPORT OF THE COMPENSATION COMMITTEE</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg15301_report_of_the_compensation_committee"><FONT SIZE=2>33</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#di15301_summary_compensation_table"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SUMMARY COMPENSATION TABLE</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#di15301_summary_compensation_table"><FONT SIZE=2>34</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#di15301_fiscal_year_2018_ceo_pay_ratio"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>FISCAL YEAR 2018 CEO PAY RATIO</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#di15301_fiscal_year_2018_ceo_pay_ratio"><FONT SIZE=2>35</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DI1"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>GRANTS OF PLAN-BASED AWARDS FOR 2018</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DI1"><FONT SIZE=2>36</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DI1"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Grants of Plan-Based Awards Table</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DI1"><FONT SIZE=2>36</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DK1"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DK1"><FONT SIZE=2>37</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#DK2"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Outstanding Equity Awards at Fiscal Year-End Table</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#DK2"><FONT SIZE=2>37</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk15301_option_exercises_and_stock_vested"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OPTION EXERCISES AND STOCK VESTED</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk15301_option_exercises_and_stock_vested"><FONT SIZE=2>38</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk15301_equity_compensation_plan_information"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EQUITY COMPENSATION PLAN INFORMATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk15301_equity_compensation_plan_information"><FONT SIZE=2>39</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk15301_employment_contracts_and_other_arrangements"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EMPLOYMENT CONTRACTS AND OTHER ARRANGEMENTS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk15301_employment_contracts_and_other_arrangements"><FONT SIZE=2>39</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk15301_proposal_#3_#151;annual_adviso__pro03890"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PROPOSAL #3 ANNUAL ADVISORY "SAY ON PAY" VOTE TO APPROVE OUR NAMED EXECUTIVE
OFFICERS' COMPENSATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk15301_proposal_#3_#151;annual_adviso__pro03890"><FONT SIZE=2>39</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk15301_recommendation_of_the_board_of_directors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>RECOMMENDATION OF THE BOARD OF DIRECTORS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk15301_recommendation_of_the_board_of_directors"><FONT SIZE=2>40</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk15301_shareholder_proposals_for_2020__sha02268"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SHAREHOLDER PROPOSALS FOR 2020 ANNUAL MEETING OF SHAREHOLDERS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk15301_shareholder_proposals_for_2020__sha02268"><FONT SIZE=2>40</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk15301_other_business"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OTHER BUSINESS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk15301_other_business"><FONT SIZE=2>40</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk15301_annual_report_on_form_10-k"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>ANNUAL REPORT ON FORM 10-K</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk15301_annual_report_on_form_10-k"><FONT SIZE=2>41</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk15301_electronic_delivery_of__dk102361"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>ELECTRONIC DELIVERY OF FUTURE SHAREHOLDER COMMUNICATIONS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk15301_electronic_delivery_of__dk102361"><FONT SIZE=2>41</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk15301_householding_of_annual_meeting_materials"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>HOUSEHOLDING OF ANNUAL MEETING MATERIALS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk15301_householding_of_annual_meeting_materials"><FONT SIZE=2>42</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>iii</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=5,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=814480,FOLIO='iii',FILE='DISK126:[19ZAE1.19ZAE15301]BG15301A.;18',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><B>PROXY STATEMENT<BR>  </B></FONT><FONT SIZE=2><B>For the Annual Meeting of Shareholders<BR>
To be held on Wednesday, May&nbsp;1, 2019  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B> <A NAME="da15301_summary"> </A>
<A NAME="toc_da15301_1"> </A>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Summary    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This proxy statement is furnished in connection with the solicitation of proxies by the Board of Directors (the "Board") of USANA Health
Sciences,&nbsp;Inc. for our Annual Meeting of Shareholders to be held via live webcast on Wednesday, May&nbsp;1, 2019, at 11:00&nbsp;a.m. (Mountain Daylight Time), and any adjournment or
postponement thereof (the "Annual Meeting"). The virtual Annual Meeting can be accessed by visiting </FONT><FONT SIZE=2><I>www.virtualshareholdermeeting.com/USNA2019</I></FONT><FONT SIZE=2>, where
you will be able to listen to the meeting live, submit questions, and vote online. In this document, the words "USANA," the "Company," "we," "our," "ours," and "us" refer only to USANA Health
Sciences,&nbsp;Inc., and not any other person. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whether
or not you plan to participate in the virtual annual meeting online, we encourage you to vote promptly. A person giving a proxy has the power to revoke it. If you attend the
virtual annual meeting, you may revoke your proxy and vote via the virtual meeting website. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="da15301_internet_availability_of_proxy_materials"> </A>
<A NAME="toc_da15301_2"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Internet Availability of Proxy Materials    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are taking advantage of Securities and Exchange Commission ("SEC") rules that allow us to deliver proxy materials to our shareholders on the
Internet. Under these rules, on March&nbsp;22, 2019, we mailed our shareholders a Notice of Internet Availability of Proxy Materials containing instructions on how to access our proxy materials,
including this Proxy Statement and our Annual Report on Form&nbsp;10-K for the Fiscal Year ended December&nbsp;29, 2018 ("Fiscal Year 2018"). The Notice of Internet Availability of Proxy Materials
also provides instructions on how to vote over the Internet, by mail or by telephone. If you received a Notice of Internet Availability of Proxy Materials by mail, you will not receive a printed copy
of the proxy materials unless you specifically request these materials. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Internet
distribution of proxy materials helps us expedite receipt of the materials by shareholders, lower the cost of our Annual Meeting, and reduce the environmental impact of our
Annual Meeting. However, if you received a Notice of Internet Availability of Proxy Materials by mail and would like to receive a printed copy of the proxy materials, please follow the instructions
for requesting those materials contained in the Notice of Internet Availability of Proxy Materials. If you have previously elected to receive our proxy materials electronically, you will continue to
receive these materials via e-mail unless you elect otherwise. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="da15301_voting_and_quorum,_abstentions_and_broker_non-votes"> </A>
<A NAME="toc_da15301_3"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Voting and Quorum, Abstentions and Broker Non-Votes    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Only holders of record ("shareholders") of our common stock at the close of business on March&nbsp;1, 2019 (the "Record Date") are entitled to
notice of and to vote at the Annual Meeting. On the Record Date, there were 23,324,485 shares of our common stock outstanding. Common stock is our only class of voting stock. You may vote all shares
owned by you as of the Record Date, including (i)&nbsp;shares held directly by you in your name as the shareholder of record, and (ii)&nbsp;shares held for you as the beneficial owner in street
name through a broker, bank, trustee, or other nominee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="da15301_shareholder_of_record."> </A>
<A NAME="toc_da15301_4"> </A>
<BR></FONT><FONT SIZE=2><B><I>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholder of Record. </I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;If, on the Record Date, your shares were registered directly in your name with our transfer
agent, American Stock Transfer&nbsp;&amp; Trust Company,&nbsp;LLC,
then you are considered the shareholder of record with respect to those shares. As a shareholder of record, you are entitled to vote in any one of the following
ways:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> By Internet or by telephone. Follow the instructions included in the one-page Notice of Internet Availability of Proxy Materials or, if you
received printed materials, in the proxy card, to vote by Internet or telephone. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> By mail. If you received your proxy materials by mail, you can vote by mail by completing, signing, dating and returning the proxy card as
instructed on the card. If you sign the proxy card </FONT></DD></DL>
</UL>
<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=6,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=1010729,FOLIO='blank',FILE='DISK126:[19ZAE1.19ZAE15301]DA15301A.;8',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_da15301_1_2"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>but
do not specify how you want your shares voted, they will be voted in accordance with the Board's recommendations as noted below. </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Online at the Annual Meeting. Shareholders who choose to attend the virtual Annual Meeting can vote via the virtual meeting website by visiting </FONT> <FONT
SIZE=2><I>www.virtualshareholdermeeting.com/USNA2019</I></FONT><FONT SIZE=2>. You will need the 16-digit control number included on your Notice of Internet Availability of proxy
materials in order to participate in the virtual Annual Meeting. Instructions on how to attend and participate via the Internet, including how to demonstrate proof of stock ownership, are posted at
www.proxyvote.com. Even if you plan to participate in the Annual Meeting online, we recommend that you also vote by proxy as described below so that your vote will be counted if you later decide not
to participate in the virtual Annual Meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><A NAME="da15301_beneficial_owner."> </A>
<A NAME="toc_da15301_5"> </A>
<BR></FONT><FONT SIZE=2><B><I>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beneficial Owner. </I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;If, on the Record Date, your shares were held in an account with a brokerage firm, bank, or other
nominee, then you are the beneficial owner of the shares held in
street name. As a beneficial owner, you have the right to direct your nominee on how to vote the shares held in your account, and your nominee has enclosed or provided voting instructions for you to
use in directing it on how to vote your shares. However, the organization that holds your shares is considered the shareholder of record for purposes of voting at the Annual Meeting. Because you are
not the shareholder of record, you may not vote your shares at the virtual Annual Meeting unless you request and obtain a valid proxy from the organization that holds your shares giving you the right
to vote the shares at the Annual Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="da15301_quorum."> </A>
<A NAME="toc_da15301_6"> </A>
<BR></FONT><FONT SIZE=2><B><I>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Quorum. </I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Each share of common stock is entitled to one vote on all matters on which shareholders may vote. There is no
cumulative voting in the election of directors or
any other matter. A majority of our shares of common stock outstanding as of the Record Date must be present at the Annual Meeting in order to hold the meeting and conduct business. This is called a
"quorum." Shares of common stock held of record by shareholders in attendance online at the Annual Meeting or represented by a properly executed and returned proxy will be treated as present at the
Annual Meeting for purposes of determining the presence of a quorum, without regard to whether the proxy is marked as casting a vote or withholding authority or abstaining with respect to a particular
matter. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="da15301_broker_non-votes"> </A>
<A NAME="toc_da15301_7"> </A>
<BR></FONT><FONT SIZE=2><B><I>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Broker Non-Votes </I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;When shares held by a broker for a beneficial owner are not voted because (i)&nbsp;the broker did not
receive voting instructions from the beneficial owner, or
(ii)&nbsp;the broker lacked discretionary authority to vote the shares a broker non-vote occurs. Under New York Stock Exchange ("NYSE") rules, a broker is entitled to vote shares held for a
beneficial owner on "routine" matters without instructions from the beneficial owner of those shares. On the other hand, absent instructions from the beneficial owner of such shares, a broker is not
entitled to vote shares held for a beneficial owner on "non-routine" matters. Accordingly, we encourage you to provide voting instructions to your broker, whether or not you plan to attend the virtual
Annual Meeting. All of the proposals presented at the Annual Meeting, other than the ratification of KPMG&nbsp;LLP as our independent registered public accounting firm for the Fiscal Year 2019, are
non-routine matters. Broker non-votes and abstentions are counted for purposes of determining whether a quorum is present. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="da15301_shares_held_in_multiple_accounts."> </A>
<A NAME="toc_da15301_8"> </A>
<BR></FONT><FONT SIZE=2><B><I>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares Held in Multiple Accounts. </I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;If your shares are held in more than one account, you will receive a Notice of
Internet Availability of Proxy Materials or separate voting instructions for each
account. To ensure that all of your shares in each account are voted at the Annual Meeting, you must vote in accordance with the Notice of Internet Availability of Proxy Materials or the separate
voting instructions that you receive for each account. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="da15301_election_of_directors."> </A>
<A NAME="toc_da15301_9"> </A>
<BR></FONT><FONT SIZE=2><B><I>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Election of Directors. </I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Shares may be voted "FOR" or "WITHHOLD" in the election for directors. Directors will be
elected by a plurality of the votes cast. This means that the nominees
with the most "FOR" votes will be elected. A "WITHHOLD" vote will have no effect on the election's outcome, because the candidates who receive the highest number of "FOR" votes are elected, and when </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=7,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=395274,FOLIO='2',FILE='DISK126:[19ZAE1.19ZAE15301]DA15301A.;8',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_da15301_1_3"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>candidates
run unopposed they only need a single "FOR" vote to be elected. However, because of a new provision added by our Second Amended and Restated Bylaws, adopted by the Board in March 2019 (the
"Amended and Restated Bylaws"), "WITHHOLD" votes may still have an effect on individual director nominees. Under this new provision, an incumbent director nominee elected in an uncontested election
(i.e.,&nbsp;an election in which the number of nominees is equal to the number of directors to be elected at the meeting) who receives a greater number of "WITHHOLD" votes than
"FOR" votes at the Annual Meeting, must tender his or her resignation to the Board. The remaining Board members will then determine whether to accept the resignation and publicly disclose its decision
following the date they make their decision. See "Plurality Plus Voting for Directors; Director Resignation Policy" in the section "Board of Directors and Corporate Governance," below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A NAME="Rat"></A>Ratification of Selection of Independent Registered Public Accounting Firm.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Ratification of the selection of
KPMG&nbsp;LLP as our independent registered public accounting firm requires the affirmative vote of the majority of the votes cast (meaning the number of shares voted "FOR" the proposal must exceed
the number of shares voted "against" such proposal). On this proposal you may vote "FOR," "AGAINST" or "ABSTAIN." Abstentions and broker non-votes are not considered votes cast for the foregoing
purpose, and will have no effect on the vote for this proposal. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A NAME="App"></A>Approval of Executive Compensation.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The approval of this proposal requires the affirmative vote of the
majority of the
votes cast (meaning the number of shares voted "FOR" the proposal must exceed the number of shares voted "AGAINST" such proposal). On this proposal you may vote "FOR," "AGAINST" or "ABSTAIN."
Abstentions and broker non-votes will have no effect on the vote's outcome on this proposal. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DA1"></A>Revocation and Voting of Proxies  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you give your proxy pursuant to this solicitation, you may revoke it at any time prior to the Annual Meeting. You may revoke a previously
provided proxy by: (i)&nbsp;delivering to our Corporate Secretary a written revocation of proxy; (ii)&nbsp;executing a new proxy that bears a later date; or (iii)&nbsp;attending the Annual
Meeting and voting your shares online at the Annual Meeting. Attendance at the virtual Annual Meeting online will not, by itself, result in revoking a proxy. You should also be aware that if you are a
beneficial owner, meaning that your shares of USANA common stock are held of record in an account by a broker, bank, trustee, or other nominee, and you wish to revoke a proxy or change your vote, you
must contact the broker, bank, trustee, or other nominee to revoke any prior voting instructions and provide new voting instructions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
valid, unrevoked proxies will be voted in accordance with the specifications in the proxies and as directed. If a proxy is properly executed and returned and no voting specifications
are indicated therein, the shares will be voted as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B>FOR</B></FONT><FONT SIZE=2> each of the seven nominees for director named in this Proxy Statement, to serve for a term
of one year or until their respective successors are elected and qualified; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B>FOR</B></FONT><FONT SIZE=2> the proposal to ratify the appointment of KPMG&nbsp;LLP as our independent registered
public accounting firm for Fiscal Year 2019; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B>FOR</B></FONT><FONT SIZE=2> the non-binding advisory resolution to approve the compensation of our named executive
officers, as disclosed in this Proxy Statement pursuant to Item&nbsp;402 of Regulation&nbsp;S-K, including the Compensation Discussion and Analysis, compensation tables, and related narrative
discussion. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
respect to such other matters as may properly come before the Annual Meeting, votes will be cast in the discretion of the appointed proxies. We are not aware of any other matters
that are to be presented for action at the Annual Meeting. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=8,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=904028,FOLIO='3',FILE='DISK126:[19ZAE1.19ZAE15301]DA15301A.;8',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_da15301_1_4"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DA2"></A>Proxy Solicitation  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are making this proxy solicitation both through the mail and Internet, although proxies may be solicited by personal interview, telephone,
facsimile, letter, e-mail or otherwise. Certain of our directors, officers and other employees, without additional compensation, may participate in the solicitation of proxies. We will pay the cost of
this solicitation, including the reasonable charges and expenses of brokerage firms and others who forward solicitation materials to beneficial owners of the common stock. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DA3"></A>Attending the Virtual Annual Meeting  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholders as of the Record Date are invited to attend the virtual Annual Meeting by visiting </FONT> <FONT SIZE=2><I>www.virtualshareholdermeeting.com/USNA2019</I></FONT><FONT
SIZE=2>. To participate in the Annual Meeting, you will need the 16-digit control number included on your Notice of
Internet Availability of the proxy materials. The Annual Meeting will begin promptly at 11:00&nbsp;a.m. (Mountain Daylight Time). Online check-in will begin at 10:55&nbsp;a.m., (Mountain Daylight
Time), and you should allow sufficient time for the online check-in procedures. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DA4"></A>Voting Results  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Voting results will be tabulated and certified by the inspector of elections appointed for the Annual Meeting. The preliminary voting results
will be announced at the Annual Meeting. The final results will be tallied by the inspector of elections and filed with the SEC in a current report on Form&nbsp;8-K within four business days of the
Annual Meeting. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="DA5"></A>PROPOSAL #1&#151;ELECTION OF DIRECTORS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It is proposed that we elect seven directors to serve one-year terms until the annual meeting of shareholders in 2020, or until their successors
shall have been duly elected and qualified. The nominees for director are listed in this Proxy Statement. As of the date of this Proxy Statement, our Board consists of eight directors. However, one of
our directors, J. Scott Nixon, has accepted a three-year voluntary leadership assignment in Brazil for The Church of Jesus Christ of Latter-day Saints and has informed the Board that he will therefore
not stand for reelection at the Annual Meeting. The Board and management extend their gratitude to Mr.&nbsp;Nixon for his service on the Board and to USANA. The Board intends to continue its ongoing
review of its composition and expects to add a new independent director in the near future. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
may not give a proxy to vote for more than the number of nominees (seven). Unless a proxy otherwise specifies, the shares voted by such a proxy will be voted "FOR" the election of
each of the seven nominees listed below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of the seven nominees listed below is currently a director and member of our Board. Six of the incumbent directors nominated for reelection were elected by the shareholders at our
2018 annual meeting. In December 2018, the Board appointed Ms.&nbsp;Peggie Pelosi as a director and member of our Board, on the recommendation of the Governance, Risk&nbsp;&amp; Nominating Committee
of the Board. Each of the nominees listed has agreed to serve if elected, and we know of no reason why any of the nominees would not be available for election or, if elected, would not be able to
serve. If any nominee is unable to serve or for good cause will not serve as a nominee at the time of the Annual Meeting, the persons named as proxies may vote for a substitute nominee designated by
the Board to fill the vacancy. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Governance, Risk&nbsp;&amp; Nominating Committee has determined that each nominee for election at the Annual Meeting meets the criteria set forth in its charter and in the USANA
Corporate Governance Guidelines. Those guidelines direct the Committee to consider criteria such as the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=9,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=923662,FOLIO='4',FILE='DISK126:[19ZAE1.19ZAE15301]DA15301A.;8',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_da15301_1_5"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>nominee's
independence, expertise, and experience applicable to our business, substantive knowledge of our industry, high personal and professional ethics, and their ability and willingness to devote
the required time to the business of the Board and the Company. In addition, we believe that each nominee possesses the personal qualities and attributes we consider to be essential to allow the Board
to fulfill its duties to our shareholders, including personal accountability, integrity, ethical leadership, and business acumen, and the ability to exercise sound and independent business judgment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DA6"></A>Director Nominees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Information for each person nominated for election as a director at the Annual Meeting, including age, term of office and business experience,
including directorships during the past five years, is set forth below. In addition, for each person, we have included information regarding the business or other experience, qualifications,
attributes or skills that factored into the determination by the Governance, Risk&nbsp;&amp; Nominating Committee and by our Board of Directors that each of them should serve as a director of USANA. The
nominees for director are Robert Anciaux, Gilbert A. Fuller, Kevin Guest, Peggie Pelosi, Feng Peng, Myron W. Wentz, Ph.D., and Frederic Winssinger. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Robert Anciaux</B></FONT><FONT SIZE=2><B><I>,</I></B></FONT><FONT SIZE=2> 73, Director, Mr.&nbsp;Anciaux has served as a director of USANA since July 1996. Since 1990, he
has been the Managing Director of S.E.I. s.a., a consulting and investment management firm in Brussels, Belgium. Additionally, since 1982, Mr.&nbsp;Anciaux has been self-employed as a venture
capitalist in Europe, investing in various commercial, industrial, and real estate venture companies. In
some of these privately held companies, Mr.&nbsp;Anciaux also serves as a director. Mr.&nbsp;Anciaux received an Ingenieur Commercial degree from Ecole de Commerce Solvay Universite Libre de
Bruxelles. We believe that Mr.&nbsp;Anciaux's financial expertise and experience in providing consulting and strategic advisory services to complex organizations, and his extensive experience and
familiarity with the business of the Company qualify him to serve on our Board. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Gilbert A. Fuller,</B></FONT><FONT SIZE=2> 78, Independent Director, Audit Committee Chairman and Governance, Risk&nbsp;&amp; Nominating Committee member.
Mr.&nbsp;Fuller has served as a director of USANA since September 2008. Prior to that, he served as our Executive Vice President, Chief Financial Officer, and Secretary since January 2006.
Mr.&nbsp;Fuller joined USANA in May 1996, as the Vice President of Finance and served in this role until June 1999, when he was appointed as the Company's Senior Vice President. Before joining
USANA, Mr.&nbsp;Fuller served in various executive positions for several companies. Mr.&nbsp;Fuller served as Chief Administrative Officer and Treasurer of Melaleuca,&nbsp;Inc., a manufacturer,
and direct seller of personal care products. He was also the Vice President and Treasurer of Norton Company, a multinational manufacturer of ceramics and abrasives. He obtained his certified public
accountant license in 1970 and kept it current until his career path developed into corporate finance. Mr.&nbsp;Fuller received a B.S. in Accounting and an M.B.A. from the University of Utah. In
December 2012, Mr.&nbsp;Fuller was appointed as a director of Security National Financial Corporation, a NASDAQ-listed company. We believe that Mr.&nbsp;Fuller's more than 12&nbsp;years of
experience as an executive officer of USANA, his deep understanding of our business, people and products, his 15&nbsp;years of experience as a financial officer in the direct selling industry, as
well as his accounting, finance and corporate strategy expertise qualify Mr.&nbsp;Fuller to serve on our Board of Directors. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Kevin Guest,</B></FONT><FONT SIZE=2> 56, Chief Executive Officer. Mr.&nbsp;Guest joined USANA on a part-time basis in April 2003, as Executive Director of Media
and Events. Following our acquisition of the media, video, and event-productions company, FMG Productions founded by Mr.&nbsp;Guest, he became a full-time employee of the Company and he was promoted
to Vice President of Media and Events in February 2004. In January 2006, he was appointed Executive Vice President of Marketing and served in that role until July 2008, when he was appointed Chief
Marketing Officer. Mr.&nbsp;Guest served in this role until May 2011, when he was appointed President of North America. In October 2012, he was appointed President of the Americas, Europe and South
Pacific. In August 2014, Mr.&nbsp;Guest was appointed President of USANA and served in this role until August 2015, when he was appointed Co-Chief </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=10,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=359997,FOLIO='5',FILE='DISK126:[19ZAE1.19ZAE15301]DA15301A.;8',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_da15301_1_6"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Executive
Officer. He served in this role until November 2016 when he was appointed Chief Executive Officer. Mr.&nbsp;Guest earned a B.A. in Communications from Brigham Young University.
Mr.&nbsp;Guest's important role as the leading force of our management and sales efforts and his talent as a motivating leader qualify him to serve as a member of the Board. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Peggie Pelosi</B></FONT><FONT SIZE=2>, 64, Independent Director. Ms.&nbsp;Pelosi is a corporate social responsibility/sustainability practitioner. Since 2005,
Ms.&nbsp;Pelosi has been the Founding Partner and Strategic Advisor at Orenda
Connections, a corporate social responsibility consultancy in Toronto, Ontario, Canada. She is also an Instructor in the Certificate Program in Corporate Social Responsibility at the University of
St.&nbsp;Michael's College in the University of Toronto, and a part-time Professor in Sustainable Business Management Post Graduate Studies at Seneca College, Faculty of Business in Toronto. Since
2015, she has also served as the Executive Director of Innovators Alliance, a network of CEOs focused on sustainable and profitable growth through innovation. Prior to her career and academic work in
corporate social responsibility and sustainability, Ms.&nbsp;Pelosi served as a member of the Company's management team, first as Executive Director of Sales for Canada and then as Vice President of
Network Development. She worked for the Company until 2004. While at the Company, Ms.&nbsp;Pelosi began the program that would evolve into the USANA True Health Foundation, and this led to her
interest in corporate social responsibility. Prior to her roles at the Company, Ms.&nbsp;Pelosi had 15&nbsp;years of direct selling leadership experience. Ms.&nbsp;Pelosi has also previously
served on the Board of Directors of a number on non-profit organizations including the Children's Hunger Fund and Big Brothers Big Sisters of Toronto. She is a graduate of the Corporate Social
Responsibility&nbsp;&amp; Sustainability Program at St.&nbsp;Michael's College at the University of Toronto. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Feng Peng,</B></FONT><FONT SIZE=2> 45, Independent Director, Audit Committee, Compensation Committee and Governance, Risk&nbsp;&amp; Nominating Committee member.
Mr.&nbsp;Peng was elected to the Board in May 2016. Mr.&nbsp;Peng has served as a Partner and Portfolio Manager at Linden Rose Investment since January 2017. From March 2013 to December 2016,
Mr.&nbsp;Peng served as Chief Financial Officer of Ossen Innovation&nbsp;Co.,&nbsp;Ltd. (NASDAQ:OSN), a China-based manufacturing company. Prior to that, Mr.&nbsp;Peng served as Senior Vice
President at MZ Group from August 2007 until September 2012 where he was responsible for providing strategic consulting services related to U.S. capital markets to Chinese clients. At MZ Group,
Mr.&nbsp;Peng conducted extensive financial and industry due diligence, performed analysis on companies' financials, and provided management teams of client companies with extensive coaching,
including detailed intelligence on investor expectations, perceptions and concerns, industry analysis, compliance, and reporting and disclosure requirements. Prior to working at MZ Group, he served in
various capacities at Thomson Financial and Citigroup. Mr.&nbsp;Peng has been trained in both finance and accounting. He received a Master of Science in Computer Science from the New Jersey
Institute of Technology. He also received a bachelor's degree in Automation Control from Shanghai Jiao Tong University in Shanghai, China in 1995. Mr.&nbsp;Peng is a certified Senior International
Finance Manager (SIFM) in China. Mr.&nbsp;Peng's qualifications to sit on our Board include his extensive business experience in China, as well as his financial and corporate strategy experience. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Myron W. Wentz, Ph.D.,</B></FONT><FONT SIZE=2> 78, Founder and Chairman of the Board. Dr.&nbsp;Wentz founded USANA in 1992 and served as the Chief Executive
Officer and Chairman of the Board from 1992 to July 2008, when he retired as Chief Executive Officer. In 1974, Dr.&nbsp;Wentz founded Gull Laboratories,&nbsp;Inc., which was a developer and
manufacturer of medical diagnostic test kits and was the former parent corporation of USANA. Dr.&nbsp;Wentz was Chairman of Gull from 1974 until 1998. In 1998, Dr.&nbsp;Wentz founded
Sanoviv,&nbsp;S.A. de C.V. ("Sanoviv"), a holistic integrative medical center and hospital located near Rosarito, Mexico. Joining a pathology group in Peoria, Illinois, from 1969 to 1973,
Dr.&nbsp;Wentz served as infectious disease specialist and directed the microbiology and immunology laboratories for three hospitals in the Peoria area. He received a B.S. in Biology from North
Central College, Naperville, Illinois, an M.S. in Microbiology from the University of North Dakota, and a Ph.D. in Microbiology and Immunology from the University of Utah. Dr.&nbsp;Wentz is our
largest shareholder, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=11,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=60843,FOLIO='6',FILE='DISK126:[19ZAE1.19ZAE15301]DA15301A.;8',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_da15301_1_7"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>founder,
and the visionary force behind the science and mission of USANA. His vast education and professional experience as a microbiologist, immunologist, and pioneer in the development of human cell
culture technology, as well as his service as our Chairman and former Chief Executive Officer, uniquely qualify him to serve as a member of our Board and as our Chairman. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Frederic J. Winssinger,</B></FONT><FONT SIZE=2> 50, Independent Director, Audit Committee, Compensation Committee and Governance, Risk&nbsp;&amp; Nominating
Committee member. Mr.&nbsp;Winssinger became a director in May 2016. Mr.&nbsp;Winssinger has been a Managing Partner of RW Partners&nbsp;LLC (RWP) since 2006. RWP is a commercial real estate
private equity investment company based in Phoenix, Arizona. Mr.&nbsp;Winssinger also oversees his family's general investment operations and in 2014, he co-founded PlanninCore Wealth Advisors to
provide investment advice to individuals and families. Prior to 2006, Mr.&nbsp;Winssinger worked in strategy consulting for the Boston Consulting Group and as a Portfolio Manager/Financial Analyst
for JP Morgan Asset Management and other privately held asset management companies. Mr.&nbsp;Winssinger received a B.A. in Mathematics and Economics from Claremont McKenna College and an M.B.A from
The Wharton School of the University of Pennsylvania. Mr.&nbsp;Winssinger's qualifications to sit on our Board include his 20&nbsp;years of experience in financial analysis, and his training in
evaluating corporate strategy towards the creation of shareholder value under sound corporate governance. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="REC"></A>RECOMMENDATION OF THE BOARD OF DIRECTORS  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board unanimously recommends a vote </FONT><FONT SIZE=2><B>FOR</B></FONT><FONT SIZE=2> each director nominee named above. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="DA7"></A>BOARD OF DIRECTORS AND CORPORATE GOVERNANCE  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have adopted a number of policies and practices, some of which we describe in this section of the proxy statement, which highlight our
commitment to sound corporate governance principles. We also maintain a corporate governance page on our website that includes additional related information, as well as our codes of conduct,
principles of corporate governance, and the charters for each of the standing committees of the Board. The "Corporate Governance" page is located on the "Investor Relations" section of our website at </FONT> <FONT
SIZE=2><I>www.usana.com</I></FONT><FONT SIZE=2>. The information contained on the website is not incorporated by reference in, or considered part of, this Proxy Statement.
 </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DA8"></A>Independent Directors  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In accordance with the current listing standards of the NYSE, the Board, on an annual basis, affirmatively determines the independence of each
director or nominee for election as a director. The Board has determined that Mr.&nbsp;Feng, Mr.&nbsp;Fuller, Ms.&nbsp;Pelosi and Mr.&nbsp;Winssinger are "independent directors," using the
definition of that term in the Listed Company Manual of the NYSE. As a result, a majority of the Board, and all of the members of the Audit Committee, Compensation Committee, and Governance,
Risk&nbsp;&amp; Nominating Committee, are independent directors in accordance with the independence requirements of the NYSE and the SEC, including certain additional standards applicable to those
committees. From time to time in this Proxy Statement, we refer to our independent directors and Mr.&nbsp;Anciaux, none of whom is an employee or executive of USANA, as our "non-management
directors" or "non-employee directors." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=12,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=1040818,FOLIO='7',FILE='DISK126:[19ZAE1.19ZAE15301]DA15301A.;8',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_dc15301_1_8"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC1"></A>Communicating with the Board of Directors  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our shareholders or other interested parties wishing to communicate with the Board, the non-management directors as a group, or any individual
director may do so in writing by addressing the correspondence to that individual or group as follows: </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>USANA
Health Sciences,&nbsp;Inc.<BR>
c/o Joshua Foukas, Chief Legal Officer, General Counsel and Corporate Secretary<BR>
3838 West Parkway Boulevard<BR>
Salt Lake City, Utah 84120 </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please
address any communication by e-mail to </FONT><FONT SIZE=2><I>investor.relations@us.usana.com</I></FONT><FONT SIZE=2> and mark "Attention: Corporate Secretary" in the "Subject"
field. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Chief Legal Officer serves as Corporate Secretary and determines, in his discretion, whether the nature of the communication is such that should be brought to the attention of the
Board, a committee, the Lead Independent Director, or all independent directors. Accounting, audit, internal accounting controls, and other financial matters will be referred to the Chair of the Audit
Committee. Other matters will be referred to the non-management directors, or individual directors as appropriate. As a general matter, the Corporate Secretary does not forward spam, junk mail, mass
mailings, job inquiries, surveys, business solicitations, advertisements, or offensive or inappropriate material. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC2"></A>Principles of Corporate Governance  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have summarized below governance practices we have implemented that are intended to enhance and encourage effective independent oversight of
Board decisions. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC3"></A>Stock Ownership Requirements  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have adopted minimum stock ownership requirements for directors and executive officers to align the interests of our executive officers and
non-employee directors with the interests of our shareholders, and to promote our commitment to sound corporate governance. Non-employee directors are expected to hold at least equal to two times
their annual retainer fees in USANA common stock. Unexercised Stock-Settled Stock Appreciation Rights ("SSAR's") (whether or not vested) and unearned and unvested DSU's and RSU's held by an
independent Board member will be considered as stock held in satisfaction of this policy. Non-employee directors have five years from April&nbsp;23, 2018 (the date this policy was adopted) to
achieve compliance with these minimum ownership requirements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
executive officers (including executives who serve as directors) are expected to comply with the following stock ownership guidelines: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="140pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Position

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Ownership Requirement </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Chief Executive Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.5 times base salary</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2>All other executive officers</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2>1 times base salary</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;More
information about the minimum stock ownership requirements applicable to our executives is included in "Compensation Discussion and Analysis." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC4"></A>Lead Independent Director  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because the Board believes that strong, independent board leadership is an important aspect of corporate governance and beneficial to USANA and
our shareholders, the Board has historically designated one of the directors as a Lead Independent Director. The Lead Independent Director is an independent director selected for a one-year term, or
until their successor is chosen, by the other independent directors and is responsible for coordinating the activities of the independent directors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=13,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=798292,FOLIO='8',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dc15301_1_9"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>The
Lead Independent Director presides at executive sessions of the independent directors and at meetings of the Board when the Chair is not present, and is a contact person for shareholders and third
parties who may desire to contact the Board independently of the Chair. Mr.&nbsp;Fuller was Lead Independent Director during Fiscal Year 2018. We believe that Mr.&nbsp;Fuller is an effective Lead
Independent Director due to, among other things, his independence, his leadership experience in executive positions as chief financial officer and executive officer, his strong strategic and financial
acumen, and commitment to ethics, as well as his extensive knowledge and deep understanding of USANA and our business. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC5"></A>Separation of Chairman and Chief Executive Officer Roles  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our corporate guidelines provide that the roles of CEO and Board Chair may be separated or combined. Although the Board does not have a formal
policy on whether the roles of CEO and Chair should be separate, USANA has separately maintained these roles since 2008.&nbsp;Separating the CEO and Board Chair roles allows us to efficiently
develop and implement corporate strategy that is consistent with the Board's oversight role, while facilitating strong day-to-day leadership. Our founder, Dr.&nbsp;Myron Wentz, is the Board Chair
and Kevin Guest is our CEO and reports directly to the Board. The Board believes it is most appropriate to retain the discretion and flexibility to make these determinations at any given point in time
in the way that it believes best to provide appropriate leadership for the Company at that time. The Board believes it is currently appropriate to separate the roles of CEO and Board Chair as a result
of the demands of and differences between each role. Our CEO is responsible for setting the strategic direction for the Company, with guidance from the Board. The CEO is also responsible for the
day-to-day leadership and performance of the Company, while the Board Chair provides guidance to the CEO and sets the agenda for Board meetings and presides over meetings of the full Board. Although
Dr.&nbsp;Wentz is not independent under the rules of the NYSE, the Board believes the experience, leadership and vision he provides as Board Chair are essential to the short-and-long-term success of
the Company. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC6"></A>Executive Sessions of Independent Directors  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In accordance with NYSE listing standards, our independent directors regularly meet in executive session without employee directors or other
executive officers present as part of every regularly scheduled Board and committee meeting. The Lead Independent Director chairs these executive sessions. In the event that the Lead Director cannot
preside at an executive session, the chairs of the Audit Committee, Compensation Committee, or Governance, Risk&nbsp;&amp; Nominating Committee lead these meetings on a rotating basis. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC7"></A>Prohibition Against Pledging USANA Securities and Hedging Transactions  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consistent with our Insider Trading Policy, we prohibit our executive officers and members of the Board from pledging our common stock or other
securities and engaging in hedging transactions with respect to our securities. Our policies specifically prohibit our executive officers and non-employee directors from holding our securities in any
margin account for investment purposes or otherwise using our securities as collateral for a loan. Our policy prohibits the purchasing of certain
instruments (including prepaid variable forward contracts, equity swaps, and collars) and engaging in short sales of our stock and other similar transactions that could be used to hedge or offset any
decrease in the value of our securities. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC8"></A>Code of Ethics  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have adopted a Code of Ethics that applies to all of our directors, officers (including our Chief Executive Officer and Chief Financial
Officer), and employees. We require that all of our directors, officers, and employees certify on an annual basis that they comply with the Code of Ethics. If we </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=14,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=617017,FOLIO='9',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dc15301_1_10"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>make
any amendment to or grant any waivers of, a provision of our Code of Ethics that applies to our principal executive officer, principal financial officer or principal accounting officer, that
would require disclosure under applicable SEC rules, we will disclose such amendment or waiver and the reasons therefor on a Current Report on Form&nbsp;8-K or on our next periodic report filed
under the Securities Exchange Act of 1934, as amended ("Exchange Act"). The Code of Ethics may be found on the "Corporate Governance" page of the "Investor Relations" section of our website at </FONT> <FONT SIZE=2><I>www.usana.com</I></FONT><FONT
SIZE=2>. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC9"></A>Corporate Governance Guidelines  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have also adopted Corporate Governance Guidelines that outline the Company's corporate governance policies and principles. The Corporate
Governance Guidelines may be found on the "Corporate Governance" page of the "Investor Relations" section of our website at </FONT><FONT SIZE=2><I>www.usana.com</I></FONT><FONT SIZE=2>. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC10"></A>Committees of the Board of Directors  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Board has three standing committees: The Audit Committee, the Compensation Committee, and the Governance, Risk&nbsp;&amp; Nominating
Committee. Each committee meets regularly and you may find the written charters for the committees on the "Corporate Governance" page of the "Investor Relations" section of our website at </FONT> <FONT SIZE=2><I>www.usana.com.</I></FONT><FONT SIZE=2>
At each regularly scheduled Board meeting, the Chair or a member of each committee reports on any significant matters addressed by the
committee. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC11"></A>Annual Assessment of Board Effectiveness  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To ensure that our Board and its committees are performing effectively and in the best interests of the Company and its shareholders, the Board
performs an annual assessment of itself, its committees, and its members, overseen by the Governance, Risk&nbsp;&amp; Nominating Committee. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC12"></A>Plurality Plus Voting for Directors; Director Resignation Policy  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Amended and Restated Bylaws contain a "plurality plus" voting standard for the election of directors. Directors are elected by a plurality
of the vote under the Amended and Restated Bylaws. However, the newly adopted "plurality plus" standard provides that in an uncontested election (that is, an election where the number of nominees is
equal to the number of seats open), if an incumbent director standing for reelection is elected but fails to receive more "FOR" votes than "WITHHOLD" votes cast, the director must submit their
resignation to the Board. The Governance, Risk&nbsp;&amp; Nominating Committee shall promptly consider the resignation and recommend to the Board the action to be taken on the offered resignation. The
Board then is required to act on the Committee's recommendation no later than the date of the Board's next regularly scheduled meeting. The director whose resignation is under consideration may not
participate in the recommendation of the Committee or deliberations of the Board with respect to their resignation. Following the Board's decision, we would promptly disclose the decision by filing a
Current Report on Form&nbsp;8-K. If a resignation is accepted, the Governance, Risk&nbsp;&amp; Nominating Committee would also recommend to the Board whether to fill such vacancy immediately, retain
the vacancy for a period, or reduce the size of the Board. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC13"></A>Term Limits and Mandatory Retirement Age  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board has not established a maximum length of service or a mandatory retirement age for directors. The Board believes that the skill set and
perspectives of its members should remain sufficiently current and broad in dealing with current and changing business dynamics, and therefore seeks to maintain a balance of directors with varying
lengths of service and ages. While the Board recognizes that term limits and/or a mandatory retirement age could assist in this regard, they may have the unintended consequence of forcing the Board
and the Company to lose the contribution of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=15,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=16567,FOLIO='10',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dc15301_1_11"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>directors
who over time have developed increased judgment, knowledge, and valuable insight into the Company and its operations. The Board also believes that there are other, more effective means to
address board refreshment, including through a robust annual self-assessment process. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC14"></A>Risk Oversight and Management  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Board is actively involved in the oversight and management of the material risks that could affect the Company. The Board carries out its
risk oversight and management responsibilities by monitoring risk directly as a full board and, where appropriate, through its committees. Effective risk oversight is a priority of the Board. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Board has delegated responsibility for risk management largely to the Audit Committee and the Governance Risk&nbsp;&amp; Nominating Committee. The Audit Committee oversees management
of risk related to our financial, legal and fraud policies. This includes regular evaluation of risks related to our financial statements, internal control over financial reporting, liquidity, capital
structure, and investments, including land acquisition and development. The Governance Risk&nbsp;&amp; Nominating Committee oversees our general risk identification and mitigation process. This includes
regular evaluation of strategic, operational, legal, regulatory, and corporate governance risks. The Board and its committees also receive regular reports from members of senior management on areas of
material risk to the company. While the Board has an oversight role, management has the direct responsibility for management and assessment of risks and the implementation of processes and controls to
mitigate
their effects on the Company. Each standing committee of the Board has the following risk oversight responsibilities and provides regular reports to the Board on at least a quarterly basis: </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC15"></A>Audit Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee oversees the management of the following financial risks:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> accounting matters; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> liquidity and credit risks; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> corporate tax positions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> insurance coverage; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> cash investment strategy; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> financial results. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the committee is responsible for managing risk relating to our financial and business process systems, including the performance of our internal audit function and its
independent registered public accounting firm, whistleblower complaints and internal investigations, systems of internal controls and disclosure controls and procedures. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC16"></A>Compensation Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee oversees the management of the following risks:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> executive compensation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> compensation and benefit plans and arrangements; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> compensation strategies, practices and policies; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Board compensation. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee ensures that our compensation programs, including those applicable to our executives, do not encourage excessive risk taking. The Compensation Committee works </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=16,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=876192,FOLIO='11',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dc15301_1_12"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>periodically
with its independent compensation consultant to structure executive compensation plans that are appropriately balanced and that incentivize management to act in the best interest of our
shareholders. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC17"></A>Governance, Risk&nbsp;&amp; Nominating Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Governance, Risk&nbsp;&amp; Nominating Committee oversees management of the following risks:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> corporate governance practices; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> compliance and ethics programs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> regulatory risk </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> operational risk related to our information technology systems, including data security and privacy matters; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> director independence; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Board composition; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Board performance and effectiveness. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
committee also reviews, monitors and assesses the allocation of responsibility for risk oversight among the Board and the standing committees of the Board. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC18"></A>Composition and Meetings of the Board of Directors and its Committees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shareholders elect directors annually to serve for one-year terms or until their successors are elected and qualified. As disclosed above,
we currently have eight directors serving on the Board, with seven directors standing for re-election at the Annual Meeting. The Board establishes policy and provides strategic direction, oversight,
and control of the Company. The Board met four times during Fiscal Year 2018 and each director attended at least 75% in the aggregate of the total number of meetings of the Board and the committees on
which he served during Fiscal Year 2018. We encourage, but do not require, members of the Board to attend our Annual Meeting of Shareholders, and six of our directors attended last year's Annual
Meeting. Independent directors also met in executive session four times during Fiscal Year 2018, with all currently incumbent members in attendance at each of those sessions. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC19"></A>Audit Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee has been formed to comply with the requirements of the definition of "audit committee" under Section&nbsp;3(a)(58)(A) of
the Exchange Act. Members of the Audit Committee as of December&nbsp;29, 2018 and as of the date of this Proxy Statement are its Chair, Mr.&nbsp;Fuller, and directors Nixon, Peng, and Winssinger.
The Board has determined that each member of the Audit Committee meets the independence criteria established by the SEC under Rule&nbsp;10A-3 under the Exchange Act and qualifies under the
independence standards of the NYSE. The Board also has determined that each member of the Audit Committee is financially literate, as interpreted by the Board in its business judgment, and that
Mr.&nbsp;Fuller and Mr.&nbsp;Nixon each qualifies as an "audit committee financial expert" as defined in Item&nbsp;407(d)(5) of Regulation&nbsp;S-K of the Exchange Act. The Audit
Committee met four times during Fiscal Year 2018, with all incumbent members of the Committee in attendance at each meeting. In addition, the Committee met privately with internal audit, management
and finance staff and with our independent registered public accounting firm during the year in fulfilling its duties described below. The Audit Committee also makes recommendations to the Board with
respect to financial and accounting matters in fulfilling the following duties. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=17,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=741684,FOLIO='12',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dc15301_1_13"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee appoints and establishes the compensation for our independent registered public accounting firm, approves in advance all engagements with the independent registered
public accounting firm to perform audit and non-audit services, reviews and approves the procedures used by us to prepare our periodic reports, reviews and approves our critical accounting policies.
The Audit Committee also discusses audit plans and reviews results of the audit engagement with our independent registered public accounting firm, obtains and reviews a report of our independent
registered public accounting firm describing certain matters required by the listing standards of the NYSE, reviews the independence of our independent registered public accounting firm, oversees our
internal audit function and our accounting processes, including the adequacy of our internal control over financial reporting and, where it determines to do so, makes recommendations to the Board with
respect to rotation of the lead partner or the independent registered public accounting firm and with respect to other financial and accounting matters. Our independent registered public accounting
firm and internal audit department report directly to the Audit Committee. The Audit Committee oversees and approves certain related party transactions and other matters that may involve conflicts of
interest. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC20"></A>Governance, Risk&nbsp;&amp; Nominating Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Governance, Risk&nbsp;&amp; Nominating Committee of the Board reviews, develops and makes recommendations regarding various matters related to
the Board, including its size, composition, standing committees and practices. The Committee also reviews and implements corporate governance policies, practices, and procedures. The Governance,
Risk&nbsp;&amp; Nominating Committee reviews the performance and effectiveness of the Board, its standing committees, and its individual members. The Committee met four times during Fiscal Year 2018,
with all incumbent members in attendance at each meeting. Members of the Governance, Risk&nbsp;&amp; Nominating Committee as of December&nbsp;29, 2018 and the date of this Proxy Statement, were its
Chair, Mr.&nbsp;Nixon, and directors Fuller, Peng, and Winssinger. Each member of the Governance, Risk&nbsp;&amp; Nominating Committee meets the definition of "independent" set forth in the NYSE
standards. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Governance, Risk&nbsp;&amp; Nominating Committee may from time to time consider qualified nominees for director who are recommended by shareholders. The Governance, Risk&nbsp;&amp;
Nominating Committee
does not use different standards for evaluating nominees based on whether they have been suggested by our shareholders or by our directors. Shareholders who wish to make such a recommendation may do
so by sending a written notice to our Corporate Secretary, as described under the heading "Shareholder Proposals for 2020 Annual Meeting" below. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC21"></A>Compensation Committee  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee has responsibility, authority, and oversight relating to the development of our overall compensation strategy and
compensation programs. The Compensation Committee establishes our compensation philosophy and policies, and it oversees compensation plans for our executive officers and non-executive employees. The
Compensation Committee seeks to ensure that our compensation policies and practices promote shareholder interests and support our compensation objectives and philosophy. Members of the Compensation
Committee as of December&nbsp;29, 2018 and the date of this Proxy Statement, were Mr.&nbsp;Winssinger, as Chair, and directors Nixon and Peng. Each member of the Compensation Committee qualifies
as a "non-employee director" within the meaning of Rule&nbsp;16b-3 under the Exchange Act, and as an independent director under the NYSE listing standards, for purposes of service on a compensation
committee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee met four times during Fiscal Year 2018, with all members in attendance at each meeting. The Compensation Committee's responsibilities include:
(i)&nbsp;reviewing and recommending to the Board the salaries, bonuses, and other forms of compensation and benefit plans for management and (ii)&nbsp;administering our equity and long-term
incentive compensation plans. The duties of the Compensation Committee as the administrator of those plans include, but are not limited </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=18,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=216902,FOLIO='13',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dc15301_1_14"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>to,
determining those persons who are eligible to receive awards, establishing terms of all awards, authorizing officers of the Company to execute grants of awards, and interpreting the provisions of
the equity compensation plans and grants that are made under those plans. The Compensation Committee determines the compensation of our Chief Executive Officer, Named Executive Officers (as defined in
the notes to the Beneficial Ownership Table under "Security Ownership of Certain Beneficial Owners and Management"), and other executive officers as assigned by the Board. The Compensation Committee
is also responsible for reviewing and approving the Compensation Discussion and Analysis included in this Proxy Statement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
assist it in carrying out its responsibilities, the Compensation Committee is authorized to retain the services of independent advisors. For purposes of advice and consultation with
respect to compensation
of our executive officers, the Compensation Committee has historically engaged Frederic&nbsp;W.&nbsp;Cook&nbsp;&amp;&nbsp;Co. (the "Compensation Consultant" or "FW Cook"), a national compensation
consulting firm. More information is provided about FW Cook in the "Compensation Discussion and Analysis" section of this Proxy Statement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="DC22"></A>COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee at December&nbsp;29, 2018 and as of the date of this Proxy Statement was comprised of Frederic J. Winssinger,
Chair, J. Scott Nixon, and Feng Peng. All members of the Compensation Committee are independent directors. None of the members of our Compensation Committee has ever been an officer or employee of
USANA or any of our subsidiaries. No member of the Compensation Committee had any relationship requiring disclosure under "Transactions with Related Persons." During Fiscal Year 2018, none of our
executive officers served as a director or member of the compensation committee (or other committee of the board of directors performing equivalent functions) of another entity that had an executive
officer serving on our Board. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="DC23"></A>DIRECTOR COMPENSATION  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that our director compensation program is designed to attract and fairly compensate highly qualified, non-employee directors to
represent our shareholders and to act in the shareholders' best interests. The director compensation program was recommended by the Compensation Committee to and approved by our Board. The annual
retainer paid to our non-employee directors consists of a quarterly cash retainer. These directors also generally receive an initial grant of equity, followed by annual equity grants. Our executive
officers do not play any role in determining or recommending the amount of non-employee director compensation, except that Mr.&nbsp;Guest, our CEO, is a director and votes on the recommendations of
the Compensation Committee in his capacity as a member of the Board. Dr.&nbsp;Wentz has elected not to receive compensation as a director. Mr.&nbsp;Guest is compensated as our CEO and he does not
receive any cash or other additional compensation for his service as a director. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="DC24"></A>Fiscal Year 2018 Director Compensation  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the purpose of determining non-employee director compensation for Fiscal Year 2018, the Compensation Committee considered recommendations
from FW Cook, the Director Compensation Report published by the National Association of Corporate Directors, and other resources. The Compensation Committee also considered an overview of the
corporate governance
environment as well as recent trends and developments relating to director compensation. The Committee also specifically considered the amounts payable under and the various components of our director
compensation program, as well as the aggregate director compensation cost, in comparison to the boards of directors of the same group of peer companies that the Compensation Committee used in
determining executive compensation. See the "Director Compensation Table" below, for total compensation paid to our directors in Fiscal Year 2018. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=19,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=648149,FOLIO='14',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dc15301_1_15"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A NAME="DC25"></A>Cash Compensation.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In Fiscal Year 2018, we paid our non-employee directors an annual cash retainer of
$91,400. We paid
additional amounts to our Senior Director ($17,800 per year), Audit Committee Chair ($18,950), Compensation Committee Chair ($12,400 per year), and Governance, Risk&nbsp;&amp; Nominating Committee Chair
($9,200 per year). Under this program, we do not pay our non-employee directors meeting attendance fees unless the Board or any standing Board committee is required to hold an unusually high number of
meetings, in which case the Compensation Committee may in its discretion, approve additional compensation for those directors affected by these additional meetings. Directors are also eligible for
reimbursement of their expenses incurred in attending Board and committee meetings in accordance with Company policy. Examples of reimbursable expenses are airfare, hotel and meals for the director.
We pay the director retainer fees in quarterly installments. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A NAME="DC26"></A>Equity Compensation.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our non-employee directors also participate in an equity compensation program. This
program
involves an initial grant of equity in connection with the director's initial election or appointment to the Board, with the target delivered value prorated for the fiscal year based on the date of
election or appointment. Initial equity awards generally vest in equal quarterly installments beginning on the quarter following the grant date for the number of quarters remaining in their initial
year of service. We also make annual equity awards to each director. These awards also vest in four equal quarterly installments beginning on the quarter following the grant date. By delivering a
portion of the annual director retainer in the form of equity-based compensation, the structure strengthens the alignment between the interests of our non-employee directors and our shareholders. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A NAME="dc15301_director_compensation_table."> </A>
<A NAME="toc_dc15301_1"> </A>
<BR></FONT><FONT SIZE=2><B><I>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director Compensation Table. </I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth the compensation awarded to, or earned by, each of our
non-employee directors during Fiscal Year 2018. Mr.&nbsp;Guest is an
executive of the Company and accordingly, his compensation is reported under the caption "Executive Compensation" and he is not included in the table below. As indicated above, he is not paid any
compensation related to his service as a director. In Fiscal Year 2018, equity awards made to non-employee directors were in the form of Restricted Stock Units ("RSUs") as indicated in the notes to
the table below. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="DC27"></A>Director Compensation Table  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fees earned<BR>
or paid in<BR>
cash ($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
awards<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All other<BR>
compensation<BR>
($)(3) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Myron W. Wentz</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Robert Anciaux(4)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>109,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>108,006</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>217,206</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gilbert A. Fuller(5)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>141,150</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>108,006</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>249,156</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>J. Scott Nixon(6)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>98,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>108,006</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>206,906</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Feng Peng(7)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>91,400</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>108,006</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>199,406</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Peggie J. Pelosi(8)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>D. Richard Williams(9)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25,650</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25,650</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Frederick J. Winssinger(10)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>101,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>108,006</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>209,006</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>This
amount reflects the aggregate dollar amount of all cash compensation earned for service as a director.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>These
amounts set forth in the "Stock Awards" column represent the aggregate grant date fair value of the RSUs granted during Fiscal Year 2018, computed in
accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 718. The aggregate grant date fair value is calculated using the closing price of our
common stock on the grant date as if all of the shares underlying these </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=20,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=970890,FOLIO='15',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dc15301_1_16"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <UL>

<P style="font-family:times;"><FONT SIZE=2>awards
were vested and delivered on the grant date. Each of these awards was granted under our 2015 Equity Incentive Plan.  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Non-employee
directors do not receive any other perquisites or personal benefits or property as part of their compensation.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
1,128 RSUs granted to Mr.&nbsp;Anciaux on April&nbsp;23, 2018, vesting in four equal quarterly installments, commencing on the last day of the second
fiscal quarter of 2018. Mr.&nbsp;Anciaux serves as Senior Director.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
1,128 RSUs granted to Mr.&nbsp;Fuller on April&nbsp;23, 2018, vesting in four equal quarterly installments, commencing on the last day of the second
fiscal quarter of 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
1,128 RSUs granted to Mr.&nbsp;Nixon on April&nbsp;23, 2018, vesting in four equal quarterly installments, commencing on the last day of the second
fiscal quarter of 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
1,128 RSUs granted to Mr.&nbsp;Peng on April&nbsp;23, 2018, vesting in four equal quarterly installments, commencing on the last day of the second
fiscal quarter of 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Ms.&nbsp;Pelosi
was paid a prorated retainer for her 10&nbsp;days of service during Fiscal Year 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(9)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Williams
left the Board in April 2018. The amount indicated represents the fees paid during the first quarter of Fiscal Year 2018 for his service as a
director and as Chair of the Compensation Committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(10)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
1,128 RSUs granted to Mr.&nbsp;Winssinger on April&nbsp;23, 2018, vesting in four equal quarterly installments, commencing on the last day of the
second fiscal quarter of 2018.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="Pr2"></A>PROPOSAL #2&#151;RATIFICATION OF SELECTION OF INDEPENDENT<BR>
REGISTERED PUBLIC ACCOUNTING FIRM  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee of the Board has appointed KPMG&nbsp;LLP ("KPMG") as our independent registered public accounting firm for Fiscal Year
2019. KPMG has served as our independent registered public accounting firm since September&nbsp;16, 2013. Services provided to us and our subsidiaries by KPMG in Fiscal Year 2018, and the Fiscal
Year ended December&nbsp;30, 2017 ("Fiscal Year 2017"), are described below. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are asking our shareholders to ratify the selection of KPMG as our independent registered public accounting firm. Although ratification is not required by our bylaws or otherwise, the
Board is submitting the selection of KPMG to our shareholders for ratification because we believe it is a sound corporate governance practice. If our shareholders do not ratify the selection, the
Audit Committee will consider whether to retain KPMG, but may retain them in the Audit Committee's discretion. In addition, even if the appointment is ratified, the Audit Committee could in its
discretion subsequently appoint a different independent registered public accounting firm without shareholder approval, if it were to determine that doing so would be in the best interests of the
Company and our shareholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
ratification of the appointment of KPMG requires the affirmative vote of a majority of the votes cast at the Annual Meeting. Representatives of KPMG will be present at the Annual
Meeting and will
have an opportunity to make a statement and/or to respond to appropriate questions from shareholders. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dc15301_independence"> </A>
<A NAME="toc_dc15301_2"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Independence    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KPMG has advised us that it has no direct or indirect financial interest in us or in any of our subsidiaries and that during Fiscal Year 2018,
it had no connection with us or any of our subsidiaries, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=21,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=664036,FOLIO='16',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dc15301_1_17"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>other
than as our independent registered public accounting firm or in connection with certain other services, as described below. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dc15301_audit_fees"> </A>
<A NAME="toc_dc15301_3"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Audit Fees    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During Fiscal Year 2018, we entered into an engagement agreement with KPMG, which set forth the terms by which KPMG agreed to perform audit
services for us and our subsidiaries. Those services consisted of the audit of our annual consolidated financial statements, and the effectiveness of our internal control over financial reporting,
review of the quarterly financial statements, stand-alone audits of financial statements of certain subsidiaries, and accounting consultations, consents, other services related to our SEC filings, tax
compliance services and transfer pricing services. KPMG did not perform any financial information systems design and implementation services for us or our subsidiaries for Fiscal Year 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
Fiscal Year 2017, we entered into an engagement agreement with KPMG, which set forth the terms by which KPMG agreed to perform audit services for us and our subsidiaries. Those
services consisted of the audit of our annual consolidated financial statements, and the effectiveness of financial statements of certain our internal control over financial reporting, review of the
quarterly financial statements, stand-alone audits of subsidiaries, and accounting consultations, consents, other services related to our SEC filings, tax compliance services and transfer pricing
services. KPMG did not
perform any financial information systems design and implementation services for us or our subsidiaries for Fiscal Year 2017. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes the fees paid by us to KPMG during Fiscal Years 2017 and 2018. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="77pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="77pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Type of Service and Fee

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fiscal Year 2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fiscal Year 2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,074,116</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,073,545</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Related Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tax Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>111,300</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>147,133</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All Other Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,185,416</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,220,678 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dc15301_policy_on_pre-approval_of_audi__pol02605"> </A>
<A NAME="toc_dc15301_4"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Policy on Pre-Approval of Audit and Permissible Non-Audit Services    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It is the policy of the Audit Committee, as set forth in the Audit Committee's Charter, to pre-approve, consistent with the requirements of the
federal securities laws, all auditing services and permissible non-audit services provided to the Company by its independent registered public accounting firm. The Audit Committee pre-approves any
engagement of KPMG and has the ultimate authority and responsibility to select, evaluate, and where appropriate, replace the independent registered public accounting firm and nominate an independent
registered public accounting firm for shareholder approval. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the performance of any services, the Audit Committee approves all audit and non-audit services to be provided by the Company's independent registered public accounting firm and
the fees to be paid therefor. Although the Sarbanes-Oxley Act permits the Audit Committee to pre-approve some types or categories of services to be provided by the independent registered public
accounting firm, it is the current practice of the Audit Committee to specifically approve all services provided by the independent registered public accounting firm in advance, rather than to
pre-approve any type of service. In connection with this practice, the Audit Committee has considered whether the provision of non-audit services is compatible with maintaining KPMG's independence and
has established policies and procedures for the pre-approval of audit, audit related, tax and permissible other services to be </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=22,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=67881,FOLIO='17',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dc15301_1_18"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>provided
to the Company by its independent registered public accounting firm. All fees listed in the table above were pre-approved by the Audit Committee. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dc15301_recommendation_of_the_board_of_directors"> </A>
<A NAME="toc_dc15301_5"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


RECOMMENDATION OF THE BOARD OF DIRECTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board unanimously recommends a vote </FONT><FONT SIZE=2><B>FOR</B></FONT><FONT SIZE=2> ratification of the appointment of KPMG&nbsp;LLP
as the Company's independent registered public accounting firm for Fiscal Year 2019. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=23,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=185169,FOLIO='18',FILE='DISK126:[19ZAE1.19ZAE15301]DC15301A.;13',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_de15301_1_19"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="de15301_report_of_the_audit_committee"> </A>
<A NAME="toc_de15301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  REPORT OF THE AUDIT COMMITTEE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee is composed of four directors, all of whom meet the independence standards contained in the NYSE listing standards, SEC
rules, and USANA's Corporate Governance Principles, and operates under a written charter adopted by the Board. Management has the primary responsibility for the financial statements and the reporting
process, including the Company's system of internal control over financial reporting. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee selects, subject to shareholder ratification, the Company's independent registered public accounting firm, and oversees and monitors the Company's financial reporting
process on behalf of the Board. The Audit Committee selected KPMG&nbsp;LLP ("KPMG") as the Company's independent registered public accounting firm for Fiscal Year 2018. KPMG is responsible for
performing independent audits of the Company's consolidated financial statements and internal control over financial reporting and issuing opinions on the conformity of those consolidated financial
statements with U.S. generally accepted accounting principles, and on the effectiveness of the Company's internal
control over financial reporting. KPMG is also responsible for communicating its judgments as to the quality and the acceptability of the Company's financial reporting, and such other matters as are
required to be discussed with the Committee under the standards of the Public Company Accounting Oversight Board ("PCAOB"). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Management
has reported to the Audit Committee that the Company's consolidated financial statements for Fiscal Year 2018 were prepared in accordance with U.S. generally accepted
accounting principles. The Audit Committee has also reviewed and discussed the audited consolidated financial statements for Fiscal Year 2018 and accompanying management's discussion and analysis of
financial condition and results of operations with management and KPMG. This discussion included KPMG's judgments about the quality, not just the acceptability, of the accounting principles, the
reasonableness of significant judgments and the clarity of disclosures in the financial statements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee discussed with KPMG its independence from management and the Company, including the impact of any non-audit-related services provided to the Company, the matters in
KPMG's written disclosures, and the letter from KPMG to the Audit Committee pursuant to the applicable requirements of the PCAOB regarding the firm's communications with the Audit Committee concerning
its independence. The Audit Committee also discussed with KPMG the matters required to be discussed by the statement on Auditing Standards No.&nbsp;1301, as adopted by the PCAOB. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board that the audited consolidated financial statements be included in USANA's
Annual Report on Form&nbsp;10-K for the Fiscal Year ended December&nbsp;29, 2018, filed with the Securities and Exchange Commission. The Audit Committee also evaluated and reappointed KPMG as the
Company's independent registered public accounting firm for Fiscal Year 2019. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Respectfully
submitted by the members of the Audit Committee: </FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>Gilbert
A. Fuller, Chairman<BR>
J. Scott Nixon<BR>
Feng Peng<BR>
Frederic Winssinger </FONT></P>

</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=24,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=221111,FOLIO='19',FILE='DISK126:[19ZAE1.19ZAE15301]DE15301A.;16',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_de15301_1_20"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="de15301_security_ownership_of_certain___sec02525"> </A>
<A NAME="toc_de15301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information regarding the beneficial ownership of our common stock, as of March&nbsp;1, 2019, by
(1)&nbsp;each person known by us to be the beneficial owner of more than 5% of the issued and outstanding common stock based upon their most recent filings or correspondence with the SEC,
(2)&nbsp;each of our Named Executive Officers (see Note&nbsp;5 below the table below) and directors individually, and (3)&nbsp;the Named Executive Officers and directors as a group. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as indicated in the footnotes below, each of the persons listed below is believed to exercise sole voting and investment power over the shares of common stock that are listed for
such individual or entity in this table. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name and Address

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percent of<BR>
Class(2) </B></FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2><B>Beneficial Owners of More Than 5%</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gull Global,&nbsp;Ltd.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
9,865,614</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>42.3%</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PO Box&nbsp;N-4899, 2/F Bahamas Financial Ctr.<BR>
Shirley&nbsp;&amp; Charlotte Streets<BR>
Nassau, C5 BH1-1000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Renaissance Technologies&nbsp;LLC(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
1,844,100</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>7.9%</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 800 Third Avenue<BR>
New York, New York 10022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vanguard Group&nbsp;Inc.(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
1,324,548</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>5.7%</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PO BOX 2600 V26<BR>
Valley Forge, PA 19482-2600</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2><B>Directors and Executive Officers(5)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Myron W. Wentz, Ph.D., Board Chair(6)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
9,865,614</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>42.3%</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Kevin G. Guest, Chief Executive Officer(7)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
6,615</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>G. Douglas Hekking, Chief Financial Officer(8)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
3,138</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Jim Brown, President&nbsp;&amp; Chief Operating Officer(9)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
5,605</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David Mulham, Chief Sales Officer(10)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
12,146</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Walter Noot, Chief Information Officer(11)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
6,667</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Robert Anciaux, Director(12)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
14,503</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Gilbert A. Fuller, Director(13)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
5,104</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Peggie J. Pelosi(14)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
233</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Feng Peng(15)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
4,224</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Frederic Winssinger(16)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
2,162</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Scott Nixon(17)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
1,987</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>*</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Directors and Officers as a group (12 persons)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
9,927,968</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>42.5%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Less
than one percent. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=25,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=350658,FOLIO='20',FILE='DISK126:[19ZAE1.19ZAE15301]DE15301A.;16',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_de15301_1_21"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>All
entries exclude beneficial ownership of shares that are issuable pursuant to SSARs or RSUs that have not vested or that are not otherwise exercisable or vested
as of the date hereof and which will not become vested or exercisable within 60&nbsp;days of March&nbsp;1, 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Percentages
are rounded to nearest one-tenth of one percent. Percentages are based on 23,324,485 shares outstanding on March&nbsp;1, 2019. Shares of common stock
subjected to SSARs that are presently exercisable or exercisable within 60&nbsp;days of March&nbsp;1, 2019, are deemed to be beneficially owned by the person holding the SSARs for the purpose of
computing the percentage ownership of that person, but are not treated as outstanding for the purpose of computing the percentage of any other person.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the number of shares held at year-end, as reported on Form&nbsp;SC 13G/A filed on February&nbsp;13, 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the number of shares held at year-end, as reported on Form&nbsp;SC 13G filed on February&nbsp;12, 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>For
Fiscal Year 2018, our "Named Executive Officers" (pursuant to Item&nbsp;402 of Regulation&nbsp;S-K, comprising our principal executive officer, principal
financial officer, and three additional highest compensated executive officers) are Kevin G. Guest (Chief Executive Officer), Douglas G. Hekking (Chief Financial Officer), Jim Brown (President and
Chief Operating Officer), David Mulham (Chief Sales Officer) and Walter Noot (Chief Information Officer).
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
9,865,614 shares held of record by Gull Global,&nbsp;Ltd., a Bahamas company, which is 100% owned by Dr.&nbsp;Wentz. Because of his control of Gull
Global,&nbsp;Ltd, Dr.&nbsp;Wentz is deemed to be the beneficial owner of the shares that are owned of record by Gull Global,&nbsp;Ltd.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
5,207 shares held of record and 1,408 shares that are held in the executive's 401(k) account.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>This
includes 849 shares held of record, 886 RSUs that will vest within 60&nbsp;days of March&nbsp;1, 2019 and are converted to shares of stock at a one-for-one
ratio. Includes also 1,403 shares that are held in the executive's 401(k) account.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(9)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
3,425 shares held of record and 2,180 shares that are held in the executive's 401(k) account.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(10)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
3,784 shares held of record and 8,362 shares that are issuable pursuant to SSARs, which are presently exercisable, or which become exercisable within
60&nbsp;days of March&nbsp;1, 2019. This share count assumes settlement of this individual's SSARs at the closing market price on March&nbsp;1, 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(11)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
812 shares held of record and 5,855 shares that are issuable pursuant to SSARs, which are presently exercisable, or which become exercisable within
60&nbsp;days of March&nbsp;1, 2019. This share count assumes settlement of this individual's SSARs at the closing market price on March&nbsp;1, 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(12)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>This
includes 3,591 shares held of record, 282 RSUs that will vest within 60&nbsp;days of March&nbsp;1, 2019 and are converted to shares of stock at a one for
one ratio. Includes 10,630 shares that are issuable pursuant to Deferred Stock Units ("DSUs"), which are vested.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(13)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>This
includes 282 RSUs that will vest within 60&nbsp;days of March&nbsp;1, 2019 and are converted to shares of stock at a one-for-one ratio. Includes also 4,822
shares that are issuable pursuant to DSUs, which are vested.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(14)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>This
includes 233 RSUs that will vest within 60&nbsp;days of March&nbsp;1, 2019 and are converted to shares of stock at a one-for-one ratio. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=26,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=225445,FOLIO='21',FILE='DISK126:[19ZAE1.19ZAE15301]DE15301A.;16',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_de15301_1_22"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(15)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>This
includes 282 shares held of record, 282 RSUs that will vest within 60&nbsp;days of March&nbsp;1, 2019 and are converted to shares of stock at a one-for-one
ratio. Includes also 3,660 shares that are issuable pursuant to DSUs, which are vested.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(16)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>This
includes 282 RSUs that will vest within 60&nbsp;days of March&nbsp;1, 2019 and are converted to shares of stock at a one-for-one ratio. Includes also 3,660
shares that are issuable pursuant to DSUs, which are vested.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(17)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>This
includes 846 shares held of record, 282 RSUs that will vest within 60&nbsp;days of March&nbsp;1, 2019 and are converted to shares of stock at a one-for-one
ratio. Includes 859 shares that are issuable pursuant to DSUs, which are vested.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="de15301_section_16(a)_benefici__de102018"> </A>
<A NAME="toc_de15301_3"> </A>
<BR></FONT><FONT SIZE=2><B>  SECTION&nbsp;16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;16(a) of the Exchange Act requires our officers, directors, and persons who beneficially own more than 10% of our common stock to
file statements with the SEC, reporting their initial beneficial ownership of common stock and to report any subsequent changes in their beneficial ownership, by specified due dates that have been
established by the SEC. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
solely upon our review of: (a)&nbsp;Section&nbsp;16(a) statements filed on behalf of these persons for their respective transactions during our Fiscal Year 2018, and
(b)&nbsp;representations received from these persons that no other Section&nbsp;16(a) statements were required to be filed by them for their respective transactions during Fiscal Year 2018, we
believe that all Section&nbsp;16(a) filing requirements applicable to our directors and executive officers and persons beneficially holding more than 10% of our outstanding common stock were
complied with by these individuals except that Mr.&nbsp;Robert Anciaux, a director, inadvertently failed to file&nbsp;a Form&nbsp;4 following two sales totaling 3,500 shares of common stock on
November&nbsp;13, 2018 and Decemeber 11, 2018. Mr.&nbsp;Anciaux promptly filed a Form&nbsp;5 reporting these transactions after this oversight was discovered. Consequently, we believe that all
holdings and transactions of Mr.&nbsp;Anciaux have been accurately disclosed in our reports filed with the SEC. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, during Fiscal Year 2018, the Company became aware of a transaction by a director of the Company resulting in an unintentional violation of Section&nbsp;16(b) of the
Exchange Act. In June 2018, the director voluntarily disgorged $906,811 to the Company, representing full disgorgement of the short-swing profit realized on the transaction. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="de15301_certain_relationships_and_related_party_transactions"> </A>
<A NAME="toc_de15301_4"> </A>
<BR></FONT><FONT SIZE=2><B>  CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="de15301_policies_and_procedure__de102492"> </A>
<A NAME="toc_de15301_5"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Policies and Procedures Regarding Related Party Transactions    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the ordinary course of business, we may engage in transactions which have the potential to create actual or perceived conflicts of interest
between USANA and our directors and officers or their immediate family members. The Audit Committee charter requires that the Audit Committee review and approve any related party transaction or, in
the alternative, that it notify and request action on the related party transaction by the full Board. While we have not adopted formal written procedures for reviewing such transactions, in deciding
whether to approve a related party transaction, the Audit Committee may consider, among other things, the following factors:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> information regarding the goods or services that are proposed to be provided, or that are being provided, by or to the related party; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the nature of the transaction and the costs to be incurred by the Company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an analysis of the costs and benefits that are associated with the transaction and a comparison of alternative goods or services that are
available to the Company from unrelated parties; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an analysis of the significance of the transaction to the Company; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=27,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=725103,FOLIO='22',FILE='DISK126:[19ZAE1.19ZAE15301]DE15301A.;16',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_de15301_1_23"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> whether the transaction would be in the ordinary course of our business; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> whether the transaction is on terms that are comparable to those that could be obtained in an arm's-length dealing with an unrelated third
party; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> whether the transaction could result in an independent director no longer being considered to be independent under the NYSE rules. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
considering these and other relevant factors, the Audit Committee either (1)&nbsp;approves or disapproves the related party transaction, or (2)&nbsp;requests that the full
Board consider the matter. The Audit Committee will not approve any related party transaction which is not on terms that it believes are both fair and reasonable to USANA. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="de15301_related_party_transactions"> </A>
<A NAME="toc_de15301_6"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Related Party Transactions    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Founder and Board Chair, Myron W. Wentz, Ph.D. is the sole beneficial owner of USANA's largest shareholder, Gull Global,&nbsp;Ltd. As of
March&nbsp;1, 2019, Gull Global,&nbsp;Ltd. owned 42.3% of our issued and outstanding shares. Dr.&nbsp;Wentz devotes much of his personal time, expertise, and resources to a number of business
and professional activities outside of USANA. The most significant of these is the Sanoviv Medical Institute, which is a unique, fully integrated health and wellness center located near Rosarito,
Mexico, that Dr.&nbsp;Wentz founded in 1998. Dr.&nbsp;Wentz's private entity, Sanoviv&nbsp;S.A. de C.V. ("Sanoviv"), contracts with Amarevita S DE RL DE CV (formerly Medicis,
S.C.) ("Amarevita"), an entity that is owned and operated independently of Dr.&nbsp;Wentz, to conduct the operations of the Sanoviv Medical Institute. Sanoviv leases the medical building to
Amarevita and Amarevita carries out all of the operations of the medical institute, which include employing all of the medical and healthcare professionals who provide services at the medical
institute. The Amarevita medical and healthcare professionals possess expertise in the fields of human health, digestive health, nutritional medicine, lifestyle medicine and other medical fields that
are important to USANA. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amarevita
performs research and development of novel product formulations for future development and production by USANA, and they also perform research and development of improvements
in existing USANA product formulations. In addition to providing contract research services, Amarevita provides physicians and other medical staff to speak at USANA Associate events. Amarevita also
performs health assessments and physical examinations for our executives. In consideration for these services, USANA paid Amarevita $322,000, $337,000, and $161,077 in 2016, 2017, and 2018,
respectively. Our agreements with Amarevita were approved by the Audit Committee prior to entering into them. We may terminate our collaboration with Amarevita at any time, without any continuing
commitment by USANA. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have a long-standing relationship with Drive Marketing, a promotional product distributor located in Sandy, Utah. Drive Marketing provides USANA with customized products for Associate
recognition. We paid Drive Marketing $523,000, $781,000, and $803,601, in 2016, 2017, and 2018, respectively. During 2016, Drive Marketing hired Nathan Guest as a sales representative for its various
network marketing accounts, including the USANA account. Nathan Guest is the adult son of Kevin&nbsp;Guest, our CEO. Drive Marketing is one of many promotional product distributors that we utilize.
Our arrangement with Drive Marketing was approved by the Audit Committee prior to entering into it and it is terminable at will by us at any time without any continuing commitment. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have had a long-standing contractual relationship with Shane Farmer, the sole owner of Dark Horse Rowing,&nbsp;LLC located in San Diego, California. Mr.&nbsp;Farmer is the stepson
of Dr.&nbsp;Wentz. Mr.&nbsp;Farmer provides consulting and other advisory services to USANA related to our development of nutritional products. Under our agreements with Dark Horse
Rowing,&nbsp;LLC, we paid $136,000, $135,000, and $135,792, in 2016, 2017, and 2018, respectively. Mr.&nbsp;Farmer is just one of many consultants and experts we use to provide advice on
nutrition. The arrangement since 2017 with Dark </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=28,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=600388,FOLIO='23',FILE='DISK126:[19ZAE1.19ZAE15301]DE15301A.;16',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_de15301_1_24"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Horse
Rowing,&nbsp;LLC has been approved by the Audit Committee in advance and we may terminate the relationship with Dark Horse Rowing at will at any time without any continuing commitment. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="de15301_executive_officers"> </A>
<A NAME="toc_de15301_7"> </A>
<BR></FONT><FONT SIZE=2><B>  EXECUTIVE OFFICERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our executive officers at December&nbsp;29, 2018 and as of the date of this Proxy Statement were: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="354pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Position </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Kevin G. Guest</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chief Executive Officer and Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>President and Chief Operating Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>G. Douglas Hekking</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>Chief Financial Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Paul A. Jones</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chief Leadership Development Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>P. Joshua Foukas</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chief Legal Officer, General Counsel and Corporate Secretary</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Daniel A. Macuga</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chief Communications and Marketing Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Robert Sinnott</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chief Scientific Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Walter Noot</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chief Information Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David Mulham</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chief Sales Officer</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following information is provided to us by our executive officers. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Kevin G. Guest,</B></FONT><FONT SIZE=2> 56, CEO. Mr.&nbsp;Guest's biographical and business background information are provided for you in the section above
titled "Director Nominees," where he is listed as a nominee for director. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Jim Brown</B></FONT><FONT SIZE=2>, 50, President and Chief Operating Officer. Mr.&nbsp;Brown joined USANA in 2006 as Vice&nbsp;President of Operations. In
July 2011, he was appointed Vice President of Global Operations and served in that role until July 2012, when he was appointed Chief Production Officer. He served in that role until November 2013 when
he was appointed Chief Operating Officer. He served in that role until November 2016 when he was appointed President and Chief Operating Officer. Prior to joining USANA, Mr.&nbsp;Brown was employed
at Sonoco as a plant manager where he was responsible for safety, quality, finance, production, and maintenance. Mr.&nbsp;Brown received a bachelor's degree with a double major in computer science
and math as well as an M.B.A. from Francis Marion University in Florence, South Carolina. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>G. Douglas Hekking</B></FONT><FONT SIZE=2>, 49, Chief Financial Officer. Mr.&nbsp;Hekking joined USANA in 1992 and served in several management positions until
March 1996, when he was appointed as Controller. Mr.&nbsp;Hekking served as Controller from March 1996 until February 2005, when he was appointed as Vice President of Finance. He served as Vice
President of Finance until July 2007, when he transitioned to our operations group and was appointed as Executive Director of Special Projects. He served in this position until May 2011, when he was
promoted to Chief Financial Officer. Mr.&nbsp;Hekking served in this role until December 2012, when he stepped aside to attend to certain family health matters. In December 2012, Mr.&nbsp;Hekking
was appointed as Vice President of Finance until May 2016, when he was appointed as Executive Vice President of Finance. Mr.&nbsp;Hekking served in this role until he was again appointed as Chief
Financial Officer in May 2017. Mr.&nbsp;Hekking received a B.S. in accounting from the University of Utah and an M.B.A. from Brigham Young University. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Paul A. Jones,</B></FONT><FONT SIZE=2> 55, Chief Leadership Development Officer. Mr.&nbsp;Jones joined USANA in 2005 as Vice President of Human Resources and
served in this role until June 2007, when he left to complete a three-year service mission. Mr.&nbsp;Jones returned as Vice President of Human Resources in July 2010, and served in this role until
December 2012, when he was appointed Chief Financial Officer. In August 2015, Mr.&nbsp;Jones was also appointed Chief Leadership Development Officer. Mr.&nbsp;Jones ceased serving as Chief
Financial Officer in May 2017 and has served solely as Chief Leadership Development Officer. Prior to joining USANA, Mr.&nbsp;Jones was Vice President of Human Resources and later Vice President </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=29,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=104921,FOLIO='24',FILE='DISK126:[19ZAE1.19ZAE15301]DE15301A.;16',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_de15301_1_25"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>of
Operations for Associated Food Stores,&nbsp;Inc. Mr.&nbsp;Jones received a B.S. in finance from Utah State University and M.A. in organizational management from the University of Phoenix.
Mr.&nbsp;Jones is also a Certified Management Accountant. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>P. Joshua Foukas</B></FONT><FONT SIZE=2>, 43, Chief Legal Officer, General Counsel and Corporate Secretary. Mr.&nbsp;Foukas joined USANA in 2007 as Associate
General Counsel and served in that role until he was appointed as Vice President of Finance and Legal in 2011. He served in this finance role on an interim basis until December 2012, when he was
appointed as Vice President of Legal and Investor Relations. He served in this role until January 2017, when he was appointed as Executive Vice President of Legal. Mr.&nbsp;Foukas served in this
role until July 2018, when he was appointed Chief Legal Officer and Corporate Secretary. Prior to joining USANA, Mr.&nbsp;Foukas served as corporate counsel for a public biotech company. Prior to
that, he practiced law as a corporate and securities attorney with a law firm in Salt Lake City, Utah. Mr.&nbsp;Foukas received a B.A. from the University of Utah and a J.D. from the University of
Idaho. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Daniel A. Macuga, Jr.</B></FONT><FONT SIZE=2>, 49, Chief Communications and Marketing Officer. Mr.&nbsp;Macuga joined USANA in 2007 as Vice President of Network
Development and Public Relations. In July 2008, he was appointed as Vice&nbsp;President of Marketing, Public Relations and Social Media and served in that role until December 2011, when he was
appointed Chief Communications Officer. He served in that role until February 2014 when he was appointed Chief Communications Officer and Executive Vice&nbsp;President of Field Development for the
Americas. He served in that role until November 2016 when he was appointed Chief Communications Officer. He served in that role until November 2017 when he was named Chief Communications and Marketing
Officer. Prior to joining USANA, Mr.&nbsp;Macuga was employed at the Chrysler Corporation, where he spent 15&nbsp;years working closely with independent dealership entrepreneurs to help them build
their businesses, increase awareness for their products, and keep them focused on effective customer relationship management. Mr.&nbsp;Macuga received a B.A. in communications from the University of
California, San Diego. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Robert A. Sinnott, M.N.S., Ph.D.</B></FONT><FONT SIZE=2>, 54, joined USANA as our Chief Scientific Officer in August 2016. From 2005 to 2016, he was Chief Science
Officer of Mannatech,&nbsp;Inc. From 2009 to 2012, he also served as Co-Chief Executive Officer and from 2012 to 2016 as CEO of Mannatech. During his tenure at Mannatech, Dr.&nbsp;Sinnott has
served to further the company's proprietary science, research and development, and initiated independent clinical trials, was responsible for oversight of quality assurance/quality control, global
regulatory affairs, legal department, human resources, and global supply chain. Dr.&nbsp;Sinnott has held scientific and business positions in both industry and government over the past
25&nbsp;years with experience in life sciences, chemistry, biotechnology and nutrition. For the past 18&nbsp;years, he has worked directly in the dietary supplement industry both in the United
States and internationally. From 2006 to 2011, Dr.&nbsp;Sinnott held a seat on the Board of Directors of the Council of Responsible Nutrition's (the "CRN"), the leading trade association
representing ingredient suppliers and manufacturers of dietary supplements. From 2009 to 2011, Dr.&nbsp;Sinnott also served as chair of the Senior Scientific Advisory Committee (SSAC) for the CRN.
The SSAC is comprised of the highest-ranking scientific officers of member companies. Its role is to assist the CRN with development and implementation of scientific strategy relating to scientific
publications, scientific policies and programs by government agencies. Dr.&nbsp;Sinnott holds a B.S. degree in Biological Sciences, a Masters in Natural Science, and a Ph.D. in Plant Sciences from
Arizona State University, in Tempe, Arizona. His focus was on applied biological sciences, including biotechnology and plant medicinal chemistry. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Walter Noot,</B></FONT><FONT SIZE=2> 53, joined USANA as Chief Information Officer in December 2016. Mr.&nbsp;Noot has more than two decades of executive
leadership experience and has worked with a wide range of businesses in many industries, from start-ups to multibillion-dollar companies. From 2014 until 2016, he was an executive officer of Young
Living Essential Oils, LC, where he served as Chief Information Officer and
Senior Vice President of Operations before joining USANA. While at Young Living he oversaw improvements to the supply chain, implementation of a new ERP, and a software systems </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=30,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=650383,FOLIO='25',FILE='DISK126:[19ZAE1.19ZAE15301]DE15301A.;16',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_de15301_1_26"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>rebuild.
Prior to joining Young Living, Mr.&nbsp;Noot was COO of MonaVie, another direct sales company from 2012 to 2014 and has held leadership positions with Computer Associates, Canon (Oce), and
Onyx Graphics. He holds a B.S. degree in mechanical engineering from Brigham Young University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>David Mulham,</B></FONT><FONT SIZE=2> 58, Chief Sales Officer. Mr.&nbsp;Mulham joined USANA in 2009 as Field Development, Marketing and Customer Service Manager
for Australia and New Zealand. In February 2011, he was appointed General Manager, for Australia and New Zealand and served in that role until June 2011, when he was appointed Vice President, Pacific
Region (Australia, New Zealand and Philippines). In February 2014 he was appointed Executive Vice President of Field Development, Pacific Region and then in May 2015 he was appointed Executive Vice
President, Pacific Region. He served in that role until January 2016 when he was appointed Executive Vice President, Pacific and Europe and then in September 2016, he was appointed Executive Vice
President, the Americas, Pacific and Europe. He served in that role until February 2017, when he was appointed Chief Field Development Officer and this title was later changed to Chief Sales Officer.
Prior to joining USANA, Mr.&nbsp;Mulham had extensive experience in the Direct Selling Industry having worked for Amway, Mary Kay, Nutri Metics and Dorling Kindersley Family Learning. He
subsequently worked in property development as Director of both Hunter Valley Gardens and Tempus Two Winery. Mr.&nbsp;Mulham has a post graduate diploma from Macquarie Graduate School of Management,
Sydney, and received the Silver Stevie Award in 2015, for Executive of the Year&#151;Health Products&nbsp;&amp; Services and Pharmaceuticals. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="de15301_executive_compensation"> </A>
<A NAME="toc_de15301_8"> </A>
<BR></FONT><FONT SIZE=2><B>  EXECUTIVE COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="de15301_compensation_discussion_and_analysis"> </A>
<A NAME="toc_de15301_9"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Discussion and Analysis    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="de15301_introduction_and_executive_summary"> </A>
<A NAME="toc_de15301_10"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Introduction and Executive Summary    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following Compensation Discussion and Analysis describes our executive compensation philosophy, the structure of our executive compensation
programs, the factors that we consider when making decisions regarding the compensation for our Chief Executive Officer and other executive officers, including those Named Executive Officers
identified in the Summary Compensation Table (referred to and included in the group referenced below by the terms "executive" and "executives" in this Compensation Discussion and Analysis). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="de15301_executive_summary"> </A>
<A NAME="toc_de15301_11"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Summary    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that our executives and employees, as well as the compensation programs that incent them, are key factors in driving strong financial
and operational performance and creating shareholder value. With that in mind, our executive compensation program is designed to, among other things, (i)&nbsp;provide a competitive and equitable
compensation and benefits package for our executives; (ii)&nbsp;promote a pay-for-performance philosophy, and (iii)&nbsp;motivate and retain effective executives. Proposal Number&nbsp;3 of this
Proxy Statement provides you the opportunity to vote to approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers as set forth in this Proxy Statement. At our 2018
Annual Meeting of Shareholders held on May&nbsp;2, 2018, shareholders had the opportunity to provide an advisory vote on the compensation paid to our Named Executive Officers. Over 81% of the votes
cast by our shareholders were in favor of the non-binding resolution approving executive compensation paid in Fiscal Year 2017 to our Named Executive Officers. The Compensation Committee believes that
those results generally affirm shareholder support of our approach to executive compensation. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="de15301_summary_of_2018_accomplishments"> </A>
<A NAME="toc_de15301_12"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Summary of 2018 Accomplishments    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In fiscal 2018, we generated our 16<SUP>th</SUP>&nbsp;consecutive year of record sales, reported the highest net earnings in the history of
the Company, and concluded the year with a record 616,000 total active </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=31,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=364109,FOLIO='26',FILE='DISK126:[19ZAE1.19ZAE15301]DE15301A.;16',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_de15301_1_27"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>customers.
Customer growth is our highest priority as we strive to improve the health and nutrition of individuals and families around the world. During the year, we accomplished several initiatives,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Launching Celavive&reg;, our innovative skincare system formulated with the USANA InCelligence Technology&reg;.
Celavive&reg; offers a comprehensive skin care regimen benefiting multiple skin care types and ethnicities, with upgraded science and more noticeable user benefit; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Expanding our operations in Europe with four new markets; Germany, Spain, Italy, and Romania. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Significantly improving to our global IT infrastructure particularly in China where we launched our new WeChat&reg; platform, along
with a new enrollment system, mobile app, and website. These initiatives improved the USANA customer experience, making it easier for our Associates to attract and retain customers. </FONT> <FONT SIZE=2><I>WeChat</I></FONT><FONT SIZE=2>&reg; is a
trademark of Tencent Holdings Limited. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="de15301_compensation_philosophy_and_objectives"> </A>
<A NAME="toc_de15301_13"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Philosophy and Objectives    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our compensation philosophy, as approved by the Compensation Committee, is to establish and maintain executive compensation programs that are
designed to accomplish the following objectives:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> To attract and retain, through a fair and competitive compensation plan, executives who have the intelligence, education, and experience that
is required to effectively administer the affairs of the Company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> To motivate our executives to achieve certain financial and non-financial performance objectives for the benefit of our shareholders by tying
components of their total compensation to individual and Company performance; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> To ensure that compensation practices do not impair our financial strength or future success. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="de15301_overview_of_components__de102397"> </A>
<A NAME="toc_de15301_14"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview of Components of Executive Compensation Program    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our executive compensation program includes three main components: base salary, short-term incentive compensation (in the form of a cash bonus),
and long-term incentive compensation (in the form of equity awards). Short-term incentive compensation is performance-based and designed to motivate our executives to achieve annual financial and
non-financial performance objectives. To minimize potential risk, the potential for short-term incentive compensation has historically been capped at 100% of an executive's base salary. Long-term
incentive compensation utilizes equity awards, which vest over several years. These awards reward the executive for sustainable corporate performance and are intended to align the financial interests
of our executives with those of our shareholders. The Compensation Committee believes that these three components provide an appropriate framework to attract, retain and motivate our executives, and
align a significant portion of executive compensation with short-and long-term performance objectives that drive shareholder value. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
than as described in this Compensation Discussion and Analysis, we typically do not provide benefits to our executives that are different from, or in addition to, those that are
provided to our general employees. As shown in the compensation tables included in this Proxy Statement, our executives do not currently receive retirement benefits, pre-determined severance
arrangements, deferred compensation opportunities, or other perquisites that are commonly provided to executives of similarly sized companies. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=32,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=142736,FOLIO='27',FILE='DISK126:[19ZAE1.19ZAE15301]DE15301A.;16',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_dg15301_1_28"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_role_of_compensation_committee"> </A>
<A NAME="toc_dg15301_1"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Role of Compensation Committee    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our executive compensation philosophy and practice has been developed through a collaborative effort of the Compensation Committee, the Chief
Executive Officer, and the Chief Leadership Development Officer. In addition, the Compensation Committee has historically engaged the services of an independent, outside compensation consulting firm
FW Cook. The Compensation Committee regularly seeks input in its meetings from these officers and, in its discretion, the Compensation Consultant, including their ideas, opinions, and proposals
regarding executive compensation; however, the Compensation Committee functions and votes independently and is responsible for all changes to the executive compensation philosophy and program. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_role_of_corporate_management_i__rol02639"> </A>
<A NAME="toc_dg15301_2"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Role of Corporate Management in Assisting Compensation Committee    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee has the primary authority to determine the Company's compensation philosophy and to establish compensation for our
Named Executive Officers. It is responsible for ensuring that executive compensation decisions are thoroughly researched and implemented. All of our executives and employees participate in an annual
performance review with their immediate supervisor, during which the executive or employee receives input about his or her performance and contributions to our results for the period being assessed.
The Compensation Committee seeks input from the Chief Executive Officer and the Chief Leadership Development Officer to identify key factors and to obtain information related to executive
compensation. These key factors and information generally involve an executive's level of responsibility, years of experience, current overall compensation level in relation to external market studies
and internal equity analysis between executives, the impact of current compensation practices on our financial statements and condition, the relationship between executive compensation and performance
of the Company, and other relevant data. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Chief Leadership Development Officer takes direction from and makes suggestions to the Chairman of the Compensation Committee in establishing the quarterly committee meeting agenda
and preparing the materials to be presented to the Compensation Committee. These materials contain minutes from prior meetings, key items to be addressed, and background information to help the
Compensation Committee in its decision-making process. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_compensation_consultant"> </A>
<A NAME="toc_dg15301_3"> </A></FONT> <FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Consultant    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee has historically retained and utilized FW Cook to assess the Company's executive compensation program. The
Compensation Committee's most recent engagement of FW Cook was in Fiscal Year 2017, during which FW Cook advised the Committee regarding various factors of executive compensation, including total
compensation benchmarking, aggregate equity compensation, and various other incentive practices. Additionally, the Committee continued to utilize materials from FW Cook to render executive
compensation decisions in Fiscal Year 2018. Prior to engaging FW Cook, the Compensation Committee has considered and assessed FW Cook's independence. To ensure FW Cook's continued independence and to
avoid any actual or apparent conflict of interest, the Compensation Committee does not permit FW Cook to be engaged to perform any services for the Company beyond those services provided to the
Compensation Committee. To that end, in 2017 FW Cook did not perform any work for the Company outside of the services it performed for the Compensation Committee. The Compensation Committee has sole
authority to retain or terminate FW Cook as its executive compensation consultant and to approve its fees and
other terms of engagement. The Compensation Committee regularly considers the independence of the Compensation Consultant and determines whether any related conflicts of interest require disclosure. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=33,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=643059,FOLIO='28',FILE='DISK126:[19ZAE1.19ZAE15301]DG15301A.;10',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dg15301_1_29"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_peer_group"> </A>
<A NAME="toc_dg15301_4"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Peer Group    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To assist it in rendering the executive compensation determinations for our executives, the Compensation Committee has utilized, among other
things, a peer group of 20 publicly-traded direct sales, nutritional, or personal product companies to benchmark the Company's position in its use of cash and equity compensation for executives. These
companies were all within a reasonable range of our revenue, operating income, and market capitalization. This information was gathered and analyzed for the 25<SUP>th</SUP>, 50<SUP>th</SUP>, and
75<SUP>th</SUP>&nbsp;percentiles for annual salary, short-term incentive and long-term incentive pay elements. Where possible, the Compensation Committee matched our executives to appropriate
proxy and survey positions based on job duties and level of responsibility to their counterparts in this peer group. The peer group has included: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Coty,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Nature's Sunshine Products, Incorporated</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>GNC Holdings,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Nu Skin Enterprises,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>The Hain Celestial Group,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Nutraceutical International Corporation</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Herbalife,&nbsp;Ltd.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>NutriSystem&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>International Flavors and Fragrances&nbsp;Inc.</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>Prestige Brands Holdings,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Inter Parfums,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Primerica,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>LifeVantage Corporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Revlon,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Mannatech, Incorporated</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Tupperware Brands Corporation</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Medifast</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Vitamin Shoppe,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Natural Health Trends Corp.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Weight Watchers International, Inc</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_compensation_risk_assessment"> </A>
<A NAME="toc_dg15301_5"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Risk Assessment    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Compensation Committee considers the risk to the Company associated with each component of our executive compensation program, namely base
salary, and short-and-long term incentive compensation. In considering these risks, the Compensation Committee believes that the following factors, among others, reduce the likelihood of excessive
risk taking in connection with executive compensation at USANA:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our compensation components provide a balanced mix of (i)&nbsp;cash and equity compensation, (ii)&nbsp;short-term and long-term incentive
compensation, and (iii)&nbsp;financial performance metrics; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our executives generally all participate in the same short-term incentive program with similar performance metrics; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Maximum pay-out levels for short-term incentive compensation are generally capped at 100% of an executive's base salary; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our equity awards generally vest over several years and generate incremental value (over the value at the grant date, if any) if the Company
performs well financially and our stock price increases over time; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We maintain strict internal controls over the determination and payout of each component of executive compensation; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We do not typically enter into employment or other management agreements with any of our executive officers that contain post-termination or
change-in-control payments; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We generally do not provide significant perquisites or personal benefits to our executive officers. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on the Compensation Committee's review of these factors and on the results of the risk assessment, the Committee determined that our executive compensation is designed according to
its </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=34,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=798293,FOLIO='29',FILE='DISK126:[19ZAE1.19ZAE15301]DG15301A.;10',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dg15301_1_30"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>stated
philosophy and does not create risks that are reasonably likely to have a material adverse effect on the Company. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_components_of_compensation"> </A>
<A NAME="toc_dg15301_6"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Components of Compensation    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_base_salary"> </A>
<A NAME="toc_dg15301_7"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Base Salary    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Base salary represents the fixed component of executive compensation and is intended to compensate executives for their qualifications and the
value of their job in the competitive market. Our goal is to target the market median as our strategic target for base salary with actual individual compensation ranging between the
25<SUP>th</SUP>&nbsp;and 75<SUP>th</SUP>&nbsp;percentile of market pay. We review each executive's salary and performance every year to determine whether base salary should be adjusted.
Along with individual performance, we also consider movement of salary in the market and peer group, as well as our financial results from the prior year to determine appropriate salary adjustments.
While the Compensation Committee applies general compensation concepts when determining the competitiveness of our executives' salaries, the Compensation Committee generally considers base salaries as
being competitive when they are within approximately 10% of the stated market target. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_fiscal_year_2018_salary_review."> </A>
<A NAME="toc_dg15301_8"> </A>
<BR></FONT><FONT SIZE=2><I>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fiscal Year 2018 Salary Review. </I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Following its review of executive compensation for Fiscal Year 2018, the Compensation
Committee reviewed the information outlined above and approved base salaries
for the Named Executive Officers for 2019 as set out in the table below. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Executive and Title

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 Base Salary </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 Base Salary </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Kevin G. Guest, Chief Executive Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>800,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>865,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown, President and Chief Operating Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>535,600</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>562,380</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>G. Douglas Hekking, Chief Financial Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>431,600</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>453,180</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David Mulham, Chief Sales Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>427,450</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>440,274</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Walter Noot, Chief Information Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>430,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>452,025</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_short-term_cash_incentive_(non__sho02523"> </A>
<A NAME="toc_dg15301_9"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Short-Term Cash Incentive (Non-Equity Incentive Plan Compensation)    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We offer our Named Executive Officers non-equity incentive plan compensation in the form of a cash bonus that is based on our achievement of
certain financial performance objectives during the fiscal year. Cash bonuses are based on a percentage of the executive's base salary. Each year, the Compensation Committee sets the range of the cash
bonus for which each executive is eligible and sets the performance objectives on which cash bonuses for that year will be based. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_2018_executive_bonus_plan."> </A>
<A NAME="toc_dg15301_10"> </A>
<BR></FONT><FONT SIZE=2><I>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018 Executive Bonus Plan. </I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;For Fiscal Year 2018, the Compensation Committee approved the 2018 Executive Bonus Plan (the
"2018 Bonus Plan"), based on the performance objectives of growth in
net sales and profitability. As part of its determination to utilize these bonus criteria and this structure, the Compensation Committee noted that we have used this bonus structure for several years
and that with this structure we have generated strong operating results and achieved internal equity amongst the executives. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the 2018 Bonus Plan, a cash bonus based on 9.5% of our adjusted operating profits in excess of 10% of net sales is paid to executives in the form of a cash bonus. Payments are
equal to a percentage of the executive's base salary, up to 100% of base salary, depending on the Company's performance under the criteria of the plan. Each executive's target bonus percentage under
the 2018 Bonus Plan was 50% of the executive's base salary, with the exception that the target bonus percentage for Mr.&nbsp;Guest, our Chief Executive Officer, and Mr.&nbsp;Brown, our President
and Chief Operating Officer, was 75% of their respective base salaries. The Compensation Committee set the bonus targets under the 2018 Bonus Plan pursuant to recommendations of the Compensation
Consultant and other market resources. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=35,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=626096,FOLIO='30',FILE='DISK126:[19ZAE1.19ZAE15301]DG15301A.;10',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dg15301_1_31"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shortly
after the yearend, the Compensation Committee reviewed the performance objectives established under the 2018 Bonus Plan and evaluated the actual performance delivered by the
Company during Fiscal Year 2018. The Compensation Committee noted the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We achieved Fiscal Year 2018 net sales of $1.189&nbsp;billion, which is a 13.6% increase compared to Fiscal Year 2017; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our Fiscal Year 2018 adjusted operating profit was $162.1&nbsp;million; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We had 2018 adjusted operating profit in excess of 10% of net sales of $57.3&nbsp;million. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on our performance, and the criteria of the 2018 Bonus Plan, the Compensation Committee determined that each executive had earned a cash bonus equal to 62.6% of the executive's
base salary under the 2018 Bonus Plan. Consequently, the Compensation Committee awarded a bonus at this level to each executive participating in the plan. The actual cash bonuses paid to our Named
Executive Officers under the 2018 Bonus Plan are reflected in column (g)&nbsp;of the Summary Compensation Table of this Proxy Statement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_2019_executive_bonus_plan."> </A>
<A NAME="toc_dg15301_11"> </A>
<BR></FONT><FONT SIZE=2><I>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019 Executive Bonus Plan. </I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In February 2019, the Compensation Committee approved the 2019 Executive Bonus Plan and again
designated growth in net sales and profitability as the performance
objectives under the plan. The 2019 Executive Bonus Plan will continue to utilize 9.5% of operating profits in excess of 10% of consolidated net sales as the basis for the executive cash bonus in
2019. Estimated payouts for the 2019 Bonus Plan are included in the section below in the table titled "Grants of Plan-Based Awards." </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_equity_compensation"> </A>
<A NAME="toc_dg15301_12"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Compensation    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_overview_and_historical_practice."> </A>
<A NAME="toc_dg15301_13"> </A></FONT> <FONT SIZE=2><I>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Overview and Historical Practice. </I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Equity compensation is an integral part of our compensation
philosophy. We believe that equity grants that vest over a period of years tie a portion of our
executives' compensation to our long-term performance and align the interests of the executives with the interests of our shareholders. This practice delivers additional compensation to executives
when the Company's performance results in an increase in the value of our stock. The Compensation Committee awards equity compensation to supplement cash compensation and to ensure that total
compensation paid to our executives is competitive in the marketplace and aligned with our long-term goals and objectives. Over the last several years, the Compensation Committee has granted equity
awards consisting of SSARs and RSUs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Components
of our equity compensation program are as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The Compensation Committee grants annual equity awards to exeutives to, among other things, help ensure each award has potential value if the
Company performs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Awards generally vest and become exercisable in four equal annual installments of twenty-five percent (25%) of the total award on each of the
first through fourth anniversary of the grant date; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The value of the annual equity award to an executive is (i)&nbsp;in-line with the market for each executive's title and position, and
(ii)&nbsp;inclusive of an internal equity review comparing ascpects of each position with other positions, and (iii)&nbsp;calculated to generate total compensation for the respective executive at
a level that acomplishes the described purposes of the compensation committee. The total compensation is targeted to be with the 50<SUP>th</SUP>&nbsp;to 75<SUP>th</SUP>&nbsp;percentile of
the peer group; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The Compensation Committee utilizes awards of RSUs in addition to SSARs to diversify the mix of equity granted to executives; and </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=36,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=970095,FOLIO='31',FILE='DISK126:[19ZAE1.19ZAE15301]DG15301A.;10',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dg15301_1_32"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Each of the grant value, share usage rate and shareholder value transfer rate associated with annual grants to executives is managed to be
in-line with the market and, more specifially, between the 50<SUP>th</SUP>&nbsp;and 75<SUP>th</SUP>&nbsp;percentile of the peer group. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
grant price for equity awards is determined by the closing price of the Company's common stock on the date of grant. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_excutive_stock_ownership_policy."> </A>
<A NAME="toc_dg15301_14"> </A>
<BR></FONT><FONT SIZE=2><I>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excutive Stock Ownership Policy. </I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee has also adopted a formal executive stock ownership policy. Under
this policy, executive officers identified by the Compensation
Committee are required to hold at least a percentage of their annual base salary in USANA common stock as follows: (1)&nbsp;the CEO is required to hold a minimum of 1.5 times the value of his annual
base salary; and (2)&nbsp;all other officers are required to hold a minimum of one times the value of their annual base salary. Unexercised SSARs, whether or not vested, unvested RSUs, and unearned
and unvested DSUs are also be considered as held in satisfaction of this policy. The amount of an officer's personal stock holdings is reviewed by the Compensation Committee annually and each officer
has been allowed two years from the 2017 implementation date of the policy to achieve compliance with the policy. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_other_compensation"> </A>
<A NAME="toc_dg15301_15"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Compensation    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than as described above, we do not provide benefits to our Named Executive Officers that are different from or in addition to those that
we provide to our general employees. Those benefits are described below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_retirement_"> </A>
<A NAME="toc_dg15301_16"> </A>
<BR></FONT><FONT SIZE=2><I>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retirement: </I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Executives may participate in our employer-sponsored 401(k) retirement plan on the same terms and conditions,
including employer-matching provisions, as other
employees. For the year ended December&nbsp;29, 2018, we contributed matching funds totaling $2,015,568 to our 401(k) plan in which all eligible employee participants shared, including our
executives. During 2018, each of our eligible U.S. executives participated in our 401(k) plan and shared matching funds totaling $77,000, and Mr.&nbsp;Mulham received retirement compensation of
$89,938 pursuant to the local law in his country of residence. Except as disclosed in this paragraph, we provide no other retirement benefits to our executives. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_severance_"> </A>
<A NAME="toc_dg15301_17"> </A>
<BR></FONT><FONT SIZE=2><I>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severance: </I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We do not have any pre-arranged severance agreements or contracts with any of our executives that contain
post-termination or change-in-control payment
provisions. From time to time, we have provided severance benefits to terminated or departing executives on a case-by-case basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_perquisites_"> </A>
<A NAME="toc_dg15301_18"> </A>
<BR></FONT><FONT SIZE=2><I>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Perquisites: </I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;It is our general practice not to provide significant perquisites or personal benefits to our executives. The
Compensation Committee, however, retains the
discretion to consider and award reasonable perquisites or personal benefits to executives as necessary to accomplish the objectives under our compensation philosophy. In this regard, please note that
we do not currently provide pension arrangements, post-retirement health coverage, or similar benefits for our executives or employees. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_insurance_plans_and_other_benefits_"> </A>
<A NAME="toc_dg15301_19"> </A>
<BR></FONT><FONT SIZE=2><I>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance Plans and Other Benefits: </I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We provide insurance plans and other benefits to our executives that are similar to those
plans and benefits that we customarily provide to our general employees.
In 2018, we paid health, life, and disability insurance premiums on behalf of our executives, all on the same terms as those that we provide generally to all of our employees. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_indemnification_"> </A>
<A NAME="toc_dg15301_20"> </A>
<BR></FONT><FONT SIZE=2><I>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnification: </I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our Amended and Restated Articles of Incorporation and our Amended and Restated Bylaws provide for
indemnification of our directors, officers, employees, and
other agents to the fullest extent and under the circumstances permitted by the Utah Revised Business Corporation Act. In addition, we have entered into agreements with our directors and officers that
require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers to the fullest extent allowed. Insofar as
indemnification for liabilities </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=37,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=770160,FOLIO='32',FILE='DISK126:[19ZAE1.19ZAE15301]DG15301A.;10',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dg15301_1_33"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>arising
under the Securities Act may be permitted to directors, officers, or control persons under the foregoing provisions, the SEC has stated that such indemnification is against public policy, as
expressed in the Securities Act, and, therefore, such indemnification provisions may be unenforceable. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dg15301_accounting_considerations_and___acc03014"> </A>
<A NAME="toc_dg15301_21"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Accounting Considerations and Tax Deductibility of Executive Compensation    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In designing compensation programs, we consider the effects that accounting and taxation may have on us, the Named Executive Officers, or other
employees as a group. We account for compensation arrangements in accordance with FASB ASC Topic 718. All share-based payments to employees are measured at fair value on the date of grant and
recognized in the statement of operations as compensation expense over the employees' requisite service periods. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Historically,
Section&nbsp;162(m) of the Code generally limited the corporate tax deduction for compensation paid to certain executive officers that was not "performance based" to
$1&nbsp;million and provided an exception to the limitation for compensation qualifying as "performance-based compensation" within the meaning of the Code and the applicable Treasury Regulations.
The "Tax Cuts and Jobs Act," (the "Tax Act") enacted in December 2017, repealed the exemption to Section&nbsp;162(m)'s deduction limit for performance-based compensation for taxable years beginning
after December&nbsp;31, 2017, such that compensation paid to our covered executive officers in excess of $1&nbsp;million is not deductible. While we will continue to monitor our compensation
programs in light of the deduction limitation imposed by Section&nbsp;162(m) of the Code, our Compensation Committee considers it important to retain the flexibility to design compensation programs
that are in the best long-term interests of the Company and our shareholders. As a result, we have not adopted a policy requiring that all compensation be deductible. The Compensation Committee may
conclude that paying compensation at levels that are subject to limits under Section&nbsp;162(m) of the Code is nevertheless in the best interests of the Company and our shareholders. Given changes
made to Section&nbsp;162(m) by the Tax Act, it is likely that we will not be able to deduct for federal income tax purposes a portion of the compensation paid to our Named Executive Officers in
2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many
other Code provisions and accounting rules affect the payment of executive compensation and are generally taken into consideration as our compensation arrangements are developed.
For example, the Code was amended to provide a surtax under Section&nbsp;409A of the Code with respect to various features of deferred compensation arrangements of publicly-held corporations, mostly
for compensation deferred on or after January&nbsp;1, 2005. Our goal is to create and maintain compensation arrangements that are efficient, effective and in full compliance with these requirements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dg15301_report_of_the_compensation_committee"> </A>
<A NAME="toc_dg15301_22"> </A>
<BR></FONT><FONT SIZE=2><B>  REPORT OF THE COMPENSATION COMMITTEE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee of the Board of USANA Health Sciences,&nbsp;Inc. has reviewed and discussed the foregoing Compensation Discussion
and Analysis required by Item&nbsp;402(b) of Regulation&nbsp;S-K with management of the Company and, based on such review and discussion in this Proxy Statement, has recommended to the Board that
it be included in this Proxy Statement and incorporated by reference into USANA's Annual Report on Form&nbsp;10-K for the year ended December&nbsp;29, 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Submitted
by the members of the Compensation Committee: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Frederic
Winssinger (Chair)<BR>
J. Scott Nixon<BR>
Feng Peng </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=38,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=635904,FOLIO='33',FILE='DISK126:[19ZAE1.19ZAE15301]DG15301A.;10',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_di15301_1_34"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="di15301_summary_compensation_table"> </A>
<A NAME="toc_di15301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  SUMMARY COMPENSATION TABLE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes, with respect to our Named Executive Officers, information relating to the compensation earned for services
rendered in all capacities during the Fiscal Years 2018, 2017 and 2016. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="26pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name and principal position<BR>
(a)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year<BR>
(b) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Salary<BR>
($)<BR>
(c) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Bonus<BR>
($)<BR>
(d) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
awards<BR>
($)(1)<BR>
(e) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Non-equity<BR>
incentive plan<BR>
compensation<BR>
($)(2)<BR>
(f) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All other<BR>
compensation<BR>
($)(3)<BR>
(g) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($)<BR>
(h) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Kevin G. Guest,</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>820,769</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,318,333</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>770,450</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,625</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,919,177</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Executive Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>811,317</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>58,613</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>754,769</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>428,542</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,450</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,062,691</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>626,628</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>306,923</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,275</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>942,826</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown,</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
533,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
669,433</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
500,793</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
9,625</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
1,713,351</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>President and Chief Operating Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>523,335</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>62,808</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>552,205</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>294,113</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,450</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,424,227</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>401,122</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>83,333</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>196,469</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,275</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>690,199</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 G. Douglas Hekking</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
429,365</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
418,627</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
268,694</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
9,625</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
1,126,311</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Financial Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>372,981</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,964</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>362,274</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>111,496</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,450</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>894,009</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David Mulham,</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
417,689</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
397,525</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
251,951</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
89,939</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
1,157,103</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chief Sales Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>411,718</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>20,124</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>351,011</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>148,990</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>64,924</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>996,688</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Walter Noot,</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
427,741</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
400,296</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
267,677</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
9,625</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
1,105,338</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Information Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Amounts
in this column reflect the grant date fair value of SSARs and RSUs computed in accordance with Accounting Standards Codification Topic 718. These amounts do
not represent the actual amounts paid to or realized by the Executive for these awards during the applicable fiscal year. Assumptions used in the calculation of these amounts are included in the
Equity Based Compensation footnote to the Company's consolidated financial statements that are included in the Company's Annual Report on Form&nbsp;10-K for the year ended December&nbsp;29, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Amounts
paid as cash bonus in subsequent fiscal year for performance realized in prior fiscal year (i.e.,&nbsp;results of 2018 executive bonus paid out in first
quarter of 2019), under the Company's short-term incentive plan discussed in the Compensation Discussion and Analysis section of this Proxy Statement.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Amounts
in this column reflect employer's matching contributions to the Executive's 401(k) plan, except in the case of the compensation paid to Mr.&nbsp;Mulham,
which is retirement compensation paid pursuant to local law in his country of residence. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=39,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=149382,FOLIO='34',FILE='DISK126:[19ZAE1.19ZAE15301]DI15301A.;12',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_di15301_1_35"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="di15301_fiscal_year_2018_ceo_pay_ratio"> </A>
<A NAME="toc_di15301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  FISCAL YEAR 2018 CEO PAY RATIO    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As required by Section&nbsp;953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item&nbsp;402(u) of
Regulation&nbsp;S-K, we are providing the following information about the relationship of the annual compensation of our employees and the annual total compensation of Kevin&nbsp;G.&nbsp;Guest,
our CEO, for Fiscal Year 2018. The Compensation Committee reviewed a comparison of our CEO annual total compensation in Fiscal Year 2018 to that of all other Company employees for the same period.
Below is the ratio of the pay of our CEO to the annual pay of our "median employee" (the "Pay Ratio") under the rule. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
identified the median employee by examining the 2018 total compensation for all full-time and part-time employees, excluding our CEO, employed by us on December&nbsp;29, 2018. We
are not using the same median employee that we used last year because that employee's wages no longer represented the median due to an increase in the number of employees with the company. We
calculated annual total compensation using the same methodology we use for our Named Executive Officers as set forth in the 2018 Summary Compensation Table above. We adjusted estimates with respect to
total compensation by annualizing the compensation for any newly-hired, full-time employees who were not employed by us for all of 2018. We have a global workforce, with employees in 24 countries.
Compensation paid in foreign currencies was converted to U.S. dollars based on average exchange rates in effect on December&nbsp;29, 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
annual total compensation for Fiscal Year 2018 for our CEO was $2,919,177 as noted in the table above. Annual total compensation for our median employee was $41,950. The Pay Ratio
for Fiscal Year 2018 is 70 to 1. Under the SEC's rules and guidance, there are numerous ways to determine the compensation of a company's median employee, including the employee population sampled,
the elements of pay and benefits used, any assumptions made and the use of statistical sampling. In addition, no two companies have identical employee populations or compensation programs, and pay,
benefits and retirement plans differ by country even within the same company. As a result of our methodology for determining the pay ratio, which is described above, our pay ratio may not be
comparable to the pay ratios of other companies in our industry or in other industries because other companies may rely on different methodologies or assumptions, or may make adjustments that we do
not make. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=40,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=18108,FOLIO='35',FILE='DISK126:[19ZAE1.19ZAE15301]DI15301A.;12',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_di15301_1_36"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="DI1"></A>GRANTS OF PLAN-BASED AWARDS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The table below summarizes estimated or targeted payouts to the Named Executive Officers under the 2019 Bonus Plan described in the Compensation
Discussion and Analysis section of this Proxy Statement. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated future payouts under<BR>
non-equity incentive plan awards </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Stock Awards;<BR>
Number of<BR>
Shares of<BR>
Stock or<BR>
Units (#)(2)<BR>
(i) </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant Date<BR>
Fair Value of<BR>
Stock<BR>
Awards<BR>
($)(3)<BR>
(j) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name<BR>
(a)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant<BR>
date<BR>
(b) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Threshold<BR>
($)(1)<BR>
(c) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Target<BR>
($)(1)<BR>
(d) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Maximum<BR>
($)(1)<BR>
(e) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Kevin G. Guest,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>648,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>865,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Executive Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>02-05-18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18,555</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,318,333</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
421,785</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
562,380</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>President and Chief Operating Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>02-05-18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,422</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>669,433</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 G. Douglas Hekking,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
226,590</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
453,180</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Financial Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>02-05-18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,892</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>418,627</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David Mulham,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
220,137</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
440,274</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chief Sales Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>02-05-18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,595</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>397,525</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Walter Noot,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
226,012</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
452,025</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Information Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>02-05-18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,634</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>400,296</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Columns
(f), (g)&nbsp;and (h)&nbsp;are intentionally omitted. There is no guaranteed payment to our Named Executive Officers under the 2019 Executive Bonus Plan.
If the minimum performance objectives are not achieved, they will receive no payout under the 2019 Executive Bonus Plan. The amounts shown in column (d)&nbsp;reflect the target payout, which is 75%
of base salary for Mr.&nbsp;Guest and Mr.&nbsp;Brown and 50% of base salary for each of the other Executives. The amounts shown in column (e)&nbsp;reflect 100% of the Executive's base salary,
which is the maximum payout that can be obtained under the 2019 Executive Bonus Plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>All
equity awards granted to the Named Executive Officers were RSUs and granted under the 2015 Equity Incentive Award Plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>All
Equity Awards granted to the Named Executive Officers were granted at the closing stock price on the date of grant. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=41,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=510541,FOLIO='36',FILE='DISK126:[19ZAE1.19ZAE15301]DI15301A.;12',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_dk15301_1_37"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="DK1"></A>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table includes certain information with respect to the value of all equity awards previously granted to the Named Executive
Officers outstanding as of December&nbsp;29, 2018. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="DK2"></A>Outstanding Equity Awards at Fiscal Year-End  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Restricted Stock Unit<BR>
awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number Of Securities<BR>
Underlying Unexercised<BR>
Options (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
shares or<BR>
units of<BR>
stock that<BR>
have not<BR>
vested<BR>
(#) </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Market<BR>
value of<BR>
shares or<BR>
units that<BR>
have not<BR>
vested<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Unexercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
exercise<BR>
price<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
expiration<BR>
date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Kevin G. Guest,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>09-01-15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70.75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>03-01-2020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Executive</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>05-01-17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,120</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>473,635</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Officer(2)(3)(4)(8)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10-23-17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,503</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>632,625</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>02-05-18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18,555</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,133,083</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
09-01-15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
30,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
70.75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
03-01-2020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>President and Chief Operating</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>05-01-17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,120</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>473,635</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Officer(2)(3)(4)(8)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10-23-17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>346,604</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>02-05-18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,422</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,083,153</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 G. Douglas Hekking,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
09-01-15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
15,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
70.75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
03-01-2020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Financial</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>05-01-17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,659</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>305,679</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Officer(4)(5)(6)(8)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10-23-17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>231,989</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>02-05-18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,892</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>677,344</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David Mulham,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
09-01-15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
30,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
30,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
70.75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
03-01-2020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chief Sales Officer(3)(4)(5)(8)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>05-01-17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,619</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>301,080</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10-23-17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,916</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>220,263</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>02-05-18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,595</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>643,201</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Walter Noot,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
12-16-16</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
16,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
48,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
62.20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
07-16-2022</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Information</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10-23-17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,894</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>217,734</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Officer(4)(5)(7)(8)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>02-05-18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,634</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>647,685</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
market value of the RSUs that have not vested is calculated by multiplying the number of units shown in the table by $114.96, the closing stock price on
December&nbsp;29, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
SSAR grants to Mr.&nbsp;Guest and Mr.&nbsp;Brown which expire on March&nbsp;1, 2020, vest 50% in September 2018 and 50% in September 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
RSU grants to Mr.&nbsp;Guest, Mr.&nbsp;Brown, and Mr.&nbsp;Mulham on May&nbsp;1, 2017, vest 25% annually beginning on February&nbsp;6, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
RSU grants that Mr.&nbsp;Guest, Mr.&nbsp;Brown, Mr.&nbsp;Hekking, Mr.&nbsp;Mulham, and Mr.&nbsp;Noot, received on October&nbsp;23, 2017, vest 25%
annually, beginning on the first anniversary of the date of grant.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
SSAR grants to Mr.&nbsp;Mulham and Mr.&nbsp;Hekking which expire on March&nbsp;1, 2020, vest 40% in September 2017, 30% in September 2018 and 30% in
September 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
RSU grant that Mr.&nbsp;Hekking, received on May&nbsp;1, 2017, vests 25% annually, beginning on the first anniversary of the date of grant. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=42,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=7462,FOLIO='37',FILE='DISK126:[19ZAE1.19ZAE15301]DK15301A.;41',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dk15301_1_38"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
SSAR grant to Mr.&nbsp;Noot, which expires on July&nbsp;16, 2020, vests 20% annually, beginning on the first anniversary of the date of grant.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
RSU grants that Mr.&nbsp;Guest, Mr.&nbsp;Brown, Mr.&nbsp;Hekking, Mr.&nbsp;Mulham, and Mr.&nbsp;Noot, received on February&nbsp;5, 2018, vest 25%
annually, beginning on the first anniversary of the date of grant.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dk15301_option_exercises_and_stock_vested"> </A>
<A NAME="toc_dk15301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  OPTION EXERCISES AND STOCK VESTED    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes information regarding the exercise of SSARs and each vesting of RSUs, for each of the Named Executive Officers on
an aggregated basis during the Fiscal Year ended December&nbsp;29, 2018. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Restricted stock unit<BR>
awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(a)<BR>
Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(b)<BR>
Number of<BR>
shares<BR>
acquired on<BR>
exercise (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(c)<BR>
Value<BR>
realized on<BR>
exercise ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(d)<BR>
Number of<BR>
shares<BR>
acquired on<BR>
vesting (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(e)<BR>
Value<BR>
realized on<BR>
vesting ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Kevin G. Guest</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25,266</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,095,573</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,208</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>290,585</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13,021</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,629,032</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,378</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>203,087</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>G. Douglas Hekking</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,993</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,023,225</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,559</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>165,307</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David Mulham</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,733</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,650,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,512</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>129,128</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Walter Noot</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,075</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>236,800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>631</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>66,520</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=43,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=694682,FOLIO='38',FILE='DISK126:[19ZAE1.19ZAE15301]DK15301A.;41',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dk15301_1_39"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dk15301_equity_compensation_plan_information"> </A>
<A NAME="toc_dk15301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  EQUITY COMPENSATION PLAN INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth information regarding outstanding awards and shares reserved for future issuance under our equity compensation
plans as of December&nbsp;29, 2018. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="107pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plan Category


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
securities to be<BR>
issued upon<BR>
exercise of<BR>
outstanding<BR>
awards(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted-average<BR>
exercise price of<BR>
outstanding<BR>
awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of securities<BR>
remaining available for<BR>
future issuance under<BR>
equity compensation<BR>
plans (excluding<BR>
securities reflected in<BR>
column (a)) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity compensation plans approved by security holders</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,536,870</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>66.07</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,298,687</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity compensation plans not approved by security holders</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>None</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>None </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,536,870</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>66.07</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,298,687</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of shares of common stock issuable under the USANA 2015 Equity Incentive Award Plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
(i)&nbsp;196,894 RSUs and 23,631 DSUs that will entitle each holder to the issuance of one share of common stock for each unit, and (ii)&nbsp;1,316,345
SSARs. A SSAR is the right to receive the appreciation in fair market value of common stock between the exercise date and the date of grant in shares of common stock. Based on the closing stock price
of $114.96 on the last trading day of fiscal 2018 and the exercise price of SSARs that were in-the-money, 559,838 shares of common stock would be issued upon the exercise of these SSAR awards.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Calculated
without taking into account 220,525 shares of common stock subject to outstanding RSUs&nbsp;&amp; DSUs, which are issuable without any cash consideration or
other payment required for such shares.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dk15301_employment_contracts_and_other_arrangements"> </A>
<A NAME="toc_dk15301_3"> </A>
<BR></FONT><FONT SIZE=2><B>  EMPLOYMENT CONTRACTS AND OTHER ARRANGEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We do not have written employment agreements with any of our Named Executive Officers. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dk15301_proposal_#3_#151;annual_adviso__pro03890"> </A>
<A NAME="toc_dk15301_4"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL #3&#151;ANNUAL ADVISORY "SAY ON PAY" VOTE TO APPROVE OUR<BR>  NAMED EXECUTIVE OFFICERS' COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Board believes that our compensation philosophy and program design are essential elements of our culture. Executive compensation is
important in providing us with a competitive advantage in successfully attracting talent in a highly competitive industry. Our Compensation Committee has carefully considered the elements of executive
compensation as it looks
to appropriately incentivize our executive management and align their interests with shareholder value creation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are required under Section&nbsp;14A of the Exchange Act, enacted pursuant to The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and rules promulgated by the SEC,
to conduct a non-binding advisory vote of our shareholders to approve the compensation paid to our Named Executive Officers as disclosed in this Proxy Statement. This is sometimes referred to as a
"say-on-pay proposal." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
vote is not intended to address any specific item of compensation, rather we are asking that you indicate your support for the overall compensation of our Named Executive Officers,
and the executive compensation policies and practices as described in the Compensation Discussion and Analysis and in the accompanying "Executive Compensation Tables" and related disclosures in this
Proxy Statement for a more detailed discussion of our compensation programs and policies, the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=44,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=1042845,FOLIO='39',FILE='DISK126:[19ZAE1.19ZAE15301]DK15301A.;41',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dk15301_1_40"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>compensation
governance measures undertaken and implemented by our Board, and the compensation awarded to our Named Executive Officers during Fiscal Year 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
is not a vote on our general compensation policies or any specific element of compensation, the compensation of our non-employee directors, our CEO pay ratio, or the features of our
compensation program designed to prevent excessive risk-taking. The results of the advisory vote are not binding on our Board. However, in accordance with SEC regulations, the Compensation Committee
will disclose the extent to which it takes into account the results of the vote in the CD&amp;A of our 2020 proxy statement and take them into consideration when structuring future executive compensation
arrangements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
affirmative vote of a majority of the votes cast at the Annual Meeting is required to approve this proposal. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A NAME="dk15301_recommendation_of_the_board_of_directors"> </A>
<A NAME="toc_dk15301_5"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


RECOMMENDATION OF THE BOARD OF DIRECTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board recommends that you vote </FONT><FONT SIZE=2><B>FOR</B></FONT><FONT SIZE=2> the approval of the following resolution: </FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2><B><I>"RESOLVED, that the shareholders approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement, including the
Compensation Discussion and Analysis, the Summary Compensation Table and the related compensation tables, notes and narrative discussion."</I></B></FONT></P>

</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dk15301_shareholder_proposals_for_2020__sha02268"> </A>
<A NAME="toc_dk15301_6"> </A>
<BR></FONT><FONT SIZE=2><B>  SHAREHOLDER PROPOSALS FOR 2020 ANNUAL MEETING OF SHAREHOLDERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholder proposals must be received by our Corporate Secretary at USANA Health Sciences,&nbsp;Inc., Attention: Corporate Secretary, 3838
West Parkway Blvd., Salt Lake City, Utah&nbsp;84120-6336, no later than November&nbsp;15, 2019, to be eligible for inclusion in our form of proxy, notice of meeting and proxy statement relating to
the 2020 Annual Meeting of Shareholders. We are not required to include in our proxy materials a shareholder proposal that is received after that date or that otherwise fails to meet the requirements
for shareholder proposals established by applicable SEC rules. The SEC has promulgated rules relating to the exercise of discretionary voting authority pursuant to proxies solicited by the Board. If a
shareholder intends to present a proposal at the 2020 Annual Meeting without including that proposal in our proxy materials and written notice of the proposal is not received by us as described above,
or if we meet other requirements of the applicable SEC rules, then the proxies solicited by the Board for use at the 2020 Annual Meeting will confer discretionary authority to the individuals acting
under the proxies to vote on the proposal at the 2020 Annual Meeting. Our 2020 Annual Meeting is currently scheduled to be held on May&nbsp;1, 2020. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dk15301_other_business"> </A>
<A NAME="toc_dk15301_7"> </A>
<BR></FONT><FONT SIZE=2><B>  OTHER BUSINESS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of the date of this Proxy Statement, the Board knows of no matter that will be properly presented for action at the Annual Meeting other than
those matters discussed in this Proxy Statement. However, if any other matter requiring a vote of the shareholders properly comes before the Annual Meeting, the individuals acting under the proxies
solicited by the Board will vote and act
according to their best judgment in light of the conditions then prevailing, to the extent permitted under applicable law. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=45,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=750041,FOLIO='40',FILE='DISK126:[19ZAE1.19ZAE15301]DK15301A.;41',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dk15301_1_41"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dk15301_annual_report_on_form_10-k"> </A>
<A NAME="toc_dk15301_8"> </A>
<BR></FONT><FONT SIZE=2><B>  ANNUAL REPORT ON FORM 10-K    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Audited consolidated financial statements for the Company and its subsidiaries for the Fiscal Year ended December&nbsp;29, 2018, are included
in our Annual Report on Form&nbsp;10-K filed with the SEC. Copies of the Annual Report on Form&nbsp;10-K for Fiscal Year 2018 (excluding exhibits, unless such exhibits have been specifically
incorporated by reference therein) may be obtained without charge by writing to USANA Health Sciences,&nbsp;Inc., Attention: Investor Relations, 3838 West Parkway Blvd., Salt Lake City, Utah
84120-6336. Our reports and other public filings, including this Proxy Statement, also may be obtained from the SEC's on-line database, located at </FONT> <FONT SIZE=2><I>www.sec.gov</I></FONT><FONT SIZE=2>. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Annual Report on Form&nbsp;10-K for Fiscal Year 2018 and other SEC filings are also available on the Investor page of our website at </FONT> <FONT SIZE=2><I>www.usana.com</I></FONT><FONT SIZE=2> and can be viewed at the SEC's Public Reference Room at
100&nbsp;F Street N.E., Washington, D.C. 20549. The Annual Report on
Form&nbsp;10-K is not deemed a part of the proxy soliciting material for the Annual Meeting. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dk15301_electronic_delivery_of__dk102361"> </A>
<A NAME="toc_dk15301_9"> </A>
<BR></FONT><FONT SIZE=2><B>  ELECTRONIC DELIVERY OF FUTURE SHAREHOLDER COMMUNICATIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered shareholders can further save us expense by consenting to receive all future proxy statements, forms of proxy and annual reports
electronically via e-mail or the Internet. To sign up for electronic delivery, please access the website </FONT><FONT SIZE=2><I>www.proxyvote.com</I></FONT><FONT SIZE=2> when transmitting your voting
instructions and, when prompted, indicate that you agree to receive or access shareholder communications electronically in future years. Your choice will remain in effect unless and until you revoke
it. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
revoke your decision to receive or access shareholder communications electronically, access the website </FONT><FONT SIZE=2><I>www.proxyvote.com</I></FONT><FONT SIZE=2>, enter your
current PIN, select "Cancel my Enrollment," and click on the Submit button. After submitting your entry, the Cancel Enrollment Confirmation screen will be displayed. This screen will show your current
Enrollment Number. To confirm your enrollment cancellation, click on the Submit button. Otherwise, click on the Back button to return to the Enrollment Maintenance screen. After submitting your entry,
the Cancel Enrollment Complete screen will be displayed. This screen will indicate that your enrollment has been cancelled. You may be asked to complete a brief survey to help us understand why you
opted out of electronic delivery. You will be sent an e-mail message confirming the cancellation of your enrollment. No further electronic communications will be conducted for your account and your
Enrollment Number will be marked as "Inactive." You may reactivate your enrollment at any time. You will be responsible for any fees or charges that you would typically pay for access to the Internet. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=46,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=966698,FOLIO='41',FILE='DISK126:[19ZAE1.19ZAE15301]DK15301A.;41',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<A NAME="page_dk15301_1_42"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg15301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dk15301_householding_of_annual_meeting_materials"> </A>
<A NAME="toc_dk15301_10"> </A>
<BR></FONT><FONT SIZE=2><B>  HOUSEHOLDING OF ANNUAL MEETING MATERIALS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The SEC has implemented rules regarding the delivery of proxy materials (</FONT><FONT SIZE=2><I>i.e.</I></FONT><FONT SIZE=2>, annual reports to
shareholders, proxy statements, and Notices of Internet Availability of Proxy Materials) to households. This method of delivery, often referred to as "householding," permits us to send: (a)&nbsp;a
single annual report and/or a single proxy statement or (b)&nbsp;a single Notice of Internet Availability of Proxy Materials to multiple registered shareholders who share an address. In each case,
each registered shareholder at the shared address must consent to the householding process in accordance with applicable SEC rules. Each registered shareholder would continue to receive a separate
proxy card with proxy materials delivered by mail or e-mail. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Only
one copy of this Proxy Statement and our 2018 Annual Report or one copy of the Notice of Internet Availability of Proxy Materials is being delivered to multiple registered
shareholders at a shared address, who have affirmatively consented, in writing, to the householding process, unless we have subsequently received contrary instructions from one or more of such
registered shareholders. A separate proxy card is being included for each account at the shared address to which paper copies of this Proxy Statement and our 2018 Annual Report have been delivered. We
will promptly deliver, upon written or oral request, a separate copy of this Proxy Statement and the 2018 Annual Report or a separate copy of the Notice of Internet Availability of Proxy Materials to
a registered shareholder at a shared address to which a single copy of these documents was delivered. A registered shareholder at a shared address may contact us by mail addressed to USANA Health
Sciences,&nbsp;Inc., Attention: Investor Relations, 3838 West Parkway Blvd., Salt Lake City, Utah 84120-6336, or by phone at (801)&nbsp;954-7100, to: (a)&nbsp;request additional copies of this
Proxy Statement and our 2018 Annual Report or the Notice of Internet Availability of Proxy Materials; or (b)&nbsp;notify us that the registered shareholder wishes to receive
a separate annual report to shareholders, proxy statement or Notice of Internet Availability of Proxy Materials, as applicable, in the future. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
shareholders who share an address may request delivery of a single copy of annual reports to shareholders, proxy statements, or Notices of Internet Availability of Proxy
Materials, as applicable, in the future, if they are currently receiving multiple copies, by contacting us as described in the preceding paragraph. Many brokerage firms and other holders of record
have also instituted householding. If your family or others with a shared address have one or more "street name" accounts under which you beneficially own common stock, you may have received
householding information from your broker/dealer, financial institution or other nominee in the past. Please contact the holder of record directly if you have questions, require additional copies of
this Proxy Statement and our Annual Report or the Notice of Internet Availability of Proxy Materials, or wish to revoke your decision to household and thereby receive multiple copies. You should also
contact the holder of record if you wish to institute householding. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>By Order of the Board of Directors,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2><B>
<IMG SRC="g189424.jpg" ALT="GRAPHIC" WIDTH="123" HEIGHT="52">
 </B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Joshua Foukas<BR></FONT> <FONT SIZE=2><I>Chief Legal Officer, General<BR>
Counsel and Corporate Secretary</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>Date:
March&nbsp;22, 2019 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>42</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=47,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=632851,FOLIO='42',FILE='DISK126:[19ZAE1.19ZAE15301]DK15301A.;41',USER='CHE109858',CD='19-MAR-2019;01:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">VOTE BY   INTERNET Before The Meeting - Go to www.proxyvote.com Use the Internet to   transmit your voting instructions and for electronic delivery of information   up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting   date. Have your proxy card in hand when you access the web site and follow   the instructions to obtain your records and to create an electronic voting   instruction form. USANA HEALTH SCIENCES, INC. ATTN: JOSHUA FOUKAS 3838 W.   PARKWAY BLVD. SALT LAKE CITY, UT 84120 During The Meeting - Go to   www.virtualshareholdermeeting.com/USNA2019 You may attend the meeting via the   Internet and vote during the meeting. Have the information that is printed in   the box marked by the arrow available and follow the instructions. VOTE BY   PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting   instructions up until 11:59 p.m. Eastern Time the day before the cut-off date   or meeting date. Have your proxy card in hand when you call and then follow   the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return   it in the postage-paid envelope we have provided or return it to Vote   Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE,   MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: E61960-P20579 KEEP THIS   PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD   IS VALID ONLY WHEN SIGNED AND DATED. USANA HEALTH SCIENCES, INC. The Board of   Directors recommends you vote FOR the following: For Withhold For All   AllAllExcept To withhold authority to vote for any individual nominee(s),   mark &quot;For All Except&quot; and write the number(s) of the nominee(s) on   the line below. ! ! ! 1. Election of Directors Nominees: 01) Myron W. Wentz,   Ph.D. 02) Robert Anciaux 03) Gilbert A. Fuller 04) Kevin G. Guest 05) Feng   Peng 06) Peggie J. Pelosi 07) Frederic Winssinger For Against Abstain The   Board of Directors recommends you vote FOR proposals 2 and 3. ! ! ! ! ! ! 2.   Ratify the selection of KPMG LLP as the Company's independent registered   public accounting firm for the fiscal year 2019. 3. Approve on an advisory   basis the Company's executive compensation, commonly referred to as a   &quot;Say on Pay&quot; proposal. NOTE: To consider and act upon such other   business as may properly come before the meeting or at any postponement or   adjournment thereof. Please sign exactly as your name(s) appear(s) hereon.   When signing as attorney, executor, administrator, or other fiduciary, please   give full title as such. Joint owners should each sign personally. All   holders must sign. If a corporation or partnership, please sign in full   corporate or partnership name by authorized officer. Signature [PLEASE SIGN   WITHIN BOX] Date Signature (Joint Owners) Date </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="935" height="1208" src="g22532bgi001.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- ZEQ.=1,SEQ=48,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=679919,FOLIO='',FILE="DISK128:[19ZAE2.19ZAE15302]2253-2-BG_ZAE15302.CHC",USER="JDAY",CD='Mar 19 07:22 2019' -->

<div style="page-break-before:always;"></div>
<div>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">Important   Notice Regarding the Availability of Proxy Materials for the Annual Meeting:   The Notice and Proxy Statement and Annual Report are available at   www.proxyvote.com. E61961-P20579 USANA HEALTH SCIENCES, INC. Annual Meeting   of Shareholders May 1, 2019 11:00 AM MDT This proxy is solicited by the Board   of Directors The shareholder executing and delivering this Proxy hereby   appoints Kevin G. Guest and G. Douglas Hekking and each of them as Proxies,   with full power of substitution, and hereby authorizes them to represent and   vote, as designated on the reverse side, all shares of common stock of the   Company held of record by the undersigned as of March 1, 2019, at the Annual   Meeting of Shareholders of USANA Health Sciences, Inc., to be held at   www.virtualshareholdermeeting.com/USNA2019, on Wednesday, May 1, 2019, at 11:00   a.m., Mountain Daylight Time, or at any adjournment thereof. This Proxy is   given in accordance with the instructions indicated and carries discretionary   authority related to any and all other matters that may come before the   meeting and any adjournments thereof. This proxy, when properly executed,   will be voted in the manner directed herein. If no such direction is made,   this proxy will be voted in accordance with the Board of Directors'   recommendations. PLEASE SIGN EXACTLY AS THE SHARES ARE ISSUED. WHEN CO-TENANTS   HOLD SHARES, BOTH SHOULD SIGN. WHEN SIGNING AS ATTORNEY, AS EXECUTOR,   ADMINISTRATOR, TRUSTEE OR GUARDIAN, PLEASE GIVE FULL TITLE AS SUCH. IF A   CORPORATION, PLEASE SIGN IN FULL CORPORATE NAME BY PRESIDENT OR OTHER   AUTHORIZED OFFICER. IF A PARTNERSHIP, PLEASE SIGN IN PARTNERSHIP NAME BY   AUTHORIZED PERSON. PLEASE DATE, SIGN AND RETURN THIS PROXY CARD PROMPTLY   USING THE ENCLOSED ENVELOPE. Continued and to be signed on reverse side </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="935" height="1208" src="g22532bgi002.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- ZEQ.=1,SEQ=49,EFW="2238104",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=517901,FOLIO='',FILE="DISK128:[19ZAE2.19ZAE15302]2253-2-BG_ZAE15302.CHC",USER="JDAY",CD='Mar 19 07:22 2019' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g769934.jpg
<DESCRIPTION>G769934.JPG
<TEXT>
begin 644 g769934.jpg
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MX$1"1.G"JF^SAQ.Q[K:>[93QHV21DS=HUUW;M4E5/Y>"?DYMZQ=F:5S-W$H
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MVV[\LMOG;/\ ?/VQ_?[_ &S]:B_('J= IAX)6UT;YBTK244Z$Y'HAL\L3E5
M&S#1NN9S"1(E6P92_B$,=@S,HBYN%AY?9$!-9>-GU@[B5 !8LG)ALB8M 6>P
MGO19?;?AKRUB+12+PX_UY:-JTYV)K&TER02)R'F-U6<Y2AD3V+O'I./L+:S,
MJ_LICA\Y(&!478/8O_*D,*.R3L2_$D<B765:P'R#\ZQ%SDK([EL>I; ]!ND+
M=C43AX>.US12;R2)P.O8G#I7/=VM+5H<.FK ,3*92(?*[-FPV$A645 _R+,'
MC6!HRF*^YTINL*(JD(C'*XJ&"QFO(4&2U3_)G'8H);"!W[M5-)']V2=)-OWI
M5^II^X(DW+Q\YV4<.%-]I6^EK/7GXYM+^F?2M'=31J:#*6L8!*H<*Z/SB,+%
MV=Z5-'"8Q5/&V1[YAL,M &!8N8J$DS])\T*1YV.%G-DD8P&W^JT]T^Z5N5/[
MW<>>:-9EP]<4(!M.G8-TL8(1P 4*6E(^@HXP<Q.(M"9YFYVB4+B#68P-=,I&
M5A!\C*'93#TBN#%MQC^.OD ?'"MWT>ZUJ3J/DPU6<3DL\$@JYZ=Q/R[T"T:H
M13"(^*7"QT'C"KR4D640Q_1\@CK'#0DZ;QJ'[C<*:K%G3$_OG/Y]<R>07'[2
MH8(5"CA<=&NY_?=\S7<1%'M@RQF-_4DUCS<H^?9&1>,AAK;+( &<%]@D(B;%
M!JH0>OMS)PJA9\DSWM8^A4E0XHX^-OW?)4$E;9].I^RV<L$>D;#$NT] .1S9
M9-NZVJ2%$M=G<7P2U1TFDIV1F*P],<"B+A2C7K=\?BX?)GFWG?H6P+XKZT=K
M>D;*OI["H\!(QY_75CD8>4FS<7'B)$R2WL6*HC01EB0E.PJ'NV9-NP_*/;LB
MZ*[1HSXF-FD^A/(_K_DE9\IDU65@VC&8UMC_ %=!<1Z,JI4@%021WWTUSG2>
MLK ?93QMIION\_\ -C.V^<9U,%JBQ[1M"+4S7\-.RNTYI+AE?1:#!VF5Y"<F
M9,CH#'QUBSWV2_,F[*?9FDAONGC"V?QWWTQC;.)NCTW[*\];>L2*!BMT\L7*
MG&Y%5MI1!XU/0&4KQ26"]FIJ(S:*F6B'\B$,#GB3]HW+C73)3.X\^%5U<I,"
M.C.?QV.!ZU]:/.WT:X=MPN>AB<)NGGJ]*9L\0(;EG-6VY(H#9\*6D#<:]>-6
MQ\>6 P]F#F,4V<AMCD:<?9N;'EFX<H';]\3_  TIKQ\@<X>,YEF[>B[7_;,K
M"NEY&=(H@VAXQQH\#5U XWN6/N8]%$"&FIL\NZ,O2TMD&C1\5518!8Z($'5^
MN^N^E5OD">!4@[[, NV.,"S*$=U56-!XW$.BK>-AKP$P=7^1AJ*4C7RDTB=N
MP]PW;M8/+2KA  5'(LHQ*GHEF.#'PX^'/R]KHY6@^*4[?\V;1CW:M?!V@.9C
M"4S0J.(S(XU0PUS.%(](8"3DT4'2)9%8IJRCK691YUG?+B.R-04[:ZM5?O1#
MVX]'?7N4C*@E!9]&ZLE<J$BH-R?00LZWCLJD#XJV:Q4<>:(K$9I<DM7)Y&ZB
MFLB=OQ29[";R+Q0 X6_#5YWQO^.1QYQO0=,V-U[2%>W1VQ)=0LUEI&TDV\WC
M562UWM_4 :NJ]AY7=6%_S$!:-6_\M*LBCI\C+AQXJ(-HQYN+:,T(/:OOSK;M
M'M>^XST1:)^0PJAN@KWK^GZK^PL-"ZLC@*Q3<61'"(V"U3'N3Z@B/"F4@EI-
M8W)CVS%'! ^];(-M$SK_ !(.J:[XSIWUOZ*O61LXE1=4P#F*5R<T[SOLNYE&
MI.\QT3B81LCE5R0D<S=.,@0(MHQ<N2!9PS03SKC&VNR:IN5E2,Y*3L5EZ +/
M92_EH]<:\=(O0Q!T:7-M56!-MAJZ1=#'2J>S5^WRW73703<H[)*:Z9U;Y\[N
MYK_]?$*ZYMZU\AZ^]<)O5*L=C++KB22XK0\]K2O]RS/;;_'B^A,9),#C,4R4
M?$TF#@X#D,\59J?O(_,90]?%7^B)S9R5S/Q]"G5>\P4765%0\B1_ERP:MXF,
MC>ATOJCAIH8D3QHE_)R(MJTT3:IDCKX@^2::)M4U]$--4\6)^N^N^N^N^JW]
M&\?\M]=QE"(=.4!4MZ &7ZNPII9D'!2EP"56QC"KF.%7[3<S&W>^O^79V!(C
M7&<9SC*G]_J$^</+/SPY&F6UB\Y\>T155@804:MIS'X0R<3 8V63_2<MPDF.
M*%S(!!XE_IODP;P=J]T_RN_UM<YQD4ON7Y_>G71-^\0==^>-JP]^;XQE"DV'
M\WS^5N(1'I!8&#R3S$W:O7&[>*2G:0Q#]W6DI!RLQ&%A\.<DD8R9WVDY]K@.
M_HCQ!\@SN0/9\,@7FOPGR'#+R>8*WN3I*=<V.+IO(EN0&&'6;1O,T60EA5D[
M,A19%V@ 91EZ6RTT:24H?9J.&ZLU>-7QM+F@%#=-\^^JD-J&0\]WM(*7L@!4
M\ LJ2+6H M^H7,I;#925LBN-8ZQ'@THO,#H',;:2J7M'[DDZ?(H@]]'#@N>J
M,_']\;HF!%QP9Y^T*]8B7;=ZV=2<;))D?77;:;:::E)/*Y*8D)EKOC;;9P.*
M$G8UUM^.[AFIMIIG4H%34U4M#0<-6=*5I!:FKR.I?H@X17,5"0V+"]<XUQOL
MS!@&3 >FNMG7&[AUE#9TY4SLJX754VVWS)7UWUWTKU[;>]MO>6'77.O.-?T+
M6]IA+IK:/S@K(YC)I8%*A71BUCM?*L1[0#C+)=NBP#X()JN?NKLZ6W3VQ^DG
MIHHT'^7]OO\ ;_W?C_\ O^/W_P#[]*A^3'R-Y/W5>79,-Z*J6JJ!J#D>A+&O
MB263'I+,CCE*.5O/1T=..2[ LDLGAHVCCEV94T&(JOUWC5-HT15RXPCJ+ZS_
M )H%OR2Q9:UY3X#'2RJ0A%1H".V',)P0G!@9OOO@8:D &N@"X*&N"B2"ZVL?
MU,R39MC'Z7\Z[50<8UO?Y)_))Z<[_P"YZNY1N;C2,TQ$[+ V2NUG8%:UWCEA
M((7!3$W&,G/]3B4 Z#(J@ (L5%G"B6=7*K35);57?1%P0GVN]_**\C&$;KIC
M#]KYZGGH/$FCM0,I%K%P<1AJ[IT.9SFS92F.,.Q TH08D&\8CH@2].290225
M47CPE%,RJN12/S5>@!-@1O?JGBFM5ZA/9;[N"%*G9[%IX/#K/5&[F2 &UCE)
M/&9UJS33WT1"_NXH@0=I;HXDX_??&J;S,$[1YHL/DL9W& M6.Z\P$:N?7$M:
M1)19@(#08,P=OI$\/-MT]WXLK&%!Q(3(8\JWV-#)"->Q_=GN51PVW21Z8^:5
M:#NU) !X@X_A<AJP"L2P-EUZOYR4F<P$C=%-U9/O!ZX* FD$&?CIESAB0D$I
M>(C_ --4JZ%.]UV#,VWB?\CZF/526K\]6-7B//'5C0$_D *'H2?:4P&W P-K
MEY(GE<'7[$4892,(RT7-%8 :;/GZ$<;NC8>0R%H,.?Q,M>U?OW0OD:PCU=-8
MDM>_5$\ ZR>,4\//)QH%%(DN]<#6DVM"5ZLBKL(*)O&1-&, 0P@D>DRXA_G?
M:/B$]3NRXM*_-6OX384>4ZFXGKA>GCVZ*BKVEC\[C%@#PBSY5!:0@4;')2.+
M3S+-%/9-,1^ZB#8D\143Q)1F=\:)/G<V]%5)UI1=8]&T5*FTTJBW(NSED.D#
M=/=NHNR<;JMG@\FQ6^SD2? E6K\#) ;S71\#/C20E[IJY9J8^L_/YB#A!GZ@
M<)/':R39HVYYAB[ARX4U1000;](SE9=9993.J::2*6,J*[[;8U3TQG??.-<?
M?ZT<\K(X;Y<953PAC&5\KY4TPCA'&WZN5LJ9S^&$L)?ZGZGY?C^'^?[_ (_W
M^LM[X[/.6>TKO]B^= \B3C^+]X,O&N $SUR[6$"#<VNR+:1,L0W'?=9R(P33
M:/'[-#.RA,,B0;II+:;J:9\WQ[;'R!O"A>Z^:JEX5EA1K,+ :RV2$#O*]DW?
M&R9P(%3CFIJO[1JA^S!R6+$A>C#*?Z1T\-:KH?FR0"DW1]!V4SBWY8W9<,ZO
MA//GJCS=$*UB$\D<>CA24@:WLBDK)J'68KH#04PDD#L*0FDI1!D'RS9T9U2:
M #30(L1."'QQ4:D ?40O5C6/27R[)4$ZJ0C9^E(WTBLA,1UB/V:=?LH'SKSB
MI)!&DNV.;I@TH*Q7@#0U*V!C\8\Z%Y+HF<*C7;[91B?Y /1'DMUMY4="12/]
M1<16I;=70D5/.<QD(O&F9'84?G "0QI-)E68J/2=0UMN?C>Y..E0()NLV(Q]
MTX_7&K)L&ZK5:FD[IG@[XB76D/;FG6HA?T4 5$SPBNH@JQ@LAS1]J&PB2B><
MY48%)0B_7=M?NFFNF7?:JY4U4VTW9[^(K0-2PGRCBMTQ^%AFMHWM9]Q.[*F^
M[%HO)#K.$3PG!(I']C"B&2"49!AP&CE@ T<_QB)DJ=+ZM_WA9TILN[WU4\%Y
M!^6/R\GSM'A55B)]TGQ3/"<>B#%$,!9F;C/@XQ:6@T6U_!FQ93=)R>?F6+-%
MLQW=R4QA%JBBOG3Z_P _4$+K3H/Y?QR$=/;!I-2H.\(<2E@Z>/F+>#L8'2W)
M(BSV0Z4[%MTP:%?C'<43>RMF5_3"NP?\SH9VRT>/E-V!/D =$^2W6_E1T)%8
M]U'Q%:MM5?"14]YR&0B\:9D=A )N!D$:T19UD*CTG4-;;2"-;DHZ5! FZS8C
M'G3C*XU9-@W5:_G?#1E1T[Y766&*$EWPV$=EVL BK=;?.Z8@*3KBFI8['M/O
MG.-&RTBD!HME/7&-?W9)VKC_ #+;YS*'R:/&&R?3>DZSN'F9BP,=.<VZ2AH-
M@3TDT#9M^L9;NP(&X@)+EG+0*RF<=.BFI^(:&'@L640?R<,X(H/WP?/TKQGT
M<^4&YYVVX 4YSZ=5>+QW>F-[,6XYM//1*D64'; -X\I::H; #+G:-YV%[6)N
M&_K78=G)O:<9*Y_G_H_GC-YD7QX@>;7:O9%E5]M-^YK&I4Q,8M0P%@\GKJ(M
M*TC4B*U34;UO"G3AU))9-I^:0(V$QB)%TB@S;@0(D@H2#OR*XV\?) ^1OIKC
M7/EI&L[8QC&^VG$?:VNNRGV_S[ZZ_P"(^WXZ[;_?;7&=M\XQG&,[;9QG;-.2
MO*OLM\B_O6E+*Z^Y8/\ .%40(1%81,)Z]I:<T37,(IX),R$EEB,5WM5Z^FMC
MV$;>DS2 H(-,'E&I5\S460C,::D2*=D6W&M[3[Y7%C2>:<Z7>MSI8G05^1B1
MV>K4TX1K5U!9[RY.X.]?)3UW&E8=^S>HF=QK$@L_78JDED$?Q<;[X04M'Z$?
M$CXJYNXFZ*O+GJ9]M6O>59UBZDE:P-T<KB8HRN4,R =JB.=1*$46-DQ[5=FX
M?*[C@#T>\V5TU736T10414&K5G)/5##XOW2]1.^:.@6MJ%/4*&2L36;JF;'0
ML$G%$*]J5FK)V$,5C6DD>Q])RR=MU3+88H.T7:N4=G&JJ"NFC=GQ@ZUL6I?'
MJ@8/:L!FM9S09.^@%R,0L&*G89*&"!&YY<^'KO8_)& TLT1?LED7C)1PT3T=
M-54G"&=TE-=\K[>M?-?1<T^4%QS;4.H.ZI950*T_/EX;LR-57.CU?!F<;L 2
MYD3LK,Q0%W'![8 W24<&EW9)%(4CINJ^V03TWVU\_,^/[OG_ ,MN:3&3\\W2
M]YQGUFRN*R.TO\+)OBL74/F/"I& &U]+!4CRL/T;K+DW01)YN25;:&<Z,MM5
M'.N6^9G]"/B1\5<W<3=%7ESS,NVK6O*LZQ=22M8&Y.5Q,497*&A .U1'.HE"
M:+&R8]JNS</E=AP%Z/>;*::KIK:(H*(J>O\ CLW[;7F-YQ2*(7-Y_>B%A2:U
M.RKOD X%3?,)\Z6BP*,5%S0-;E9J.F96!O@[&6/2KYO#W;=L0:FUHK+DM%T%
M0:R>S$_:OH'='--G=10B T42MH13OG2^ZTCY>/,XDHG%[ ;2._ VFUI[S"X:
MW<$*TW:UB"=?Q5?"S$SWU;RK;"VNZX5MF'BWH5TH0[[KSFD&XK&/5@1K3C";
MR5QO5$;EILR1Z)=V5F8C=97,^V:).0]B@W@S$=$5831/011HY*K.BP@DZ38
M2,@T?ZBEK8]';(Y:>UX\"<VOUIU57.%Z.:_M4,+M'HGGC1J_Z B+&SS 9&F9
MH,?M7<U'5P%KR0DI4,><V740FB"+,M%D&T3R;TFO&<>:%?\ 7E$VQR:/OD+
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M0V2CN%C#.+DC\W^K;'Z=@]T(7(^B[FRZ;N+2O3S&-UH[JUP&9%:UK^P0HZ3
BAMW]-UT1.Y:R]5ZA(:LOZPXH8C;N/NW>L8D>YF/,_P#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g263414.jpg
<DESCRIPTION>G263414.JPG
<TEXT>
begin 644 g263414.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ \35),3%]'4D%02$E#4SI;55-!3D%?
M2$5!3%1(7U-#245.0T5374M%5DE.7T=515-47TM?4TE'+D504__; $,  0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_   L( #H H@$!$0#_Q  ?  $  @(" P$!
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MD?(LQ%IP18\?OF[5C8X),FMKB]RO8E6#W_4>]*'CS_KWQQ3^*P?-=MWY\?\
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M=D9?KI)<EPX1*'Q$#K+-L0RF&M V4HF%=QHU-Y)'LMMAS:*9)6F65OL,#.-
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:-$$EW[M17O\ CCCCCCCCCCCCCCCCCCCG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g189424.jpg
<DESCRIPTION>G189424.JPG
<TEXT>
begin 644 g189424.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ ^35),3%]'4D%02$E#4SI;55-!3D%?
M2$5!3%1(7U-#245.0T5374I/4TA505]&3U5+05-?2U]324<N15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@ - ![ 0$1 /_$ !X  0 " 04! 0
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6 / !\  ?0!^'''''''''''''''/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g22532bgi001.gif
<DESCRIPTION>G22532BGI001.GIF
<TEXT>
begin 644 g22532bgi001.gif
M1TE&.#=AIP.X!'<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M4\!&'$(:@;/Q >FBMD0G;DPF$+#I"=CHP "/1X40_'" ,!A"NXYF W)8@H^
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MYT)*,? #CUP0,E4% E!5)! #[3FQ@(.$<JR^.JH$,8"#.><"I8P#P, ',3
M#%  @R '9\"+C6A'-[7&)%@$S%(#72 '@O4!*H  /'H##(LF73 '=6 &;R#>
M**!,&,"OX%R5%7#;3U"BQ1Q_-H[CT"6:<7C@K"VOW1KA@%TW6U5UZ<T$F6G9
M=="F$P#"'5 P:EL"3V +2Y"E>9 (2]X"694(4P &!A"VW$P!;F! D"+GX!"W
M!B0 CP ./EP:,, *^2<0A?^>?T4U!?UP![IL,T,0 & P!HXB 'O@#Z,@ V?R
M"%;0 ]<" !7@")\ !CJ97W&0Z3E(#G^ DG% !_KP2*MN,WS@#]GV)Q3 "F]@
M-/[WZMW8#Z,0!AD0"%5P+1:0!8'0 I]^-+I]-]!R+:VD5Y_0"3I0 JK.ZG30
M#["#!0Q0Z)^ ![J.?XI"E5/P)M!2.*[^2-K>2E.P,T: AO&S?CR:=I^@ =]N
M/EZM"7=SI:5^).+52X/>$7H,9B_Q[VLQ!BC@CZZQ*)\  M>B\"" *G0P0EQ
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M+\00K@*RZ8(G YBXZ"L' ,EA), $>.$' 9SPX;G(QKA! 0/JZ<$)/UP$P !
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M( U&6'$'1K. "!WX!1X89F)2EU@ )1@J %YP@"/88&-OK5$-'P@$A\F@! >
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M%O2!/@Z (A+Z@3G0A#0X ";H >^9GZ[H+!68 BPXJ'];/4!JA"W0@B?  !.
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M180O6)F?0@(AX*6&$$8X/"H%*('_"7J ]3F %!"@!/B !^" B>&J#^B#!:@
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MC0D-.4$T(*)'P00&#ARIYV-""2$1&@(H\6"! 2Y=/!X4(J/  P4F%9"L"4"
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MLQ,8$(,!-M )E>I 62HP 1(Z\ 0,&,$#<ZB"2]=)+LAX 3 %. $15H6!G=X
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M2P<84@ H[  /(ZO"39:#!,YL_Z8SF\FK$3!Y@PW<8Q!A4(/B<3#Y[1P2:10
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M")@85S"8 0U9?7C7F?A2")1=5)P \"#"24S&'*1 (055"\!$"-S "0#!#>R
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M"4WN21K(@"#PB;HA2@\8VT!V)8*4P &TQQ=<W$=4 !-81D2L@2V4U\2)@04
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M"/S "G3*I^B)/BV,,HU&#GR!09CA_,1*(I@ ]ZS1>[6&$^C!#G16$2R #=2
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M#D0  "+_OG !I!"R!P"PP0/@1A,!?, 02^ ,#ZY@A$C.1 !.@&10!'"##>A
M)PX 1B%Z&!4!O, %JY/ %<"02H+<0(0DM, 'GK#&GS11<\^SR#$,5$0[)44
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M K6E@0ASF.PO,#!9Q<: '(7E@&H_D089." #K/B$$; 2@-S6  X=N0,Y(+L
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M U)"#:AH),!!-8"-#[C#(+!@T30CBF9 8N" V?R+!^RH"C+@CES !?J0&8-
M!UP@%83H"% @<N1!BQ!A!IXMEM!Q.(GS4Q(0 :3P"4@DXDA ">"@$!2,R$[@
M"R#) C: !JS3#*9@%$",(#ANMYS !Q+@!1Z@!0H@&S!*_<(S 6" !7J@P!)
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MQSC)!IXL*&!'(WNB /H@57VI$7:UX637)UY@!K?J>X6B &0U*%;@=0%@#%"
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M-0!V_YM0$$@AB#,BF+<@JN$(!TIKC=:@$;: "ZI# I8YFGI!'SL #" 2!Y#
M<V\ "OJ1%/0Q"WR% MY@#F@%LX,YR5KZ!KA7K_. L2O $U[F1S;B<Q$!1-EW
M@TK "-@@V3![#KX"!M27FW$[5,@SJ<+S(3RP"![N!0X '$O@  JG'B[ Q<I9
ME+(A!\(@!.L!>O7-"TX  \0 GXFL'CQ@/8U0#E:!.R)R%3;@+PK@ZAQ%!%J
M MW0DPX@Q[*ND8A,/$TL\X#!N]<H!HO O7>@!X3*H3: "+3ND#9@?H&'""&Y
M#YXN#(XPE$Z !2:,(")2 43I+X0*&/1;_;!W"T;2!K)7>O^S;HU$:7Y;; Y
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M8@D8($.*!33!$#K4KR!(H9T6F)2C:LD$ RCP!P!EH04:[2"O&(^(3/R@0!7
MP1;R4!R:VI3<I"^]Z3.U@I@\X%\R;@)-;'(F+:JU!")(,1C_<C43>$#?5\UJ
M">H1!IHH(1$#!X04A, 3GV &GJM8,RTO5QM)^L&JP*A""1  ERXH()E3=L J
M4K"> 3!SM7P8#AZ:P.5.8IDS?S$"$@Q3AP$P !%:R$_Q_/+*V8X:0@4X3KWE
MX_\%(- Y7(%-T%=^72$?&] Z[G<"+7 #)^!!]%%HM*4=^8$!C189);!DK(,!
MF2 #S4$\Y)0'&!!_Q<$?V&4\$H !7> LI,8!K!,#'@@L*) ()( ! NAV+P,
M%C '_D$%')!!=7 5>9!2(N(6>Y$(0W@(:E$#2)A1&W4?3=@)F:  %) /F6 &
M(.  %<)#B3 %*-@K35@'&+!MWP9*>M$)=3!ZI\>&;>B&;\@EU_(C*C4H=#@C
M59$S<*B'>\B'?>B'O )7;X@(+,!-?VB(AXB(B:B(B\B(C>B(CPB)D2B)DTB)
ME:B'D+$J?*)%[_8B#G #:Y03UA*(T (K=DB*N#**EJC_BJO(BJWX*/L"6! B
M>_G$(HAP /\4BC7284^F(@FS<:X(C,$HC,,8)L=#-#T@0<)A!#_0;DQP :BS
M-1OP!>/"!0AQ9N=204A0-7:#5=?7"5.&$7[ !EG %45 !/37"2P@!(YS!H.3
M"%]P8K0W?TB# +;@.#- 1E^! <\S-L-A B^H"88S,L1(D 5ID =I(AD& ].(
M.3[@!5,C!T= 1E;%!%\@!Q=0 '&0" R08<QRBYO611*11W@C @JW@PQ3 $)P
M 0F35@W3887T 6ID "87$24F I2TBX3!!B?0&3$I GTP+B(@!Z.%D$5IE$<I
MC#TU1E4%'")P $EU $P@!_!V_W%4A01<T 42B0H2@PAU-),/,2I/N0!9%14^
MP ;U,)8HF0TF@"L0(V, DG(&%SIQE%?A2$8D@0@=T 5590!R)0$LH#M(*9B#
M29B-B!$'L'L-8P-..352&8I!!0Q<D )F,0!'X"VV^$\T:7!RX%6G!CDGZ0,N
M( (<IF\!)@>8]59\J9DBL K/YXN$\7_?(@=EY&=2%HN%B9NYJ9NE=SP^$ (2
M,!%-XP/ @$=,8!XTP &(\ 4]X!940 0?< 5=,#"(( >X");UP 8/D(<]Y0*#
M$8@_!C$3MP&O\P$L@ 2J5!)U*179^1@?\ 4/4%6#1"0MMYOU:9_WF5.'R0%-
M4Q-%T/\3C8DW"Q$#.L \,1$")9 -YP1)&R %40EOO]<3-?$<ER,5HCF62O$
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M#E;PCS P!)/Z%( JKW;*=>DJ)V?0 4,0!3-!/ Q 7U- !6'0.8BZ!;A"9!_
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M&@!(B0N$&= &#1  ('PY:M &_N"R1")V<! !45,!<=  _6 %&O!Y > / =
MZ(JUS"0 ]),"Y"@'2 .PO!H  6 %OPL!7%6*[F*_8W #3_M!EJ "'$N^HD:.
M" "W]%<'1_"T&8D%2) 'Y.JN#8 &2I # ,L4EE %9\RU*<#!Z94%@8 &EI (
M"""$+]Q:=/ )VXO"E5RF;O$$C%Q*?BL4%H "=;!'B5M0K\N+NY'_ 9DPR%G
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M!R>*X," #32(M;@J/BAD339WB !7$"9 I$*%<&W! NG8(@\1+8XP#DCO]BJ
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MH4Z]*()/^Z" "L@!"$05<0F$ )Q7J43#P&(+%^0 EX38H"];20!KV""$-TD
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M*0$M,*K6(ZKVB@$=(*XO2(7<HY.DZ $).+]_"S@Y. ,)Z)HGZ((O_]"$IED
M:#$"-N "J3&! @B+T8$SC"B !@$B%Z@+ 0P\LJ@_HQJ  F,9*+"*UMB :IR<
MRG&]#N@$ *N"S,& E]2K$TC&K#"M ?B1$N@:#*A&#<2L& ""61HP#- 34^,!
M*?"=Z=@ (E@!I#(#A7J=3L".Y_(@8"L!31BJO< L,] =>QF)#S R$)')[K&/
M.J@DY=@,(IB#N<F$ AL#P#0?"D(6XI#!?-F.C]H>$8(L,S V8RJ$$*'!#_G&
M!)H"#$@9(-$"K32#%L 3S5FV$CBF"JB!.I@",+ O(\+"(ZG(3D@B1# $=W@(
MWO1-AFQ.YWQ.*T(,E:(ZZ,0)9N/'ZLQ.[?_<3CQJQ'!"$1:(+NY\"43(GRD0
MS_%,3_5<3_9L3_=\3_B,3_F<3_JL3_N\S^P<G=P2FY88.8_Z18<RLR/B%'BA
M"8#"B!OHI8&R"0HQ@A'2C,G$3F$Z XB)"3Q[B3&X@:7:)0<X _@00OP,41$=
M4:"AO9AX@1AC4+_9)>D<4#]XEP(ST 4-H $$#PE]B1OHA1A]1D"X &FB"<QL
M!!OM"5(BQWNB-A)-4B5=R#'Y @5 A"\X K9I&LPY $;<"A=@K:$:$[PR@1O(
M!DLH@C_#&\$IOL$9!%NX@+X)(N7LA'LH$<K)@<'A@T2@P,"J@T(H$XA#@JI$
MG44:D<:* 3'@'?S_DM.?8IJQNIW3$BR=$C$PLI@"L+'V*IQ; 02^@K(LX)X!
MP ^/0RP_.YT8,(+5L0V%BAO4,8(Y, 3S^0&-XU0*4-7SX2"CTD+-4($I2 22
MDX#1*JU Q0/,C"L\"*GM0BV$$( 78 $52+C,43!#48-B @-3C0%WR0)>JX.1
MT,!\08 ZD ,UV"X,2*T;D##L&LR(R%0,R 0UC2\SZ($.>,D9^!PCV $1\;2J
M]!]MQ2K+@R %4],\N!H,4(X$,H,^7%*"+=A"0H0#&) 'D - L8 X&4H%X L)
M>#&,^( 30P0Y8 +L2( U )0Q\8$F.(&\"8/M.QQ(0='>ZQLYV #7D@"Q_WF=
M^5DXNCP!%=$]IGJ ?K%91JF'0I@#RW,56?N5$E@@IB@4#C(!#]@*8+ RJ&2=
M]D""!6*+ K&6G[,!'&!9TMD $V"= ]V+]A"EF=K:%RU0A+&!+O "5A' *IB#
M[7B=4B..]MFS/CL"<WF!#KB =DD GAD21&BGVQF.$L"!,/"S\/BU$&"6> 6!
M%\@".( T3=F@ ID#/K.?.: U"I =!;&/*KB81'$1(-'1&T"VC*@>!#*)Z"HI
M+\.!#Q09*/@!F"DI'H&"C#)8VJU=0#* >I"#![ *').+ W"*1G$!*SU'=;JW
M+V "(/!.N3!!!*@"MGB '?@"_-#9A1C: 1#;P_^ "_U<N -  MY[B,<%DGXS
MEHWSN ZX7AWSB]=X1/\$DA/ LB_8 &FI DY,N:1["/F=.%AB*N,Y@2YX1,<
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MVU/&O]/J!.P%J(41[D(SM3G  "8 AD+KCC^KS!]XOZI^$!HIG_.!;^D(*15
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M)9B@U:I3>O<3D[:M>C]YJ(_Z&T(1$C "WKR YSKI[,J$U +,)3BK#&B#!@B
M?5?X36B !H #2D.$.)B$%5.(Q>T$6S #(S"#'$" 1"@F0UB")N#-VC0$$W"!
MD9=ZPB]\&5I<2^ K!EBM-+@(!*J#<C-V,?F )WC;$^&!3*B""M"""8K-S@_Z
M;:V!7X #.>#\7Q;[L;^#(C0$#9" 07AZPX]]V>>2E&\#<S_X)Z "HL_]IW@N
M/:%YM4D%K*!Y(P"&*:@#'2DA-K*O1 @#+:"#1$""&D@$)O^(@SH( Q>0&RHX
MBR5@@_(Y R)(A=D??_*O$K8@!#B0J+@9 G^P FPH,*\7D[#O="OPRMIO '^
M V1ZG<]G*LXG H"@<&7)#2V=LJG0, & @RSY<AC2X"+.IWY6EB0 H'$CQXX>
M/X(,*7(DR9(F3Z),J7(ERY8N7\*,*7,FS9HV;^+,J7,GSYX^?P(-*G0HT:)&
MCR)-JG0ITZ9.GT*-*G4JU:I6KV+-JG4KUZY>OX(-*W8LV;)FSZ)-JW8MV[9N
MW\*-*W<NW;IV[P(UT$L* XT">,2X$%* $Q\+398XT/<F81\9/0HH\&#QQC$W
M4D%P.\9&GQ KQY3 \9BD@QN450K_N-%!QI@"IQG. 3/2\ID)JEO<;/VZYA@*
M;S8*0.3),][BQH\C;^M 2QTQ"PTPCQ#20N'11ZG[X  2T8;7%NKI.,PV<A_K
M* LT4F#2P8<>,1W, ;$R>*,)['';_"L_+RGBR?\#&*" 4QFPP0!R:%= !T9<
M8$$'*G12! ,PU-!)%P_0<,,#X7TDP <(9"*'#2(L@$B%4R320PDU8!"A#!V9
MV D&)G#P@2$8S,B! X"8T6(AX@$PA@2:=/*$$4D\V,D]1$A@1AIGC/$!BASZ
MA8@0/7C8B&HJ8& $!P6<( -A?C31@252O.A7 35 B*8!9DH1Q@<]HHE(!R"4
MD(T<7,A@_\ )^U6IA24#]& C!HD0@4@<G1B1R@<J*%%'$?ZEEH<E72H@@2$J
MQ&"$ NQ!VDDCHZ7F$!693H$!'NQ-$041!> 0 GQXW."0%*ML&L.I'=WPP044
M3$$%$1PY( $8!CC4R2#N 6<B'#0TD06$&+0P!K*=4/$#1V.LL*D2IPI0 I&9
M5$O!$PB\P8,2B5Q@0!QPF/'&!(HF8D@^U:KQ! ;,:C0&#_G4,04>UKX;KP!K
M_";!N?D<8]Z #T,<L<0W.5"/$$Q<0-@#<@"QD0$BZ%""$"UH_ 65'AEP@&
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M@W E.!8?A\J1U-2'IB3S7A+RD @A?($&5&19(E= D$1J$C?0&1@%.@<%(CB
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M!P!B&IS &_Q;)R2:B0&<&>3#;Y@+!OB>\W%B)])%TK2+"!P!('R! FS<$8A
MAC#!%RC-QQQ!8=Q 9.'. [2"$#0((%B3"'#: UP1+.:!%1@7,,S  0"! XB
M<VS$"@@!J(G089PB>'S,A?2 ,2*C1BCCV]2##Z74QPE.%T"C"*2 *'K-!*Q
M?U6'%_0!$@@-33V.1H3:#(&C%T#!:9C-/((-"%C #O!-"XQ-V9R-"VSCZC"
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M.LW ;'*$1"%"'A@!"WS!$0A1!!BD/_I0=[!,?<!701XD3VW.#KB79]!4=PD
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M%)OQ&:-Q&JOQ&K-Q&[OQ&\-Q',OQ'--Q'6-=E)" +7Q!;83+ '2O)O&%7TA
M#)1>2E"I2#C  _R(AY" 6&6328!-)MB"'% &FN8$:W*$B?"==#%!RPG !A O
M3?D,[/@,?$TJ"XAO$;& 0A3+*:>R'<-R+&==V1&:%G1!S+2F12&C >Q!'6PB
M2J16(0NM.G&L%@2!?%Q0%3.>%]  RM2#,,_$Q\%(#22"%_F!]18/$@+A'.3
M&$%O*9+6<*E&%YP,8<R>+*-S.LN< S0CUM1#]W['(,B!>M@)-D3 FSQ!%S"
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MC@#@017F^#VG:4!E/.B! 1KQO"A2H LF4UP$"_$#_P&HL6E.,X$"3GF&%:3
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M@*":4I4 -A3@! I8H@J(Z!],@0 #/'BA"#^XZB,KJ;BPT=&S>'@>(>/(S I
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MO'  :1Q@<2K ! 3/;O9ME,C(R\XJE12/E4(GKDP&= SNG([  SI@P%3'#QC
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M)(YQ$&$ \DR2CL %7L\"+DA[D$8>\\SSSL"]N@ !5I'(8 ^;K&E^GL#XOF@
MOJ (MH +&G*7#* #E$ %$@$=$6$0A <1Q#"//L ,S( *B( 3<$#=U+ L^(GR
M4#)0!$ 1NH\E8U(F9Y(F:](F;Q(G<U(G4\(! $$%[D$.&$  2L ,5" '^J8$
M6  /(& H$< 2I&!V>H<$.J&,3.LI&<"\$$$+$H$5D2 /+*$="7$.8.9XNJL.
M@)((;H +A" ;5( */. #IJ 30&TG8<0!@($&!J($A$ 1"X"O\A(11* %!*
M_$ !/N +HLX -J *!, &^J": E,&'/^@'J:G)XO !1Z@!1Q@ W3  78@S0C"
M $2@!PK@ =#("0J!I^IR13C!"?), )S #TK* NHAWQ !$/AQ \)@ _!@(&Y
M!!!*,@=B,5O  IS X)S)!)#@ :+)!OR@"8!AA JB %B  9XS 0C3,,/" 5R@
M$2;@!CI  W8L!VS!!VZP#H3@"QB  @Y'!?*,,UE@"A+A"YC@ T:(,''  ^;@
MN[3@"6+@ALHF Y0G#80RD2*'I,Q&><*O!++!#,Y2#G;@#03@!4Y+"0JT:.
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M!:"%V+:9\N "SF\UZ54A'  Y?V8, +6"&O^7<0UN($P3"0Y@BNQ4#B"V!$Z
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M/L =VD9X7[IX355'!1E4_UJDW5 #O#A4Y0>A1O\: %3: 4[+#(AI*+&U!/B
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MB2! A8R7(@*%PEDB&"'%70@A! DMO #%5V-D0 4'#W_!! <DYO?&"A!GLNR
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M1KYF8+[H6[[J>[[KF[[L^[[N&[_M.[_P2[_R6[_X>[_Z:[_\F[_]N[_^&\
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M!JD@"((. 4MG; .8 BX@/BL@5#2P!<" "(.F85' \V.P K\0 )OV"$*/]7#
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M/C\( L !-92@X@=!I!O@,Y%N."&"^?I  D,=;M!"A11^D( $_FQCS QLSI#
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MS>7<0$J"H-> )WF#+=B((^#Q/[B]0)?Y].@,TW*-SB*,+JV"G3>:1W"#4@>
MTR(-3: 8*R&"G6\:'AAB>T6X*.XB2*F#FN& +K4CV;0$&FC0AS$9"+_<V-I,
M:'?\QZ^35%"A_:'\RK?\R\?\S,?\7\ 3## ](WVJ)+V3XR.(%:#F">!F>7 #
M-'F$MFIQ$4(W!N $:H[@C? 6'G"#4%&^MU<^U%<*D:N5WB>)U$H*RP**H-<,
MS?HUY9O6ADB4XEL!2Y )CIA4MO<0MC\5"K"$*H"!WC<B*Y"M.1$ >$&(1PCT
M#C*"G:\"AT@4GYAX-BC_P"3( S<@@M,ZF9Y0@(VH_^>& 2+\/H<&B#QP@'#B
M$\5%G"@+*B3<DN57'2 < % $( #&DRZ:$C$H\40#!P,)3QC2X $%G L3*@(0
M265#)S&"/H9,^(/'$QT0>"2Z(&"/D1\L+>QAU>"3D0]/\$P4@*+.D0[DCJ:1
MP?(JUJQ:MW+MZO4KV+!BQY)E:>! #Z\";-1+0+% /05;'6R0<H:B@U2I"FQ@
M4-8KH@U6P[ZH-]B DQ9D!=Q8$'BP5@<[JMCHX[:KA3D@M&;>_/<SZ-"B1Y,>
MT^ TZM2J5[-N[5KT@ 8!#I"N'3O @-&<'*E:66'((0$\@D3@T<!?@'Z3Y%84
M__ (C@R1?U8,B<+!0APX"M20"^ O&)'A/2:()Q_$<T5YYP%0/V3AT2C%5Y]?
M ("HN@(>EJI4(/=&006.--!/ X%4L0<<?E$T7 L"""0#>4^ (-Y$!FC!BG5#
M[>&&# ZR@EP_?\P11!40 ,!0% H0!<<JU7F01QTM4+!?!5-$L05]%"Q%P8>?
M*'=&'FY<4&,4;!@$H$T6?##%)$2L5)$!65@2A D<8 02BFI\].(3*K'D7"=3
M)"+#E1R@F%\=.CBUB3^??/*'@G@A.-@*4Q@A5Y1I$-%!'4SP6<63M0DZ**&%
M?G96!( = )D#]="P%2(B0!:I# 4<L("A8SG@A ]/"O]0P /,$;9!"X@\@.E<
MFH7E@*I9L8I>IK'*.NMGJ<C6 !VGY8JKKKWR^NNNP?JZZZ\-_ *;/PT 0ZM8
M]QP7@P"B%?2'6Q5L\@9Y5D0@R!5X3/""4/-9D0(PCBSW37PPM/'&?5&\&(2,
MZ_T611-96#$>2^VFDL%Y$SP"KXDL_6O"'%/TJQX(!E1W71Q4+#!&*N:]X4$J
MP@6A P?#O7%#%G 0 4._>:$8IT4"$2%<'3T(D(J9<:3Q0RICY!%$#X)4AU 4
M22!(A(Y5())0$D'*H*,)-QAB@@(OI&(!C$,FE J,1\Q!SA\P.X"")3T$3)$
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M V.X_T RR-&PAC8,2VI@(QO:W# KL6D "P+UF=W\82*_>4/&B", "I#C$X$
MP=8L\HA<?6(25C% #>CP"2HHH&NLL,(4XC.<"$Q@B6WXQ"_6<Q48#,$?5O 6
M .C3-Q[L*B(KH0#-CCB1G^7J#UU\1!,/D8"?-0 ,QIM*2LAC"1U,  :_:,!
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MX 2;*< )Y/#3J/K@,@;80 0D!X*U]&$5_BR!'^3"*LKX80=06( #K%J"1G
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M+=:B+=XB+N8B/$U LN!*9K' :6R=9'6=M Q@MK0>NFR!(R0=R$ (1<  *X
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M9_! ] !@UX3.%6B ;F9 #\QB5SC &9RHG7X&450I2[P "119;:Q!)E3)EZ!
M&E22H& 11US%&@P"'KSCJ.XJU6GG+Y[&CF'H=QIH!@@!%>BJ6%B '2S DT0J
MG?*  8*&!?2",UI$!K0E#S1J6*Q $? -KXX&4:0!!X*4&;AJ;2R1(3#%4*!
M)H"@:/1/%+@H ," "C#2M]XKMRT;9^%?:.RCLB3H40CJ:%0 %8CJ5P@ %UQ7
MI$( O:H H#A %L3 $WQ!_.A I(Y!"9" &52%!?"!"L1 '52K '0 !J1J$O\
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MFGJQ*T\6!8^M?G*=;*3M6*RM6ZR &VPR9B2J$&#0PO( Y:@"!W!"Q Y""ZR
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M$WD0.5C1?@^ZJ[^Z:V4YL(*W?0\@PXH2&,Q+$ACYI8_1$=V'5?I'QNQ'PR@
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M+R0KX I(@5\41"T!<D>OQ0\@]4_$ #1'[A&$H0/0LQE8@@E)>UFLP" L#@-
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M((L2*@Q@8+!DADJ2#R2D'! B9$H4!A 0 A#0BP@$&%4ZF*FCP@2'@P[Z$)D
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M '\:J =)A&QIP)\!!$"2M-:HL.F]%OKSA &GIEJAD2V@^.&EWCSHY8)'JK
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MJ&4PP*1C/BD;HBSDD8QSE R 8 RDTD0/+/"?O G%-2'C6U#Z!1A$H 8H*T!
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M00/-D< 1SGM=)2^9R7WL[F:N6=8BI55,-C$ </H30<#LKZ I%N!.2!->!Z5
M3N\R ,$ 4%,35I83FK@ 3GX2*03SC ,.\$(',D$$A0&Q3.(Q2=H(8B _=" 1
M1W  %\Z0@ K_A0*=JD>S9!>U#6 C-029@PE$FX*EL($I$X@C0A;:6T*AH%-$
M\$"G6;6%!]3C"VATT &R<0\BI&P&$V[RK7&=Z[29091.XI80".E6(*W 73 X
MA'OS  *T["=5?SE- GA . :_2P(EA $V^,"UC?$NS8/MX"/@,  A&.(-9X;4
M&W+*$S#<@ 4TF-V"S_\"YUP"%6V31 HVQ 8I'0RD54O-6JZ^((=+'X55^4:*
M4J0&!7$+@5D(:8LI52)<F7%J)$S8@M0Z#0#G(>(>9ZA*DG4=<I&/_$C=;8!8
MD436)_D'6SRH@G@T@!T8+,%>SK88)_@@@_8&$(:+R^4%N,"E+!O(VVF&P@(.
MHALDO(DG>+@!W\"L@1(03E874(,.RA<P3*GA=6?C!'PFP ,=E$ #/Q"/#IJE
M@YK[1;41BB3P<C(A-]Z(!W/_4(6 @HA7-=0;LGN*NTFE!X]G%"<TV,D'9B "
MZ9*<\8UW_(\@,(!^?&*[1_I,#*J$)$208 IVA<$3F/:%]90'M>A%)  > 8;_
M,:@A$R30 .*\H@(\B$@3&# =MS,FA7FU%R%[8 +32:, %B* "M5.11X0H((D
MOJ &,<" &Y!P'./<\FP5:&QIUX"!N@I,\,+.CH?%DXC._\"G2E !-N0X@"Y&
M80O(,D#SGZ#.JGW #!""@5/G4U'@94$F)C"> ;0  3# !$I _1(A#* "Y!YO
M 1FP 0F#'T0)Y2S/I,[FD&S- 0$#!I#L,68,(2A@+3 P!$5P!._''RAOD!K
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MP#M5(MVB[7E\5=E@(!-^@!]YY@9>Q4;ATVQP9PPH .UL(UFLHR$)T6K&X ,
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M*/*3>=$W?8O0FEA7RHC$O-Z%87H!"=",!_! *EU##=S%0C3!(I)@#UJ'-/)
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M&0Q08CLQ)@\L(094^%=3H@+B  YJ(/\((#AQE,"./$ "5  !X  )-&$C,V8
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M,"XJ"&HW*%9@" ) ]28@@$Q0'^#@.@J<DP%C# J !L;@I+_%68-@AWQD#&X
M%=QK*$I@"/H;[=1@""8O"E)! /* %?0A ." PWYD3Q)9H\9  DS<"OY;,'@W
M_G9B#$*\'ZP@GY:[JQR@.S3@!E*V, Q@#SXA"&Y8NF\ [RR*!WX!_P18=0^
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M@% "#>W1=1I(P,W> P !4* .9K"$#A*YGA=X+0O-Z?\ *[;5CRC "P .DAD
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MX("1SD9-23XA$3.XXG4RX 9$NNAM,!@"%CY3!U<:\YQU,$$)R%,E.!1B#H;
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M %I@!(O7$Q#P B[  27P 'CC$SPY"%H)<&JW 2#0E4)) 22I G8W4$^  56
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M= 0VP%\VZ505X =B_QF1BE6<2, %-)  &2!+UID%P\F<HR0 @# #'X -J6
M?H $)T #3<#!\+&;8EF?9Z &77 X2DR4"; "@W $U_HS3  ,]P $ULH$7E (
M,E !<G &7. #6BP'2- '](L-2/  -##$%-L%+.8'9^">MX,(MB &%@ (J)
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MR(\59M(P$%0EU9I"+P4 .K,R8]"(*S0PA9$"XD<>1Q+ ,"(4  \@$-MR4*M
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M4JUZ5:QF5:M;Y6I7O:K)J ;@FOW4YE?->E:TIE6M:V5K6TEIAF"9=*!""-8
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MD?6(3"40 ITN9.TK7@=W71--#]4CJH"";Y99!9UX0A7&\ @ET-WNC[A;&#K
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M.0@#/:B'#?"!)!BYC.B%GJR :3. YY V&; !$7C' XA%_2@!(6@!#6D! W@
M)DB.;+&%6D&$50"Z+Z Y2XPYG_N">D"Y)+D/31&C ;B N\J(>I"#"6H"$3#(
M##F4"'F ,. "#9B 2)FBH&N!$H#-,<G/_>S/86JV_P(M "X@@A/0@"0I@@1P
M@ U( 2^ @@4P !&H B?04 ZU0SOSH#X0%&F\KG\*@GF3NBQ( ZM+HPKXNEVA
M #>(.FVL@&$ .Y88.WQ2I.\*)WZHJ_LD%A@0 A(  Y;3%.5Y" O@@Q8X#3D2
M@ KM@"NMT Q E(M@B3<H@25H BA  E(0BDV#B$?0ETV3 $X#@(L )P\Z 3.H
M @H @X6(4UC; "V(@CEXTTV[@0KE@1[8- _8@^"A";O( +\K"Z4P4V1: 3S(
M**K@ "[1!#PH !;P'JPD-BDH1)B@'X[Q"$D528^)#:,DB]4858F(C="8@!7(
MOE$=RXF0#$.I@9$T :&(B_\FR$L<6#F6&(!(S BUT;;048$J\+6R8"<A: W>
M&"4)F $. (0CX(32F ,+E(,M\(.5HPR[D [7X(Z5>,L3D%91RA]   9NG0!.
MR*'@D9[>D=;7B)_; P :T@(J  +K8(#5$8'R0!HY6(5V6H,C\!K]F0&/4;D)
M2*4=F!#I!))Z<($)@<[\:<P4H+D:$4]$.( P&!)!"-CT'(HAJ8\421(:8(,#
M(((/(!(#8 *7Y9/.K)]Z^($DX8(4X!-I8S>D^;F811,FT-F@RX8<0 )  ,T^
M*X -&(2PX!1$$ +]H!0M&  /?0!.E!I#*1D'$($46 4Y0MHI@L,<\ ' D;%L
M&*'_&UD%(6BZ5FJ3%]B!.0$!!]B!-JD//U!7,_*"+Y!;-_$#-B 0#E Z0!@
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MQ8H6+V+,J'$CQXX>/X(,*7(DR9(F3Z),J7(ERY8N7\*,>7% @P8'9#*DV6
MSIX^?P(-*G0HT:)&CR)-JG2I4 0U@16]U\!?C#%,KV+-JG4KUZY>OX(-*]:B
MSIM$=;*8,'8MV[9NW\*-*W<NW8IC8@1H )6HD)H8Z@(.+'@PX<*&#\^E&<#L
M4,4\$4..+'DRY<J6+SMM4*\HBZF/+X,.+7HTZ=*F5^I<553GY].N7\..+7MV
M8 $#^NDMZK!!5=J^?P,/+GSXR[*K'[8FKGPY\^;.:4\8X._3WJ%2_0T0\'P[
M]^[>O]<U?K9F<O#FSZ-/KQ[G;>I%^^Z$L/]^/OWZ]N]/%-_87X#R^/\#&*"
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M1S"PT@ 8 NP!APS<IH&$%^2HDL0-+CCR!Q(_"/++&ZFDPNI!%MBQ@%HFJ25
M!D!,L*]'B]J[D  45%'P2X02,=$8%.C P0H:*+S0&)56+-F:J AL4J8<*V3
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MPQD.Y$'[$9I,43H0:4X PR!*) ($(C5@8$()""A.!0,.9#$%%42L8+@&DP+
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MRAJ84@Q-Z$ ="E<%43U3G-LL' 9(@ $\3* $-:A#%Q203"H680L?P":U!%
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MQP09E.  2/A"(2:PA@>LV4H?$ +1?ES0$LB!R#HHF?\ G/  #M2#!@CI\P.
M(80+6, )/O#" WZ@:+50&0<*2.\1ZK$JD<F!"3T@R MR9H$':"">0_["IDL
M9R&88 (%>, J'L#($X3A 7B % Y"4 ! A&$#7-Y "N: @P540 0]N,$.= :
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M8D%64& +"/C*FV*6%J@03'C+@545P",,4@", B.BQ+H#1#V^P#$#S#<%PY+
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MOP!!!\2 $ B!'VR!)US07,70[MT V6$0'E" NF$0Q?@7%Z "Y"$!%!02!J6
MG_C+=J%6*G#CXZ&=:ZT=$ #"$1Q6:@G,"S3@07Z>#1 D)BKD"IA R%4DS0D0
MQ$A,10H ?PW" (@C#9R7Q-$=!T *1AT!]"&!&6I!"AQD 118_AR!&B" +8QC
M$@C "@P R2A<[G2D'#  @2E *SG_E?4QP'M-  ^<@0M\ 1 8@!\0 0S80B8
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M#+#(+" IJ8 1,*;P%0 +T.^>(>\@,('Q30"47< (D4 =('+)DA]H O]!G_F
M"$ORP5R1=G9 #GR!:SY@RS  #,11$1&- )0 "W3" *@0R2*+!*"P"[G8(*2D
M[GP "C\!@-5#<OI 10G!72'+!_ !!L1 %4R  ]14#$R2$&! 0'D ($C! 62#
M\-R#S<C3+P%!%"I;V6Z $JA $2 !,*QGBQ6 A)*2+J5M%*K8!DA!;AZ@%K2R
MBD%HE:X!\P+5!_Q-)S04(]74*:D:^JB +7SHTKR 0R'B$ZZB/_6!-+F3%/Q
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M=X^T1W7WA"W0@3X,_\!8CW=[N[>&>#=[]/9[TW=]8TB!Y#6"D,=QVW=_^S>
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MS9LY=_9,LBMAGS,;(/A\&G5JU:M9\YU<M\'EUK-IU[9]&W?)P"[!^A3;+X:
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MCC%/(A^T73&E,>5(,S_R3(:LX GW, 0>#$"*!6AD#"CHP3@[X@!4C($3I&"
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M0'2C5]BRWE9!#H@P!P0L_:\"T'H.PO !8!] "YW00"KF8(:MRZ $V;!$#LP
MZSJ<M>=/Z (2OD"#K3+AKP.YJAGJ4(@;?,$';)##&=I>> Z\( LJ2 03_."#
M"2!"#DSH0">,X ) D'SJ$IAVQ04OZ7PX_@-F:'077"!W%6# X#D P@V8< 1
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M=" 9"X$#5H )PL#I+, )Z@$0#J#I I(@$.$+9* "F  (8$ (!L '"D .B,
MY,#VL XM W(N+P 15H$!UN +Z@L0?& 'ON#($"(K16 OQ:X(7. +JL "/H"^
MUJ KRQ(0CBLKCR MZ\$M!< &ZB$$/N"X!@+*Q* PT>T+H+'%PH +\."$X!*R
M2N +D. !3"!1#. !<C,N;^ !2E((>L ")LL%__SO!,[@!'QS( J@'FKL 9!
M! 3Q ^X!"8 !LGHL#$0 L@  $0!AQ"S "PK!"Z"  8JL!UXKQDP3"A:@R(H+
M*)MK/!\3+;M@%;Q, +P MX(,JAS !EYP^ZJ@ /H@PVH,!V8 MTI@-9]L!WJ
MR[QL/+L.! K@!:=L#GK RF3  N8@ BK !W?0 23 -@E" $K "'8 #U"TRP2B
M ' @ 2Q  L @1G,KK:)@ GH0RYY,R3Z@11T@#RZ@NU: %#Q4#4#@0R,0/6C*
M410)(U8@$X2@$!(@J?X0 (;M\D2@!J( YX*M$;/T$ 6"!Q!0["Z@ WK@/QZA
M!8;M1C*@!1CQO;(4#/_X\ F.+/Y.0!.J8$A1D;XP,@ZK8 Y$43PW0 NBX 9Z
M80D'0B>10*D*[3]@  QP$:TRX (@=2"Z$:UX8-ENP%"C@,D03 W"  )@0 ,Z
MX AF%$%QX![S(.7(M-6FS M.(!..X -Z *UZ@0!G+AE/X W^Z@-F[K5J0 -*
MP!H53*PHX!XD$@!60"%G4@_$"A%28 =,8 '2RO92U5F7Z@-$@%7_@P?. !!2
M51_%\0,.H#F;H B0  ?.@!.H\O*Z0 AFCB9_4EI3@+$,@ 7HRP( @4'%BB89
M;P9"H%_KP0]H0 )FH+[T !CB*F 3Q0$*0 @&(04D0 ATH+(B;F)3H E\@,#_
M0NPPIU,\F>  \/5A'>L M!( /F &@$$.#N ++@!%UT#%:)(&+$ +J( !0FQA
M 2$%]E$ ], I#8 )+H LMZ >G!( :%8$5 S);J >:J +O@ 8_BK%7( )'+(>
MZF$"I!,):L\)?" !#.  1-,'2H %YLTTZ\$#)NL_', +.B 'M(\)B  1;NRK
M1(!DI4PI"V #?NH%)/, ^':T /< >J#%:NQO!< )'N  Q-8 5N%EP[._"N _
MZP$8_E8\J_, */0$5N'*!.(&%BNQM. >3&#&$H!QBZ!A>TLI+[ _?> G&W8B
M2;0$A  !3 !M-W #/#>V)M1'#=0/MD ->F .3& '_W=T Z;+ #Y $%_44W_P
M0ILLJIRW0YNWRCH@#% @M@[4R5+T+C7@!A! + 4B_FI@WKQW#36@1K5* KS,
M *3+(!Q@X#K@R*[J#4H #&Y 1@6@1JN+<M$C67)ICD+&G2;"S)QL%9. #VQ!
M"(ZS#U7RS$!,"K:@@1]8# BBZH[M4L,S RIQ3 LMP?C@'AY8!R: !RP!!+JM
MX^8Q31.E AHA%59Q 1!A #1!306B#^62OD!L *9+ /(@%!6@T)CM#0PQ&,.@
M V)5AZ41*H^@!+J AUW@OHIM&5%."V*@A+NR#QC@/]9@ .[Q V+5 @"2 W05
M52=@' &AU:"R Q*AA'<3$/_D0 'FL01,X"+U8!\-0 LP=@4Z#@ PTHM-<@YB
M8 "^X O*[@@@8 4&H(1M@5W%"@!BL@.ZZF%1E *Z8! <$A"T !L8P (:TL+D
M(!L&P(%%4)1-LK3\UP_]@$&=,F#G@%[UH/X8;Y97H2DG@":5U@(>0"H_0"*M
MC(YGTI<Y@*LZ]L-*X A^0 *8X+ P3W(]-&E'^0"$  .$X N.@#A)0 YP3" D
M@ 6VF B$=-LD  &V> >Z #^=(" =RV@!3P_$%L0.H&F]F1^_P&X;4\5,\P"^
MM@5L2VQ+0 2P5C0#DF@+>@*JZPM^H,5X3VP#=]Q(<W1;H'!'5@Y6(8 % A$>
MX*?_R#8%#C<Z\=8 1  (4K?$(JQQZX$$'E@.D&!P"2)Q6PP8\+;$D "CQ5,$
M9D $IJO'D& #3, #@$%V_4"-"R +<@ $Q!%VS].X=H 4'+BE?QIN3]@! *&$
M&? +G-FR7M0"@($^/6 .C, 'YZ .L%FKG\S(EO2KMG$.\ !#G8S+0G1YX]K*
M9D +<@";Q2"WJ@NH;: 0='D#>E@"[^$,^D 52^"(O2O)KJNJ'_.N/B %/@!/
M=PVQ^3<!(@X,+( "F/0\G)0CA*:'+$(/626I/( +'E, A"I+(4T '@$(3ALA
MABT/6@ 2.>#.+L!-BRU.^ZL7'+L"H  8*I@4?J"U2W$)_[S*P.K+$^IK#R9!
M!O[C3 4 !J+@L,Z452@@"*I ((.MM7M 16=8$\0 4P7"62MU!EL-!JB@(.^1
M!UK-6=6@"E@EM<^ 58*5(AG+5!6 O<Y@&%-AP"SM'(%A"F=RP<0N!5S &N?;
MJP92 6(2J@*V637 !8J@M!P<K( 6LCF (H$@6%4Q6F^S2^&/!TC@6#]\6D\
MPA+,Q/&5(.HUK#9@YFSXZ10V:%^9 J83'\]@ Q2V NX!ZS#/0P'R/X!</+62
M$P"R">1 9D$V*^%/ KI2*W=Y EY #F9 #I16(-0@$Z"3($(,B#]@M>3 "YB
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M_W@+K/[9MF#%E\J_$$ )_#"LXC?>ZB#S9WD&J%*6/?QFN2#;_^J ES_@[N6
M!<Q@RQ\<^;]-+#]@$&8OM5+!"]P._8 <+9UR6F6@ ):_#BH,!KH@TB7@"Q@K
MR=PN!U+V#%X@JS? [7S=K7[N"! A&ZXM$2X@NXP@<[]NZE(,(!0 D/!%!@
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M@6/6O ]10<MW/ )( ,8-."00(!@"K*&"#JF=Y>"#$$8HX8045FCAA1AF6.$
M 32PBH8@@CA  P$,$.*)*)YE@1T&I5BA #STT*"%,&B G(LH"M + V=]<,:,
M9_$ 1(,\' 'DBX"< 0%4,%0A$(Y01GF6 7X0<>2$5%HI)8IK,*& !8#XH-N6
M%(+IPXUD2GC_Y84"?. 'FFG&6:$#&YA5P E%.498G#<))>>?)ZX)Z*"$%AKB
M! /X\PDPAF)X3P/^##!&HRBN\ 0_3X @*)06=$#%#QGR,  12U+JX UGW&@
M#7 Z*"2:KX+X@I)&.9&*J852@ $"=>@P)H4/T>0KK@ZV.0 0 (R1RJVFCO$"
ML\2&^ *HT<;Y@A8I&99*J0+ )F6W<<2@0A6;5FONN>BFNV$##1R@+E0LL&OB
MN_36:^^]^.:K[[[\]NOOOP '#-4 _2Q:[Z.?#%#NNS"\L3!4&5S08 9#9L@)
M#CQ*&'&IYPI9@@;42F@ 'S8"L((&6_3!0&-%MAKD$;#"_.<8+KAL_X$>/X9Z
MQ&4#2$SL&#=P@(@<+1KJ0"HN6[C1D]T>\.2%-C@-Y44OO>C5KV<ADDT7&1_4
ME0\VB+  H0(L"VC9T&;HP [6&<;VH#< 4K2TJ3C7]H0%%&AA 7U@#=547231
M00Y,<#&VP(A+.6*[]8X8Z;\-<TRA (_X'%4&+4A>H06DI)TOC$!\G/19%" 0
M!:@KF)#R&0<)J7F00'#L^I]4=NVB!$S<4(3MIF;Y,)DE,,$[U%*?*$ )!QRN
M;K?U8"V 5RZ(3>A%#/[I@!<TO#[G''<7>L,&<VLH@!<F.,#]ED?U$0*$QS<"
M0-S*)RZ_BP(D:C"]0I X@  N6I!!)R0P0O\32,&C1_R! P+(0C8Z\9TE(# #
M&*@# RS ARE$00UU, ,(EK0"$IBN!!'41!00B,$ <B!R LA #S(0@3'D 2Y/
M>,KE(MB</%"'"ARPP!XPD(DS:$(),:@#$;R6!5X1@6(.R$,B5!###I@A$4^H
MPI)2^,0GZ  "#LB"$CXE" P\H0LU""(1#)"%&&2B"@[0Q!1BD 8B6  %U#$"
M9X @" ULP$8&P-B,+, %)$#A1ZG;@AU6!@ >/%$%)N"  ;2 @$XDLF409&(5
MKK5%!JP@!E_<P "4D,A";J<3 X"+"130LIN=80X#4,$7LO$$(_"H4[Q:!0[.
M8(#?*,$-1^B,*)__=A *K%(%1ABB -0 EQQT#08SZ8(+.@"1P/6"!(G802.G
M$,P 020'/YA##>J0@@XH03-AF(,*J ",+L@ $2QXH@XLT(LGJ#,U+_@-!G1P
M@VQ8H@N@HD!2/O,#1)A!!3716CZTHP0->&&!P0%"@GB5@GJV4@0L4 )H?B,1
MN7!D@3VQW$$J@-&<1.T'#ZE#(3@@@>WD('0*F0AF<B"&QKS FSGXR%>\B0%+
MR.$!AL  !CKYO >XX#>?X=%1--$).;@D 4#YB!]<4(_#^48I8="E*TM %7YT
MXC8]$, *Z((!.B:E"SL@*@92X )-I.$(T^ED5.9@!@S(<0Y\J E,3*."_QB(
M83Q/P(!P))!3#)BA#D?P@B&^F1+?U*$+'/!"7$%CAAATP3MU12-Q;##8&!@!
M.=WB TV*0,K;>'2P&$C$7SE+IR<,($^(>*%FB."%Q-R "P9!1!R^4X6X-2=O
M/ZV#'$+S'ZOXQPQH3(\*Y("#5'!!"&9( V?RVH+VK+$.5"C,\301VC/,12\L
M^"(2^K   Y@& 2 HP10P@ </4, 2G;C _-;[H,6YBUZ):L"\4#0&'KP! @)
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MSY.?!&4H$3,!KH#)7:)$92I5N4J>9))Y14&5/YZG$0MD(1%F  $G/*& BMB
M Q7A02* 4(%,V(($>#  #G@)  'L(0="*,0O 4 !.,A ((C01 PR(0,#D, 6
M0A##=P1 @4X@@ H*R  0)F"!#SPA!H; PQAX$ 5>"J 7,K")!>R@3@',DP$
ML  4-O"&'7PA#HD0@@XH4(5?6J //Q $'FZ@"1/\L@*%^(% !*") 9@A$=8<
MIPJ44 =UPL (_W0 "V:P@6V2Q0)<&$ -.H$':1;D!JEH&RL9(@ )F $#72""
M$VB04X6\ *<5<0 PSF !)X2S_R %V, "#&+482$" 2K @!&6R1$!V&"H72H
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M@CD(H07G]<%W$"$'(MB@'@DH@ @6T.H'/$#G%?@"$ QP@%T_^P#69"H3O/"
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MA-[BJ&R(L<>J+ !0NQ] KB$@+GUB@+C;B>BR"4ZP.P$0, 3H @\ A#,0A!0
M+@HX@L@"/((P $"0@U1X/O1:+"?P@1)8M4I+  .HAQJPA<H3+SM4 *9Z@'J(
M/*C:/#I4*ZCZI_-B D),1!$X &&KAQ-#A*A:KV5B*J<RLE4X D)$@A.PA10
M!AJX@:CJ*A80 1 0 $0 A",P11M@ 1W@@ FH1 )[DC&X@490JS$H@-G3O6Q
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M^XH Q?N!.<B'N) #?DPE];L:TX">BEB!*( PA6,X"\,_3H""^>.LB@NMEX.
M%:B# N2ET8*9T=HK*I"F@#(KPM*H/$!) <B""QBLT;H!L3N(@"JQ'G@IX<PY
M=%*G6K($YA2(%9@"(.,!2Y KVX)',(, ,5NVV3JSDNR#*Z3./S KF/1!UN(!
M02NNI9JS@^S ,ON!H50*/WM)+J !ATH.-<B[,6P"/XA!HDR(%Y #1/.!U5,
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1 !?P 2?P C?P T=PE @( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g22532bgi002.gif
<DESCRIPTION>G22532BGI002.GIF
<TEXT>
begin 644 g22532bgi002.gif
M1TE&.#=AIP.X!'<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MP10-2$$0,1$"$=2CP0 P@#G0T (0VV$!-/BC!$X0W%-W>Q \,*,D<R ($9!
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M*=!9 R$*/M!%YE %-.5:FM8_6% %.:  #V #Z6<#@^4!KE4,_)-7#)  %P:
M-K!6&X!&$L '*L!K;?!$;C0#HA "A,5/5/ &00!W@P %08!-B81-;$401&5E
M9 8)7_ "IQ8""78/2J111 !;K=4##59M:K8)&1 $/0!BI#!?/^A:GO0(<&!5
MXK:"XA9&-O\U6UT0 55  FU4!9'X 8]$05&0>FOP!7;0 79&!62( U&4 O+U
M 0Q@"T_7!MZ6!R4@"33E (*0 P'8B5MP29CH4">G SJ 9 +A $#V :9P#QZ@
M7)_& ?AU0)C0 VK6!C(P0 90<M\6!#@0 ;.D#]G@ R.W2*U& U7 7 7A )F
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M8> %)/  XYB=!7&/^?A31- &1P< %+ (![I!([1)*$H0Z-8&5B5)AJE%.%H
MMD"81Q<(N4"9)(>/0-BB$J1!6S>C*_!=2C5V^>94@S +39 "+% "D" /A,D&
MM@ (0=6E<% )#D!'$K0 :IH'X=4&#'J/@ >C=@H 6;=UXM@&7!!/6!!Z!V
M.( #B64BD$<'=O_ 7F;%52S60AT0!TXY#(/50@9@ IPWJ%:P7P @"H.U 33D
ME (13(EP _U#02' =]*D .BF7P#@J$&D5K!J4Q30E 6 B&^@AR_J S%4JI-
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M4]AD6?]:S!G\$8":V((6+0C ";X0!/_@)6UB^;C: R(P@0"D8&H("<09)!"
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M.24L " B! -H.HAY$ 11D@#ET)P8R#NFB,$6\ <O(($=$P*=843NP  ?V(0
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MB'L$%SVQ B]*Q[VCCR%P1]2#@T$ E]9[ PS(-=LS!<T3Q4>(/L6X JYX@$P
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M_/'##ZR@#PI0%( #_Q9P")!! 09T$ (7 UGBPR&F(   #A2HS+(!%"2B@'!
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M"$S "<2###S: LA!"YP  UC 1Z0A&>; !@Q$&K; %\PA':HA$G0!"R@'$/@
M$H"-'<7!%TC.]4S 2>3 3"U !*QA!O0A01C (RC"'KR _9P!4&E$#@1!#_R!
M%. A  1""" ! [R9]0B"#TP (U !#[AA4<R#((1 "TC '72!U:#!"63 !3Q
M!""B1*3 !CP &O0#$@B!*U[/"9@")"Y/!=! %4S .5 !%%Q !X1!12 !!>%
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M';3!&\0E!OS!57ID&U"0\>U?_^%=4B&AY T#E,YH%WEA'A1 %X*D*89B%KZ
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MVJ8HM@ CG*[CQ/^!7^XH&L GF!*!3OKOU]+FFG[!/1PQRWSMV,HG?+HM)M!
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MF!"=3F@9&< 1_,$7,O\BY^+A$#-U-D!KCW]L :_D&<@H[/1J;/; AYQ %W#
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M;Z88 $\/TXX3-*I40 BHKRG<PYO)+QHP,)VK!W+&YZ@@DAI32KDW 1\@K52
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M!QA\3&"4XH5#DR=1IE2YDF5+ER]AQI0YDV9-FS=QYM294X"$ !QV!CW9,X
MH4>1)E6ZE&E3IT@-#%D#QO_.HSA?MI@$<H;1ICM5-DWX4O%!CPD?-L6#)*'-
MFP1EE3"P ," B:L('H9@]'43HPP7#% X \9%2KA=(L#Y^S ,&!LAC$"9 2 0
MUS9@VPH,Y$,"W[:V2BP)>X=*EPTE!A<IT,%'UTV'PH(IN8!(G+U5XNWXLQAE
MAQ BX\&9X(5'@0H1P#*BHB_/20.HVSQ)T%NO5[43P!0'L+5-O"HMVC"8<;$4
ME083!FWQ/>$R> 8)'$10LLEKE0E(,DQV4/MVWPP> +#D$S#>*&"_/R3X *RP
M3%'@.:[XXJ./ @);A(H03OCB'AJ JT*$(IX*4<0122S11*4,V,$?)>XYT244
M)O#_1P #7*S1QAMQS'&G!2*(0XH-.JBB$!XF R")*B3X H$"DO !"1G@,ZL-
M'A)8P"PI/'"@!R6ZN, A(L[8(RL'@B@2"!]D X""J4!$R0$YN!3$!ZP D"J%
M>T(HA($"'HA@D<76Q*K/3?X*;(TOFC.@MA0VH&LK,$"T) 1_$%TMS[]\0T*\
MJ-8X(0< 3UJ AC]2R$K4J[(" (LSO&@NI0[0D$ "*G@ %0!,P@C "Q!Q]6NR
M>3"9[+DUTKLHCDT0N@<!(A8QQ4M+6"U"T3^0L(+"1_X8) \#-HN.PLJ0>,*X
M,#+K( S\#C# '*Y24 "33 JQU@! FG40 T7.H=4<#L[=_],A@70,6."!"39Q
M'UF!&K@G"8PJV.&'(8Z8)M8**;"L"7YT:"LD"@3@@17BFN%B*;Q4]"ZX9!"6
M"$CV:!2EL@I1;4TP7#VIK#^#0",[11=AH +(4F;MBY(\7N&#/EBCRJ&/CZ:0
M648=&B*U $- H@O],N'2 BP4&7KI+;M$2900,G.H@\&*,P +2%I=J8,56I#U
MCC<F\\U7C^7[]-40:*9-$0(=FJ(QU0:*X(,W'*"AA?3H0@U215LPQ67:-C'%
M@PH&*U!J,$CX.@#)*V/(H0K"\.(%M7,!0QZ![)8<8(EACUWV@E/TAQ$="*Z'
M$7]VF-WWWX$G<5Y($*7+*MD$$O]EL D][F&3J^%BH&2KI-A"2T)!!015ATJP
M 9() O 'D>(<?^%UAZ[/8!9F50ABB<,_?G(&[G) P084A'QBW3;J1P'_0L0U
MK13@93O+RXL1M!,?)7R*"'_X0D,*5SD(.L0 9P-##$P",T"M@0\U4TD':+"6
M<N5)!A9A5H, @ -S+ $2_0C?KM3F0%=UX!-M$(']4. D(6AA5"@T !#^5@0%
M\L8 5\B%MLP5'5O<JR,.P0$1-C&(#5  $FW0A_]04$4NJ"L7IJ.@57QBNND$
MCXQE-"-/)#"!A EL80T[XQOA&,>7F:4?$JBCK$X@GNU4P0A]6%H3"I&RZ G+
M+BW[6,__5.:C+0S/BO?@@ ]B5@#!I&F.A;B:5*1@@S-4SS=&D($%I.8/G]A1
M D\RQQHD(,KPE3)E//I#Q@ PC-040!0^0.!T'@"G#+#@"*]TV9N4D!^4.$X[
M#T&#_-36M<ZY1%+XF4$G_16?/^3@ OMIP0>ZL*$JM.HBN5"20RHC*Y^($C]:
M.((2G-6X,\2#!'TZ@3#I@@%2;0%S!%JB PE(&W0B  NYD%4  E!'/CSA(EVK
MF0$JP$*V=$R.#75H\!;6HH'!2$8T>NA%,1JQ82!)G*-,4E:&84OS#01L,W!
M$P@U%[6A2DO!9 $ %B"'%HCI8P 4R /"0(?BS&RD)P%F?D9 _S:P_"5^);3$
MG#QHMD\4+R4F&Z#&IM;)$L*4&9O( 0LP,#4 C& %C-#;2480!CT!+!"0*9"Z
MNM:FEL1'@K *I$#8VB!S7= AEAC<1>:YM,&E1%2D<IGCBH #>0Z"@'%50!(+
MM!4^8/!669-BZ"9H$BZV#24CZ $2TIE1S6Y61PM;8\#:R%G1CM9$D/N"RQPB
MF#X6  AKH /S4":R'@2R9+61 @)BZL"L2"4 IV4- L?S"$BL=F:%F:,29' !
MVL0M.Y8*I&R#"2H'!.MF.8#@=!/Y335-Q7QCZ^-T?LJ"K?@%,,)]IY="%0$'
MVJ%PV<I*,K^@UI/,(P@>@,^:Q@I-N/\2 9T7>)1JK,E-(G2ML% T!0$-$*S]
M2%"=D*+,8%(6E3-DIC($HF48WNF@$BCB!#_"Q&6M4*3I)@!U=$HA#@0R!30P
M0@A%(NV+89P4 PB@'Q.0J,!TUP\WQIC'/;Y)4.."7H>,("184AX88+N"/T$7
MG@,6$P!*@$J^W&&FB^3/'2 1CTW0X0VVV%Q/30+,'$Q&*OV@4U$G(RD)*,<^
M4F@(:]9,A3:[+)QW(,FC_/C;J;[)JA[@4=RP?(=-1-<P9F'$=9KKD%713"53
M^,0)7!B $S#.-V.E*CJSE(D6*"$X@H;A8%/UD!7<QSN;\,(6^NI#(#JXH)WY
M#A*P]) :GO7_7@&X3%^4P) ?GL'6AZB"$D8!&'-XTU5EN76"Y.MC92_;)9XE
M6&B9'6UI2Y:*R'..>A'5VCY^+62QI4MM&L'>!91 $N<8Q M6M8>&.. *5>!?
M$.2PB +-+*G-6T2(\V))+U4Z94NC@0_.<8<<V $'_O:!5P8^E\:%!%+_7<TG
M5CN0>"_F(V"1P@H))62?"B($2KA#%X(@6:[%5R68P,!WVC ((ID-:/M=H)?F
M$<(VJ" +.B.!+1ZQD,A^Y#<?R,$]3,K?=#[H#LODEF@8(8*>5J )1N""$PLB
M%E(((A>PQ 0-UL (;+*WQ*ER@"#L\W$"3IOLT8XHP2@ZH[*OG>UD_[<H3MS*
MF[;/G>YUCTE/U/AL6>W8[GWW^[+G 2K:Q"$[?S?\X=<^8]OA;J*,T#'B(1]Y
MC!;T,L*QFL8EGWG-9Y0HG^WLWC<?>M'+#J%+@,,Y^'>/,8Z>]:T'7@,"8&.T
MQTCMKK?][7&?>]V7W=D* _WN@1]\X0^?^*\/@ 1N'##=\:[XS7?^\Z$?_:5T
M7N\,D_[UL9]][4>_=BR:?46W'W[QCY_\F3^8!#R?(VB7G_TKP>D$^H' UUTL
M_E-%"JPPAEJ6.* $*$"E%U1 R!*L1T:B(ISCPR8 :ASBZK*.5EQ,)3X"$A)-
MLC;C!(3@?'RJ("3 "Z#@I= GZHC# U>"-O_^X+R<@P(4(1\"0 '5*1\^:F_Z
MX006ZR1PQ1].P A6QP&. /XDX 3B(0IX0.',105CL A/@ 7;+PGI0D5N)W=V
MA^^4L/VT1"3>R5;@C)4>4">X)20D  E78BLBK0=+Q6S08 *^8CB*B5M^0P)N
M:\C,@M-:X/+<[PA:H!_HRB1P  M0J1#DSCEJ@]/B #]>RF08(3EVB27*0E:\
M1K)0(Y4N"& ,X!'\*0 8IS=BI93D#EID)3J^#4'^":"\8$(2L:-DA1%$)PJ5
M$._2#T>( @I1D?P> *70XLGH0@_1 KB$(@)+$99:H@+NH5'VHXHFQ !&Y4<,
MX @@(=8^ I5DI5W_:G$JFF,K%A$ERFH"9 52 &8*(J %CD]^5.),'&PK=J4
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M(I.P]]CH]_12(KFD!R!!CY+&#ZJF8_30AB!A$Z9$DM:@#9C'7"H& P%@'BS
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M0?<&R=3VP9P5)52L$#J4KS"@ZH 17N3"!!8!:CRU*L$J!$A15K #1 )C:C
M$NZ@;XM@B12A$NWQF"Z0ANX@'N+1$IH 8'O(;%&#+DVBP@XV;J./^GS/^I07
M^F(KINJP:3+%#!(@4)JC+$HR538CC3*7)98+EA;@"OP@")UC" QB+,['92MG
M W3PE234-A70 '!@.F"ESUABUW0V@]JTWQ*, U2O3M"F %BS68NC'--QT8@&
MG,X@4WD3!=LFG!C!S? *7WNC?PL $R*@CAP,;$55Z/\ !!-6)DD6F.B2]WF=
M#_:0[_MJ#X6+#RZ$:4W\H1'P(F_?BJLFH!#4@LIHT27CAG+!5[U@R26#2>/
M] _\X?@B#6I\HS/HP]HDUT<("%;Z(1].0%? 3"6&@%L-PUQQ@'09)R0E BSD
M<#_B  [US4WD(P4TCFQ38%L "V_NXP*[25M>!0V,@([O10F@AG0 -FE54)Q,
MYWRD!B]=>'G3:!5O9/T.>?B@E# AZ6KR33XU6';?H*P6T60LUB5($); <8%/
M,FE)$98Z8&.MR@!#I8$4,'' @@H"\"4<3G/1X 3ZS65S81\)XN!,Q\5R&3W,
MUSDJHRT><%X4P0B,4S#:!@?_)+%X(G$AQLY&JV:J@KDZ,T<@$40D,C8+?^AO
M3KB1A4^%6Q5'EH]AO3D**RR+8<)11[:<V9GUF+<OBZ*=(S(2(>$_:B*FXE&>
M]9GUQI,1POE&TJ[@]KG](.([]G>@$;KY%+9YZR&AV<\W<LT.C-6A*7KW&E)@
M4$ )_$$$8+6B/?JC07JTWIE)):"A0_JD43JEXV@\96^B4FD'.EJE97JF:;KZ
M%-E&&+FFG6(!-(V&FXJ^@F"B9T<UZZLI7A<;IXO@U):H)?0FY'0/0-EX_J;>
M=*)/X#=XWG<?9P*ARE"8:8*H@UJG19I563BFQ9HF1D 2PJ>*(2T?^H&&:V,/
MFCJU_P@/E8&'R/A4*:(L31RG0E4BJ/1$Q++  RZ7)1:MWK)J&G$"J-%'/C+K
M)H8P *P8  G[*5(-9%\" =O %-#Q5C"LBI5#!>Y!X0J'5(5"-4?[K/4N[YJ7
MG%4[)F+1&E=7"H* "$I2_R@($(BG1G^GTA@*12;)?();;04'F>*8)N24J41.
M$?: JF<"S^ J;PHW)IHXC?Y)NYIBP09ANE="?]\R'06GH\BI#?'&!(-"!TW[
MM7.D;1D/QWS"M=5;)C;*" XJKG'[\/9:(6,"NFL""ZXBJ2YB,**Z)BJ,L7BD
M6>9Z)G#%DR@$ ];@70M[)X(4A6BBD+OY =CR F]%O2;MOO]S\9S8.+X_[R<6
M5L1UHK6F5+(T30HX("+:H LJ&Q!:H!C>JP1"H 5.@%;.)RHD,"%L(P4D&@ H
MH0<6008* L9O!>L"X.,(^VW$8@-6PP>XQ ,H( Y8=J5&TD:=A&Z.#L>)(PN3
M7(20_%8</ "PR;[H8KB_#*[^C3VZY&U,R0?NR!_D#P>J<>OPT,:'(R$,*H&[
MA@<B@#$'#LK.P!L?9 (IXQ-BSXX\29I^#@VN:<P'$!),L;.AF<$9PY,P-(1T
M105 )<%HP#XF(LAYQA1R1@0\X@K.(-=((0W0";/9[3?XIR+L,HT BAU- E<T
M!6 < %L LG!.8!1$)@(TI2"<I?3_)((B  8'$BH.3H X'@%\ .H@ULT<?F/4
M+<*/B^#DY"(0RG #?=+$9T)%O,\A): !!%K<:Z*U$*&G"#$M[*,* T,"M\#+
M*/TK[N"34"()'I,QP0([S">F"D$ X( -/>"HV*,*OB=-6$-3+&# P" K@,P*
M (1'ZKFI 1M*@* *^H$TJN!/7R8,$KX*QI!TV$+AL4,[I )Y^-;!M/?0/EYD
M\J1]0KTOJ$ $^F")*#T>UD LS,<6!.,$[@ .WI%2!GQMSJ$^?G@+^D0)8HTI
M(^L!0ETB;IX'XD,BE%X.S>7DW0/,S26/!:*OU?4,\H$O&"&9_7L31*#GFTMM
M%D$$#D$L_ZK"V?F"04!6@X%#.-J@A$#H.P[-%*+Z79! P_7*F=#;6=;2SCX!
MLUB@SNPC,^S2'[I#!&2@K+X'"41 !13 JF'^/B095[JRF*V@,D[@ PZ!"H!6
MW67" ,[OIFLDIU4_)H9! E$9<L)C/&R;3F1\*45VNELK2:"<-28@Q+0$/'*
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M#G6J8ZJ]_PWPC@P##E+-3AQJIQ5(8#)WQT%3"#:QE!?,>Y=@\$,0VY #8!I
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M()>D80"TP 9I&2BT4 E+F1!/D)&N8P##,PP_0):K8@##D ,3J1F5PA^980"
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MG1$(*' 0#T (%M(;]_F<F($#\Q"9F4$1(I X#M"DH=$!*(!>KU$!2Z!\(]0
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M:N?S))62.HB02DV@ M9S B-I,!(@LN AJOMP+!L %B?++Q\)$6-EDVK1 OG
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M2E8PIA1P&56A9IP !N[1 4Q %0\P/"; !A9 "4WP 5?;'3F<JA9 "X4#QCT
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M>9!2#3 =C\%&D4L#<^,9(Y3%[X'%"O  :> 2>AH#](D3;B ++!#B%P'5#.
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M[QL@HQU@"BY0W3J@OV@=\%O>!0B [U]A"EO; R,'I"K0'SJ')DD=/L'+MLS
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M.75*G!E P,Z="R:9D3CLQT( (YC< #0A0#\) 8PH*&AP 9$/#&9@;.+"ZE
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MGZ>0R( %<WS(8(.".K"!A)<<P""$"1@91($.4,@4@ =H>.(!;82H*I E3@4
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M852^BD$7%6" +K8)!2A+%O$F4@(;Q+!D?C D3'SUL:5IHPPL2!;*'F"#9]%
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M&:IBE-XLI0.)4.1-3AH#U,!/*&90BNV,HCE.Y,%.0RWJ2JQ0%;NP( E$K<I
M+/"7IA9$;,]*C0_+ZI+:;,\E0-@!!V!PF[R\R#"[VYR=4/.&U^QF(=#;@ .:
ML*4%, \(IAC8,)A@FB3!X!X%,8H=TFI7!ED .Z,32 J*^@!"V*,@E.@! UA@
MP(F$!UD[\,H#8$"#'%@G/$6MR_]\2B1%\2F(/^C!3NH\9 K;+71_"V"&;+'C
MH/TQ) )/+&(4K/4@M?C/*L,%+BF0LQ4'I*$!WD-K;_=#(_;X(8<,L>!6AK"/
M$DZ$ A_LE1-X ( %T  &WMM6&/%% 7UL ;,R6(@#@&B!"(A 2D-X4R#JP3E
M1B$(&%"5$>$T)M4\8!EO9 @6ZB$N _ W#P; P@Z(1^$'N\2^^F DOL"T 3>%
M=PJO<LF(7;-0$L>$FZ@\31XM4"HUUN,-KK2A1$9)2U_A4V/UT! WPU5)@TS!
M6;8P%P!P@(6E>(M:?>@3M0[FT61JK %](&@#;#<R+5QA78/"P-8J\"OZH$%D
M-%!8MGK_M01(BH5D#*D QTXS3R*G<TI8,(4Y=L Y3&3""A@@K,::<(-Y1.!C
MHV3F.B^ KT!(0L<%0]DZ$4 HFQ%:"T\S,B".TJ<.B'1*E$::R!PBF;?A(*-]
M&D(B,O8R@KQM2BU5Z<'$]I&12) 3!]/:0@++!IX:I $TJ5NN?2T1%-!$  ;P
MM0'"(-%A9*YPM E#!NIK!Y?,8RMB*X+CBA"YDJKTVI0( QUHTP3."44*(5I
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M!KBV"E@!R_""+=&Y'-B*!>@B$.L]^@BEEYB""( $6F$$W+H3-(,);F+( )
MA^L58FD##B.>8MK( /@.I>P'),B!$'& 1_B#.\ G!\ "13@!+_ #&T 6,+L6
M9S%&'V 9 1  WS& #EB9$V@#ZC, .[,6W<R%66F#E)0(3$!%TU2-0:&!.#B!
M0? #'R')%F"$%%@"D?E 80R# "B$?; !>?^H@#.0 &,QJ'QQLWRZ%YJ<@!/@
M Q(83?(L 1\H@N'TJ0[2$T=SIZ4A@DJ S&W<AP;0L0( @C.X3158@B1\*4)[
MKR#Y !6X-$U!1<V4ED0TS$>(B(7DQ5EX*5%+G+"8 FV4 "^ $U4C0NMLA"#0
M-&9!J6\A&M-$@#4\&$N[B,"RF9LR@!TP&QWPPU_3&W\0 !RP41[M41_]42"-
M"? IRB M4IL:D<PS4IOJ #] +"4M$/?:B1'HH1?I(B)Z4BS-4BW=TKX9 1I0
M&B[]M?KXR# MTUPCMES;!PF@*3.%B9RJAS:-4SGE4@/  ;N* !6HL3D%4O4S
M1'/<T[BA$3)]4IG_3%+%D3'0T88HN%) ;51'==0ZA:XK$ %&?52L.;M!B8!7
MLE1.Y5$9-9M>VU,44 )_$ $T[51435680(V>9(!*5=4E]0'N($@]=50@6(-B
M\)TG!1@O<-*<F-+DT)1 @E5B+58>[2"GN!@#+-8'L$Y_*(2K,E9I!0H^;-0W
MG59LS59MW59N[59O_59P#5=QG0@!\ <E"-4YK0=DU-%Q;5=W?5=XC5=YG5=Z
MK=<GS:D^G%,! ,5 M%=__5> #5B!'5B"+=@?E1NZ:=1@TZE3E=8.(%(??=A1
M"0S6>HD.. .?S$6,H\:_TEA -1$E0$JXB:U:O0E," */S0D'"(+B*]- _]"'
MD2R1M_,U(XE((#TA/=2)?6M9/S0BSC%8(%62]U/58E+0G#  3#"$G"W2#L)0
M7\L:D.+6"JA82]B&0>51F6)30 7$+1V!7)" ?#B!6X&IE7!:'I6+R-G1D_B!
M@8D)UE"KF("=M%K:.9TMNL4)B();G+#3L "$73F(E 5<^JB.NS52 3FNF>4I
MMND"F^51OAT!\RI<1ZJ'8,VU/C6^-_'1.I5<5,547\.6H<6;RR54=SD R166
M,#S3P-641XC68MM10*(G;OU0@[ $A3#279, =)53'&77+!V!1' 1\8D-5 V=
MT8&>BB7"W*%;Y$4-W>G4O"W9G, /\L$) Y # O]ZK;9SV^[:4PC:7ADRSEP;
MD<;MV7T@D"F(@LH-TP!S*%;I4;&( D,EUF\I@_GMFTL*7;L1%IS#4@-P@QUX
MU2 M0J#@#[/MFZLIIA10J'"E3:LUTFK=6F'K6L,Q"*!255:$';IU7IP(# _H
M"";KU&K$&XU;78VK,>IP@0VV#>G=4E%0@9@UD!!6W/Z!6#_\EO--BF6 /B[]
MH>842T_UHVS]7WGQ-2'37[AQ)<[]M7;Q)2T=3AA5V67Z-?JDL#4;5]L5X%_[
M5$:H44"M!T;HAW[MFXF[#"D8G2GX!#,>G<E@@AA*@F*8!4[8AS6@@[XJR2'9
M'DJ0A!CP##FXJK]8R$7_9(#1&8(UT,P[>@D*P+P"*H214PH[&(F+I8D > (@
MH (;.&0B"2$*")(   /VJ#B+\X# H,;<X1X3B$ZV$!AE*@LCJ!.[B"$*^( [
M,JT7.+(@:8-K0PU]. ,P -^KV(2I9("=@02G, +P!9C+(.3=B!WHL ,<Z(&T
MW$;J^R2&/ $KN *BN4X>>(0N8 ]/_F7TV0]FZ (LJ()^X.8*V '5X ]^B406
M8!L46 *V($JZ#01BN4QHZX!]0 &B:8,3^Q:&Y(,ED (G]8U](!8C.+%F88M>
M+0#?$($U^((MZ  T*):_ZYP&$ "BZ56<A"[!XQT::(';K)-1TBXNV0<;>40)
M_S"%>ZB':8[$K6B7-5C$==-)J*R"+^" ,C@,J6R+R^PK# @2+]AEY!P2Q*I-
M9+05<]@' ?"!/"X(8=E%NTR 2YIFNQ2$Y,SHA0H#[K 5![GH 'AH(DP#*@B!
MHAY.DAX$ZP@$-,@!A@2#[5&2LTYK5!Q*:!M.\TR4(UN#$Z!ESD,M-)C*=6M6
MQ3!,O9C%1>0-L2 $%"#I[P  8:3+-A ! 0"GL."4M<DE80D2)."YEVO,2*Q.
MC+Y?9CD"DFX#RE3*?&@#_2T]H1P$0*DYC;Q'K1#HUGX"W1N%UZAM1HB'.QM.
M%>C.T1X4[8!$42R!/_"'<,P#IPF28KP65SP!$5@"#/^MS!-@A(M[F2[P@4'V
ME LQE'[I RSP AN [-A)Q*$LJJSY@"78A$K Y=N\.XMB%RQ( 4K:R!- D6]Q
M[Q:H!$O0[ZO*FCB(ZCES9>=V"",K 448DFQXX(OER+&U4375VCW=5YWRM0K0
M2X^PA4P )\]=-LX+@V<Y R]@'Z$8OG;3$ J@@@V@@ HL6V%D DO!G2)0*?A9
MV@Y@ O9I"$B([Y.P A9@Q7/;"T@P1;M8UK0R"%;L'-3Q8!"&&N#1%D+)S4Q(
MP=?B@1VWCJN@N*T8!NH#!!PT/&IDA5X-H8B3#M\@'O$1WR3Y4WP!+0BBC1[X
M@+1 .AYH#FRBWN:IY@=!K_'_N2YHXBWR>9 T%T;DN)ZBFX&KJ&:_F0<+P)<(
M@ )*\H%!D(X2@-D":+UK,Q&BG(X0^'2]>X$ PW06JDU[?DK](!09\<<4!*34
MRB "Z8 H</-]LQ.]RP/>"B*9=!$C0I(16($O*"%+J ?2PP*8998T:) .6($.
MQ8$.B%P4ZP,+P(!Z(!#^>@$HL1VU11@UV J $1BVT0<$$(MK5Q\4<($'6()A
MG\445!(U8.#XW:LEN&TW$("819JBOCT:@#VQ\ ,0"_4*H0#9E*8[(!XABX(_
M<H-Z0  LF)2#*(%Z*"$WZ0-""4UAK ?-J-]E+<&]>I5O@81UB4\/4!(468 C
M^(!&_R2H:L$C8I:4"E$2:1&65YJ"-+BJ&RN G-VWWH:!&Q":9>GV00'@/U+*
M4;@ 2Y@RB$X#>0#Z@]C+]@L!HG  .;B#/(@5+W 12P@!8.'Y3W(S:2**;]F!
M/P*F1Z,!4SB $-P$S X.)Y2FSXD5*M"0VM2Q5MP(#RD$S5B "$BU(_B<_S4%
M\ 8$)!CP"$02ZLB#=7*1#CJ:)A 50F$ 6P $:"T 3)"#CTF "R&J$O&!)Z--
M'C\('*"%B&@WQ/?E:%H!4>FH&YY11MC=.$4!1LC1ALTUN; %.6A[$U($FI#I
MC @<JKH?*7B-*X<#SAF)473=UE&*D8N;\;%J/^@!S#,  /^"M]C(X$2 $T@V
MJ^=M'3;&AW&#'E/66X'@:O=!@.TOH R8A?. _AY(%  @ AXX#D&1@SSO 11Q
M":5 +$"(#NH-(8!X0(A' @ &37398!!(#@0+>F2881!0ER"$H$@T:* '1@ 4
M%7;8\:+  G0=#1!1P:)DQPZF7HPHTZ> 00I=[%#(L<7@D!QV:!H,*A2  9L(
M0KZA&9,'#D J/-04,3+HB!TR:#H86"'*U!'+>'1H(&.&@1)^=@((I"(/$*E*
MOU:H-W.('P1#J9;A88L9%*@ ,*C84%;%3H$,L*:!@BEQQD#[7#Q8$A' @V57
M#3I(?.&!GYD *"V#8JY>GKM$,2S_8P$ B #/'3ISYH%5F^(T&6@&0M&'Z)4H
M"H,:0 W53;W?#FBHR0@@LZD+ "K8(&&P XHW@98D!3"/A@Q,-)H#Z&##A4%,
M-MY<*?/[@;;+#JZHF45CL@,,9226(*3 -&8:0BR4 $-I!F2QQ!85+%$: )8L
M<5A0QR4U0AHD5$##$S09<-T6.& @1 $9ZD<4@FCQ9] (-G#1P1(QF':<%31Q
MF,(L'6)8@BE!],!%4!R.<D )3#AG0 4^D/! ! XZ$$$E0&&6B1F4V?"DD3HN
M=T0E#_0@W7*9L,&D T>\.!TA>3B029@+$-&E4$968A 67OPVS \;= ##?@!,
M,29P%"3B_UR23P* IA4.9!G>F"5(@:$H<PY#QWX+3'*A03AD0F53; C5 1,*
M!II)FX T E2C" PS"E"B]%FBJB4*($$ '*P:JZRS!M6J! +0JNH4-*PA@3_$
M)#!"&%Y,)=0(V]QI$"5-: F(%,K)Z=P(DB1*%"V5:!'&!!+T(X$$>UP A"*F
M;%"0:0:88,4,%!1! 1T(4 +#!070HBZZ5A24Q)Q*,4&BLDVX\&&Z&5$@!0O#
M[.!0$[L)5:]J (S A!V(/@Q $J8@ $@&X;Z !14O@+;%M-MVRX@56@QD;E!
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M4'UM8%GV10E P=803>4!0QJ[0$E(40;I9D(*-GA! A[RAHR*U)WA$0E0-*:
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MP0&4"8FU488)A8>UD1NDP(X%0I\X !%\@7,L@"$PB8NA6/'()%%@@FJ@1#S
MT0.$@;HL1_KEV([E81Z=V)F-%B:XEP- Q2=1RI)T0/>%QQF @0(L2Y@XP$.5
MP$\(GP PP@10&?(=GZW8DI6%T@0$@!0\ C$XP"3P#1BP4,0@ ).4V1I-P/V,
M!/5!C<'4"V[XP&6"@1UHD?E( 53,7J8-11+ @3S01 ? @:3(&5B.P!E,@!4
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M?,U-TZ:!*D1FV$#9@ $/8  D!$ *[$1(2&H,M4U:E$T 2%)XZ /_"FSH=%J
M* !I!\".RE"  -3#I)[XD*&0B2> /MNKMPX"=+V?D32K%[P!#D 2WQC!Y)*Y
M"*R!))4 N=*G3 UZ/R0F']II&QAA\31  W 2I\;!"5!! Q R<###H[= <QZ%
M/I3.%' I9LA!"[A*"MQ#&HA "+3 HWH2!L0!AXJBRA%R#3^ #>A#V;!Z&V%
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MM,5()$E"/ 05J X@5,&8RH'40%*>K@8<8D(NDS\+0-*[1YVXK8V5 @06%0H
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MJ&'(K!#1_PS8P1]&=$@4TD@E_0\%"0)H8-),:5%PF&(V6( 3Y$8R0 X*9?H
M*1*9<+&@)/I, E5; -CT-Q.L&(&)E?S;B(W^%NCA#0"2^&&#WPKZE3ZL>N#A
M/0!&^,&.#JBPRP 30G*RB9ZL[6R!)MZ J0-H;0&V65RWL(2)/(3"-:B1'B"$
MV9$H02=>0'*X:@$YWJA@AW9E^H&4'7C P3\*[C5(#BAF6(#>9F,"Q"$2!1;J
M 1A>T()>F R(  H+L/]"1^%=$^YO!!CZ<$ .-<B;& "(-^A@!QD:9";DD2!&
M8 26W^5A!@Q4\  'FOM[4X14@5!ABPZBZ$.H*=+@ 8LNMG#@:9B>/'@DG%)=
M@ 8_'F+&#S]E:D &"PQ(@Q2-K_@*7F-+JCF0?8H HH'$%D@CY(WUJ7%4TLX:
M FF^MFC)Z_Q <R&I)<1R$F],_.@) $J6@<)8 S:[RHUZ'+-A<>[4P$0;S@ P
MX)$RBO,CU0Y0B"&0I0IP$+J10"MB"AN2+2D'%K P?73B*J!!U/)(*&&)LP(1
M(-G_C"/AK<3\<TV-W\KCXK38#5\BCQ(((:@#&HHHH0R^ =0F-0I@0*[ ,OS_
M=,V4SF93_S\'!#EPT@H:T X'##+X[3'\1L>@2S)I&PX>L0EX& M1#X@ H13(
MH?P8(!!,N$%2H+0=&EA!"Q&0$0!<PX ' N$'@LK$$VQTIM%-P42[H1 .3,"&
M F"B"1-<DI)&@H,2_*  1I*A0421" 50@'X>0L 0BA&G*7&P"7D HE @2*;=
MN.DT17R )$05(NIA@7X4H0.22&)"&_'( ,- Q@$RE:A]2& "'"CC&ME8$ %(
M0 (":*-_ID"#-?CC!,0 @*$N0 DONDM$[>)C04:P#06\S@TA:($$^C3(!4QB
M I;JAP20P0(@*,(4&W#8Z";Q!H?1X@DS,%2Q8F*N_U(RP0[R8L7<B+4F6WF,
M$H3H0[6LX+%N,6V/IL 9*G^S 'A9@E@D0>4F;Y0#.PCEEFLB@O\ 8((N".)>
MQNK &0I!'P2.;IG]V4@7^D@(RCT08MS; >*28K('^""2DPR %9IDD CPP&/Y
MJ9@]XLDP'FC!FT+I0!G:Y3*8M0LB/RM0"")IE7VVJR1]2$ '1/ "2T3!+J.J
MR%6 8,Q G$&2$D#"&S#0!03LLP\&,8$?N&@YRHR$ DA;@-#RTX%E],1'?SB!
M.J5@CBCHJB 54$%$2?12<^P#*2Y-UD%(>A>P40<T?>C XVZ#RU$- :@ F )/
MMK,,/V0A!.KL!Q)R@Q5M+/_#?6YP@E_2D"SH@25ZO4.!'4J@B'Z<(  G: ,)
M@!!5J4: "O!43&A (RH'J4$+5X#?:>K!UC/,5 )RE8=@J5,>!]:017$( !]F
MN9H,D'(D==0.@&@@!%L(]BJC:ET>, &\ST:!!=HC2&G7, $D"*$ WYE(_XSE
M'-B.CK'Q8Y"D.M"##,"D0%ETC9L I+_?&( J 6"$*=ISS5&Q!Q+Y:(.,E+)!
MY01B>TM:(&>M4(%/!" ? >A'&TR5I=OF[U#H0E*)2/#$8Q%!014XHH]DY)PJ
MM"  79*2 AP&029<8 2$N &*I%  ."7A#WA\ZW1I<0(%!Z!/"VC3Z.#T $[(
MT '_83A1FWZ3!![%Q!*&',D(CM2R0\UQ5(QBQ#U0W.)$5:H? C" BT?@@XC1
MPH6NN@"H1&4X27 JA(1,Q!8,0(L4V&&AGNH '2;")NLJ!P-P*(*L$.9)@\ W
M <,*K3"1["Y>'HL0)# 4WS9ERR;$Q58PF9="2?0#!#R ">2,'#KZ  13'#,I
M7X9R%9CE2V9!1 9#@Y@@3,&J#E3A#@R(YUV(4#:;.<0!RQK:HYO4@3M3S)PP
MP'.%7/:\MAT+;Q88F<3ZV867\9.)1(!"$-*@CV/ZLPRX=  ,^HPW&@PD/X!
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M"&88^C(!6O%>2"5D0$HH_.D,OB"5AO^@H3I 'V"J";Y@ T8@UK;#FY3R#,#
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ML*!FD2!BB! ,:]8+&F ?$(YK8$"1D$ ]W"D4_4.!6N +[D'<ZFT9#B! :C8
M[I45,>"P;I8RLI#>T/  3D-MV78B[*,%_/_!;"^@K^H-OSZ /B#.->* $09A
M!]1 -9:AR9[0(Y Q#KAU;CN@7Y% !/8A>6P$G=I@'_R KLY@JQHN/SX#HQC!
M*G +?L1Q")Q@@DY#!!)C+TKC;L/6#T 7?)*./5W5"^S@0H>B$W71-6Z+1):
MF0S $C#*4I3KMJ31M;AI<(,.@MR*$223B4I $@*/1,) N7* !CCD(.)@NO(#
M&2>@+9)Q:17$<B !CQIC5$K@OUH*#9Y@OVI4[XSQ@M;$$I"U#;H@$XCD$?Y
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M/-'FC18,?TY(\)*G! P%'2+_[#L3H.<,A#2"MLEXX:!5!T=:,'Q28$JF"0'
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MFL #>!UDDQ/H1P#Z<8)^-((%P\C!:"X%@RTH:P'HX($%!$4H6EZ*"5<#P*T
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M;X;&EU\C0G<'_F"$#@S,X "A0#P-:#"4A@"'#37R+B/8AOE(4@7UW"@)QS7
M)$(I 5'N@04V^I(!AM$(+<@!N%BR @Z69 $;(4B73-@"!93@CU). !%Y +%?
M'E F:Z(&'U+8)X@WX,=104D.;W RG?KTR3 D&<=]@F3T%D"(L8@S3':*TD,!
M@20_U>DTM 0") )0XA,4(CL:78,$3N 00=%(4!-) I\>\P 8],&3%L,"%7@
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M"R6P ?QL:H,BY$T!ED#!=O=6AB!D M=S-L4L:) ]J/2\ RC84.@0\ CKB#(
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M%-H(%4\0!-V8&:OU%VXPCK@(=OPD.K15  50-VDW!*(S.$15CLQ# TQR%8_
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M%%Z  G[@(Q@0!S$!TQZP5!VGSDDV#Z6+H64@.#[0%/L@<PD!5,U(TR>0 1X
MI'[QO@:QNS#Q 0[!,B3G (]P<%10!G:QS '@%K*B#3D*UB'*5V9%"!G3 XW,
MTMIA?_^,Y@73L<-_(!U3%W6?9(]!U194H ^K51;'I1HMX!WZ$]!(-Q825Z.Z
M% 'C0Q,^X >$D1JF? )(H-1-0@$+,=A!97?\! =64%WTXUM6< 1LUF8?,!/E
MC'1UA*>6ZG"9@(%J<1>SPI7#1 0*V :]8GB4=Q_;T08K!PC208(L$0!(D'9
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M)2'A28  !Y8L83B Z(@FZ>_D \3&&I;R0\S2A/4<0/HPWW^!L\EC[J-78HC
M \R2Q!#N[5/8WA"Q4C^%Z19^+1.)(!!1!J[^Q(DEE$B$@:27#Y$MZG6[6.'-
M)44W>PUA\08&MBD?(.B#Z@Q6$0ULZA7)XKA>'_5^')G !@""-,<Q#,B@Z^LM
MYH%.YA+6J0%0"07H"49 ICDD(W"P"%(?0':PQI+0(C@&T(2#$)D !\5P5!1
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M7"O%@H%),1(F*?MYLL %37(.E+SAZL"F9_J=D,)BA*0)_1@]2< 0M.J%M*R
MI=2$08(13&(.!&3%0H0W,P:*,L4[X9 S$@)(\7"THXTXU^_UF("$P>J(!HBH
M6 (%(8 %S$C!@"*PPXH))[R\*/"@!P_G_PO.7^A 'Q1< X,'6XAHP1\)OMA"
MOTWR\:*(! ;CP0(L4%BBA0 &.2ZA#LK +R$*NH HD#,F". +!!Z SSD'F/%#
M$!([V$$C!X[0\(XJN@ 0AGU\F*"--RP@(@[KP.C00WWR$+$+.SKP0X S-KPG
M,48RH*JI-?H1TCF0; )2 @X!Z  &$=9@,"$#L)CRA P\L,0'!9&0P4L 6@O
MS0T6T(:0!EJ ;8."U*"**#76 X"H./+Y8+Q$,8CC!"H:V$>!*9R0H0 <*-@2
MB0PH V*?(@:J (4W;,%@AQ :O0D%1>RKZ $;] DA "]X>"0.1J2@# !,,IF
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MR7)(\[ !79: 0R)ND"@Y<*$$/T 7$'X %P=D @E,>D (.JHFM-QI&!.HF7F
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M 5&8M'K//( !-207"WY0@ ,*B8E"[A@ %:#!XY'P!$S8X)(71($"'K ,!E3
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MN[8FN"%; *[B^K:!2((="##6 "Z),"EYM (MD(,8H!Y3B$?],*<",+@=&P9
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MZ#3EC<,$]1MU(0$<>(1B. ZF(@*LZ0G\48@1. ,JL"Y:X ./T5  &(*O2,4
M_5"[=0!:B#<-E8]:Y!YVIEX:Q P69022&UR9J(?+PM[2"1RL] 2HY=&< !QM
MN4^"X(1J!+KB0;HF>$,UF81->(U<1(1>,1'(FQ[AFHR$, &^.0'L2I0FL(*(
M-H\66!":,9\'.!'-8(@OU=TH+0T:DC=(Z/\',+"O#@B#\) !WB("I/X"FO&
MH@ZA'W">)E4)2D '[2J-.G& 'NA2-;%3QNV! *:0]@4/6QD:K=&0%%B".H&.
MMH:!Q#.//U#J"@"2-E !$)F\^V6PR\MJ 0L!71R$ F(-+-B2+]#CX\ "?> R
M4FW*-5F#%&D "G.@V)N_0<J5N;F*#O"(67V($7C5WH/*L30 (,B6   #_*
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MNJ4+$&E2>(6QEF[FI79(SW("W+>L+*<KA'$OQ<52P(7[@6'/SF,7))96 %1
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M!@1!?9A(A\$A#'Q49KQ$AT55IQ: 6VK>/2S!8^)0"<C"IK9F362/% Q,:A0
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MD?&:&$9%D S)T0*)2:#$4CR J8EG6ZDE6KS2?(CGDN3!_O6(!=#2)G@&!7S
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M9=0X,RQ M&1R O<8N(32H4 <D."'<$D@* ;I0!/\P08@M')YS8G6'R2@X!D
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MC0ZSSTG:V^#<B>"@=A28 "#11"Z1684RAI;+6C:#(Z3$#U#@#!@A!U# #S:
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M"KH@ B#4 W&@ CA4^H &$]" "DBA 3+  EAT$USTN0#A YX #>_@#7H 1V7
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M#CX "LQA#7K3!JH@!11@"CRV.^\A"ZX@!/@@ X+  P#E=MEW$#P #7DS8EL
M":!0.R.@'^Z@"VB@"OB "H% $FYW@;NF WJ $3:A$&1@/".X"KH&!TBP1X^
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MA3)AM*\KN&_P"? *#JP 3I4 JXQ4^W0$^[A0$@:A\&!/$;(2:YK "S8@:ZC
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M+7ZY0"9&F#I,LB-1D@LR!RS@"1W7.2!(""?8^V6__I(D@ 0!</!OP08?;'#
M$NR#,,+/(M&30[0@D4?_3<.T8$4!(RC2"(4&A%%($>=>#-5'35!LRR2%0 <
M(!-8\=9$X,:GR!<1;"(%FC?%L\@3%'ZYVA<AV#N")")X]M9"=&S0%"T?Q.!
M&'2\0)K%D%AQ'4@?*'!N$I" 84<!E(2Q" DI?Q Q!9\F".L+6Q5"TT,ML*$%
M;R_,AD-8+SDER1=,[_5!%7R0E=4"K(D\4DVFB=  SE$!;AA)":@MA6(MPP&S
M 8!P-,OE @( !!Q=H#D2JCWKM;D4"?F[%Q4-=+7 "D>;(M)>B;PQ W6I#>:%
M2%EA47.&'?@@4"!52('2OP_!4<4=;NT%AQ#7=2 UU:>-#KH/IF U$@ZVJ-C%
M_ULEK/&%K*69P(1;%%"&U6#E+[8 $;<W58(/&5PWQ0KE&YB"Y;.1- 4TO,\2
M\TF(>'(0!*6(K#%>B($MY"><[.6 !0?,4&/V%X(12<XT5<C ST9B(/@TIA!/
ML 5Z/!BBY[B("'=X0XMPH#8,D>0!$1B<0VC ',G)QPLRHF$A?#1#I9  )E@H
M!4MP^(1S82(T3B+"!R8%J0^8 4@Q<(@Y(,$B'&#B@V%:!(*")0D\@:D$BA#"
M6S 1!K\%X@Q4R) #CK"2<YU*7?((Q)H.$"9%M'&-5# 5Z" QBJ:,@% 9(@D.
M'H$SF/S)"Y=RR78HL DVE*0)/R = .:1B39PH45,VO]5F*ZFA4R:09&**,8%
M[/B%-A&R10:8"+]*1P1&F"%/-YDE#FA1JUG%2A2Y8 -,(,D&6U!@ H$RP*U*
MY8 F@,%R>?N7 U2VJIMT:P2>0(8%QF8IDM"K#7YL6+\$X \EW,.;Y"SG8E @
M 7\TH)GFA-\DFD426A1K)$G81",TMH@O6$ 4?B %#?ZPS,74LQ]?( 4:)O"%
M"SR+#K(""2-RP($03$ *,W@;";:"!)J8; (S&V:VY#B,./CC)#'9Q GD41.0
M-.0A3RM $M;0!A5PH ?9,HE''C ).K",))V1@!?\$($)% ,!,9E:FPZ: S\<
M]#,+:0$2*K.&0CBP Y*(*0?_EO 9P)&E5\5@V3#.<(*2?6EX1I#I$JXR A\X
M2 XKF8L/VM"%JUZ%$@<=1#\]8(DJ?$ %-J@"0J-BB37\U Z&VX0I2&$#)H0-
M"#"M#"0DD!A7%N%_)?E$/LJWESA(X'X.X8MPDG \#SA@!51PP;DHL(83V#4$
M+9"" A80 4C8E08[B-QBY",!:K4I!(70AQ]"H(0NH&1X?/"#'7! A$VDP ^T
MY8$MZ-*&'-"@"@3=J4,R(P,+B(>S@S+/E_#3E2!0)P=8<8]H]B);%6BCMN=B
MDG?EDP(#CL<#&("$"/Q0#T@T\('?&9#V"J0]K+P(#$7@4<W\P($=0*%#$_K2
M?EKP_P6EML (#-#NA#"Q @T"P$ ?@.@2HJ  (RG!KCH@*A$6,0BBR*?#5P5Q
M_%I !3\,"PE +%T$P%#%(46O )8(0W0Y8(,R;,!([XN/CR%J WT0-3-/>.,'
MM!2F+EE@"(OH7YHH<*?IA=&2#@'"H@ P*"\@ +E*\ (IAO4#ZQK3"4#6[PVH
MMXDNV. ,94; &Q':3SMX&5%1RV96Z/+4.3-B:V^L590SYI!'M,#,VFC + .1
MBS9D@ ,Z@$DLI: #"PQC$;ZTQ!D*$=<S("&)MPJ4BUC33>Q09,A.0.P9P& ^
MAU" 6PZ!B)9>5*H1G"&FTTWD1!B1 @Z =5V: R@I(JJL0/_\H1C)RPH@)(#I
M&0Q# MUZ@"+H4 !Z@4$!0)#IS4S9SL4HC&#A+G?")B !?9B[<"H;C<0H-I*+
M^7)C'9-/"Z++-(%BC :0D/1U## )(^ST 318@P12W)3-P0P (84*3&@Q@6S%
M9&^+ <G+$J"Y";.,$O7*M],BUX$TM( 1*;;%,*YV'7HM;62?*GAT=S0)M)'&
M 5=8@Q(N8[(/D"($FS!/4XQI@SB<0 23-1S:*.4#OVDE#$IX I=Y&@&A#Z((
M6G"B8>AB5 -,(>HWC\%-"SZ!WME"/'?(P9XJ=]VHXH[F=+Y#%QY7 N .HJ^J
MZXR5X<?6SX!N#4:('/1&.0S47*#_,3I-$Q:JH \4K,'MW'. .7RP"3Y<18ZG
M;JWE'B (2&PBQ>Q9@(5 /0,'Q%T"=\A 0H*%ADUX 04AV(.:L9"7TW@0.\ZQ
M;NGXW??'<U> VXD0SZ/K.P"^9SOPS= !+^  ##3/GSMXP_?@$,'C'Q_,P[<B
M:]N@CRV8L(,?I%1]V["/)7!*]C-(X4Y##@F2\^ M#BBX3WN"B0@LFOAI2/\@
MUN\B0< T\3MF3 3N("1%Y"-;EWXF,@-AME.8P&^,X 50H!=.U&0U)"1X(00=
MDF5I(B8Y$RQGPATEL"*'$08ZLB4^$'8J\'05T 2;$%VK8R!*D /WL 0BF'Q^
MA21 H AL_U(6.G(NQH0&$/9;C#1@F@))GP, OC<!*^@0%="#2,!92[1H"."!
MB-8!2Q '+E@[EE **9 KA+08$^$%@]<#3H4<BX$#@* $HW1+N10UN\)A+Q@&
M;&( [K%H*@ KIF(@?X $^I '97B&<F0 NS%A-V"&TY0+@:(T&V ))&@$75!(
MYF8  M /$C!.ZT:)YR0!$B  !E")F_@E2= "]\2)SM8&- $28A6*Y487C?!T
M#;-0JT.)JT$%+W"*LX@P'"0#W4>+N:B+N\B+O>B+OPB,P2B,PTB,P0APVU:,
M!R, C# !Y):,7Q(P 2  SW@PGE@)MA"*!I %F9=0V+$$&D6-)/_A-5;0;.6D
M-+;73HY7?SD3CJ^( 5&0;^THC_-(C_5HC_>(C_G8C@_ #$1HCPUPB9,XCR@P
M ?X@ .QDCY[(!KA8;H8S :;@BO9H$N5(3B"1"&&S;MDA:12ICQWID1\)DB$I
MDB-)DB7)B]'HC/*H,--HDBW9,)KHDC$IDS-)DS5IDS>)D_5H #O@#XR@ _58
M#P+3 #E)E$5IE$>)E$FIE$O)E,"X#Q+0C/6XDDU)E55IE5>)E5FIE5O9BSO9
MDP(ICP39#YG(E65IEF>)EFFIEFOYD2@IE9?(DDIIAJ16,Y9$"9P !A%)CR?7
M$2*I.:W!D/2H.7GA30O &X1CC[*WBOW_@@.! #+DP9;R& @^((*1:9EE"4[B
M5(\HP @&>90 5PB/M E/@ ,/4 J-P#U:T7' B) ',P*?DIIA$3*4)X]Q<8OS
MR%AZYQ"S<7CA4YARD B(^9)$$ ?]D _JYQ'9&'B<A3 *TF%!X#$8H CY$  D
MYP?<8P"PYYN.2%GA)A\RA)34 Y[_TDP&\ @]0YN7J9XN.6YOB8E'N5#;<1-)
MM#'=2!(<9RGI&8KR@37>Y#6-0"=@PAH18X]_B3NX6056@!1$\ /WD'"$^2]3
MD E2 !U&UP?F9)ZRQ7HMH%NG>#V!N1B3F0*-6!I8  E4$'Z/I5O9"0=JH)\'
M,R1,8%NH& +,_WF4!E*9_1)_(N!&$+B>/SJ3CQB)8-F.!&F0K6F4[4*?DH":
MA<,0>IF+&Z&;"-,9R#.2<<$ W2F/AA.<37$:;E$P:?4%"<&EPEF+<1$^>[$(
MV\F)ZW,5#2,?:&=X:T >;Q0'7T"@Z\8CWP&B"#,%(2"G1TE XSE6(4BB0(JH
M,;F,44F/4[ENUO8%CS<!"-<R2% $!_$K5R!1?* "6 $$N0 &T$$!K:4%GF $
M$9,$?]"7$L,(200 HQJ:&"=/>9 R#*4YHYD ]6F7];)SDSI96R)17I!=:6("
M2F %BE.L/D-P9\ (5/ &%@!PZ'8"$G"LR;<&)/<">;, 5\"LIB (G_^8G*41
M<RZ  R:@<T'7!@S D<*B62;R<Q6P A. !,^CA".7.25P4!VV 36!%Y5!!79
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M]&%D>1A12L#$!J -]4 *VG &7E $ )"(=[ )U(*Y/X6\;\I3IPM1P#5!0]N
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M$SC()+'J-105'Y"0 4U!"0TR"R C,G)#CH4SH E@ G' CB?7GV#R9QZK!7(
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M4BY%@Q!?_RGE"' R9P+H+>B>48Y4M=@>0!U6@ F CI%.$1*DP9>=$Q_D@P!
ML!)OP9>J<?E6XA)=$ 11,U2I&!6&N== P!&N:#P-FQ:88 CG8C@Y( @):CP,
M -NCK3L*U0-C#!-8>AA)=ZC#4_3>LA0C<7C[S1LG8A2Q&>!@>L-Y3QAD8710
M8 Y5D&):@ 'IL\>:/3UGX'JR)CH4HBM]4!.PM0BX(PIJM>X. 1!8(&6X  !
MAQ6%WEC  D?&#%$A4B@X&&+0BR"8@F2,\ '*#(, %C!S6*!#""]Y#"($4^1D
MB@T&#<P3Y$."*8HA=3J(D.@-_P '1#YTV:C10P64*@$8*"$I1TX@9TPA> 2'
M00&>/@$\B #FA0,T8$@ F!+FRQ8 @4*8NI?)"P^-&BUPO3/6 (925C"AJ6LP
MD \1&TJL&63'@: J9@JH'40QZ(<G>_G$,.@@4QMY2!L#C<"'"P <%9;$X6-&
MYVG4J56O9MW:]6O8L67/IEW;]FW<N0WL\,?H7F[@J%%,\"< 1^X%GI"0* "
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MOT"  8A* ! M \9YKL]HS_=<"O)2#!!E L8Q*RL01QA0EC'\F:7  !_HT<K
M@!S D?6<@@@PC?G2,,[$A +  4"0@ *K#"*P L<$Q^8P '_Z@*KL1A8P@2.3
MB0Y@ HHH2;$,B>MH X@:1\9A5!BXKJ7@4@KX ;&TC!]0%DP B>MXCY 0A6U@
MFTRHA)!1&\Y\2?;,A# )B?]Y,$_;"+IT*SK=F(2>7 !.R(,DV+RA'++M^,/T
MR*@FB%'1HU, :8(B0#(#: (&@1O:/ U:2($JP,*(D@>C P2N]!TY((@;? -Z
MZ0 1N <F,,"5B%?'W HFB!,36$Z@6 $9H)%A, 7P.HTGY(#O(Y+$W*S46,SI
M' $8V$[.4DSG+#,#Z $%FR+GW"Q1 -@&.4Y!P"G!RH$^.5@81$*1L$U?/8W%
M) 4;>,Z>D8'_&(F/<( T(-DI8@839$SS'($RZ-:M6(:*-0A1B(*OF%GSI(!]
ML,,.:-B3-8@A4 %1K8!'4,O[(@46P #K#(D'* -="03O!!!MH+# DMG@E DL
MT ?_X&(*%!#5I0""?5 SE'4#^ZP,;<A/G0""):""*,@)-["!YKH"KDE1H% >
M 1#5#KC$!BD!OC6(%_W.*2H!)V@LF;VD![ !NB4/&KB*88#1D$BN,L@)!:R'
MP@2*N44R42P#X[&$ _71>B"%);!#T<!1IB@#!)A<*750&BA2UQ!%.&W/GVG/
M'* 7WFT0L]JP@R $.^Q".*W3Y'70$D!33;4!,T@D+=6)']T"II %QFG/2A!'
M2V61*QB%B@&"';!#SK@GK(T E-F@VEU&"J"#$+#&1YA4J"S5@L"!<;2!2LA+
M(JB$!7@$HCS/)LB#^7+>D$@^ 1!* ! %DV21$C#5TQB"_V(X@)")X-08 4X0
M@'<TB"1(A M8@%E-I \(@0USR2,+&00^&J;#N0#02=J0O'MRIQL  J#LO%'(
M5 V*U@=@@BHM$D0%D!X(70"1@P4*":J\E!I.6%JP BP@K$'QRJ$T'DUE@GN(
M@*5D$1-@ "W8OKDYU*4-/_#:CJ_R$X"%P<:$2KKL& ;P' HPA<9*C7=1@=$:
MS0:AOP>*@.D\C>;45YFP8\:QS#9Y &: BQAL$"#X3!AQ6='L5CIFC4 H@Q<(
M!!' 3-<L"!+<SD064IBU .=<%PT=6_*(P4\IY#P0VZ]$SHPB@MY4C2?4%0/(
M@LV)EJW0!GNPA4=0T )V D,1A?\:K!C>9$*T$-MVQ64+;,\6U8DI< )/7I9E
M>!1@KMM]4%E6=H.\-8@IH($W>-'AJ>8,F%OU*%P$+0'_7 D; &(&1H'&JN8*
MK<_O-( K($4/A5 OM5(U %X,B&??N0)9L.% L 'F( MMD %,L '<90HG4 D0
MA8$+J&8Z70 W@ '/78WVQ-V(?J8>D%:F@ $<;=(>M='CQ0#PW5PWZ%X(Q=X"
M7@)YX)7EO95C:F ;9E V=5,,R  ;GH(CH-/V_-];B=X&+K,%P )3:"W'H($>
MALJ_<(Q'L )S^('FP(2*#@KY3=+N'0(.3B*#[('/&& " @(FR&@'I8 :OL&>
M1 T0>8'_,+AJ2]B&#O[@4@V"K5X*$Y#%# EK%"ZGO:.QOH.\V\ !8N52$_B"
M"TC6\P*$1K#AD!B&Q8DH*R 2?VP8T<,;U?#'%+ #W]'6 DCB+C[C28A .<#"
MPI:BL82$)=D)RE[C$3$ .7#8(+S7!LE7122"6HI,U!!-!OG7-MD.*KACE+7C
M.";9Q+0_(MC%(.P!$9!7(0+NE3 %PB6F "PHD$V+AN6O9="!O,$2$6 _J,0"
M%?  2HC!U,( ?NH7?9!L!R $U#Z-!4@#/Y@!ZB[O+P%87IW9BNG.K^!N\CM:
MZFU"=T'O&< !'0B""( #7>D 'K!>[,:HK WPKF41;?"#(%B"_X\X[WF&*3_8
MX=/H9"1;@+EEUOID9AJ(\!Q! 58Y30#8V_%" 6BD@3+XCQ%8!AFX!!3@K@-=
M5'!NK"%H@*E(#<<]Y\NU #=P@H=60!.WQ!AE9T+ *'9>AO/R)"H@[BZ, L:Q
MA$M47!LH D\D1<6ETK0 7?ZR 6JU0N+VHROHW4<87^?^\1%8@JI4TP81C1A%
M7L)NSR/\E"O8@32-@+?94SS& "&P@!+8 8QJSS4=1\^]BR.6"4& 1.OH 3X$
MBDR(WIAVS'X9A5D@@B-S $FM5T\R#9[(@TIEFTXW@/BMF <XUK0@8(/ A  &
M BI@&P5^:$$ME_F#X /H]"!L@AO88/^*Z "3I!LV4$ AHX4C$U28I/6D\3J<
M\[L6GKRGF0@_,=7.(P[7&\G!X8(YT3S&>9<; @G)FS[0<FP $0K%HH1D* );
M(-9%Y8Y^0 3^2>(#L 1IE#QY,+W;.0'B\NL"5H11."^P_ ]N+0!*: *>_9Q[
MG1NZ1-@J>4;'I !*Y*\F0.WYDH\X^7;C_L!S=+T34)'[R\8 ,#^4-9G(]&#4
M4[=SI ,&F60%W(%K5< U" !_V*[F@)L .$<CL)0%:!53(K3B],G(/#U_J*X_
M;H) -(*?!0K;'%$VNOG*.(([2&/R]&0@.*0-F@"97XCC5):0Z8(VGB+LAI]&
M8B-\&0(34Z'_,M2R !#Z A %ECI'K\#P9;B (:B'H86"X!L"$T^-8RYOD6B&
M*$##.+5EH)"#/^AY)% 4(#!Q#>U7:0[J"*?[L9C<?L6 */  4?"#GS (<'YH
MIKYM\V2*M->R$^! 6VAGW-KG(MCG(1=]%JGG\Q*)5B&LH/B#?%"WI^$##NG"
M>+;1>/FB<VP#=B6+'LB'GF\#*>T7(%K]G4B;,FP#1+WH'^\ &^A)'EW40$C[
M;.P'),!= "D!("IM++";RJ-W(^ "3%@"N0:K#.!S[!5>H5Z,-OW&1W?_C]Z)
M:QJ63>("0&\.097Z-B"!.03?+[D!@,!!Q$H!  8/&G3PB(V%0$PN_SSHP04'
M!2D%<-#R=Z+?QA-@%  8\N=$/@ET#G1@HL!!)@8%'%Y :#!0""]; %#\<2#0
MM@L%1RCJQXA-@1%,\AC(5 E'DD07%B@U0*%844EY )@@FF0;2 ! ^TEH5% F
MV;((#0@ >\\LV[9NWQY$,<&? !QPVQJ8Q$5F$CHQ#P*R*#/E50"4FL1(@/!!
M&"DS\NYU.Z6QA05-BMBBQ4#QP0=,[!0P8>4Q+2M:Y#RQ>W"8E+\(%_385T7>
MV 5RWG V(<6# 3D\.)?U#-J@B2XL9 *RXJ'L B(R9A@,O.$L("HO@!M,^MR@
M\+$  '7A'0$*]+8LI2 PX+P\@ ZF7@!X0/^HCV(#/<@# ))CBX,>X>/#P(-W
M"+%DBATR#9/#@>WM("  1/@Q@R5,\ "= VDX2-8":41XD ,1&(A0!RMDX,$#
MRT !G"A=O'!AA@91H,)-V<4XG5FBZ/-"%O?,T($/*2"@@R$%8>"':R,L(Z H
M*A1Q%C-&+J"-'YBD@9]!EC 9'(H#&D"#'UE\LA$830+@!@HS.J"-&@,&@@()
M(=63AQLVW-2!#3QPY\2:)\I0P!1.O%$!"C$49$ )9Y(%1 ,9L&=H/0AX2(,,
M%I10CXW9M9F')4N\F5T)A'2%DQOUN+98!")L88":WMD9 P"8T/!$0C0P"D %
M2^3A  VFQ/0 #6;_F$5)&CL41I8#& A14 =+,(##K3<,QBEW-! T4QK%&G!%
M!@>410D-1V5;!K?<16"&K[01*(@0%IBS@VNZ5F*+0]!FA\$HXP)@  :"D171
M("RPM!0@1"&$20\DX.!&"@?@@$$&%BPTX%D.;5!"L@8LI,41P&),L$%3-(&4
M*$Z):%5[3&PQ<JAG80$'"08,40Q**LGTB$4/<')5!U9UD,@&."@5DDX 4/"%
M!2:(912]@(EU5UL",#(!!TY37;5, D@@@0!6:QA&9 <E\4.I@94* "T32!
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M6 (:3$ !%L.E=$=T1*#:@,&!A!19#,.GR81G\  6K($$ML$;G%\#9<*I,4'
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MYWJR9WNZ_^=[PF=OHH5:P*9J^L,.Q&=^ZN=^\F=_^N=_CB?4$.9K'N8^9">
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MJL)I65# &;BCC8*!'X3 YQ2D0>6'/DQ63SU:+4I@#6:"K-KH'OA!F'"$$?"
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M0\\D/!\%?$ #>#@.D.[XG>Z$BF8]9-F!KA- M4\I^"\3$!8._@ +%$WZYM^
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M3>L%0/C3 I@AJ@)%( 5#?  A^@ A3R%@ 3WH@A.'\*F_E$%6!B"""@ZR@ A
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M -)\&>K"H"RY*$OV*D 3KA8J.Y1@H7J+0)TTUU<&S"'5U*.8" '"/O)@RQD
M1PU./,HW'5>0@.VC?X+9QP8<T .R!< ?2,@*#BXY@P70( H>J%@]3G5)"UPA
MR0^+;0"$//^#!_@AF  P"2F(Z2/!S/,Q6-'*%%!@6M6$8<H2<%5QKL( D1$E
M+5PQ@U:H0A&E&& L)/"98ZBRT+AH)9QI6YO>^%82G9)N;6^Y&DSZ*0N[@%0R
M1UU+OVJDOCN\:X TL-MBEE"$-EO.=0^(@#LO4SY]$K4UF@...=^2B32?XS9B
M8S5&>F!  TS!!^]]A!0P^(@O6,\!OG%3K94J"5WS>E:S#1DM)G#=SS$"KCUV
M9Z.V$\3D:8<%%$"&]180!GF8NJ\C$0 C)L"^<)\;  )HTOSP.E62H#9YAOV.
M6DEBH4(6T+4(3(AY")N03+#!%@1<H88&(D*UF" %(9@0#9=B\+3_S!%*,V1"
ME4@R#%/5)#S=': <*E> (5"!BAFGD"(S8.*8[ "XRZW)$'XX$A,$^"LOO\!Q
M"7NIB,MRO"0!@BD0,$6,[XE11)#!S(G@AR4L*H\G!$0&%.#SCY1A"5*PPP+0
MP8-^OZ7J%YFC/8JB1L?D$9$=*,/-U<@M00X=(:+808K53LUA3'CCA&1/(/0!
MFSF*$0!,=,QR(42)2\IN 44>E1_0$HA]N*5;'+X,,&5L2#6PX '+$!4SWW45
MB8PD(XC,"'(MSP(@H*!Q>:\' BQ_D2'4HP@*<2)TZHZQ#03"722A0#VV8,F7
M.)0&.Q  RW9JDM"/,LL?M364O[, ;5Q^_R0WV>#Q\QDENLAX* $+Z'X6I@]2
M9/G-K35,0Z^2@:)P]"QW.>>A?1D(UA@' RKM9P[LL@12ZZ5J?N9^5]C\YSB/
M>FC<*\EN*F8*&8<Y,HZ"$-(II)B ]-  0,KOT+H#L4)&.YH/=KX#!P!A.VHC
MUH((:(1M)";0.S:0 @] .2XPK*Q-YQ3(.LC*.PBH$BB$@RH!!P2$T;H*#> *
MW1I ?>P*W?JJ'A@A/W  K^3-3<+@"1P@",3JI/SM"%EH&RA(0I3$WC"O"2+I
M<3 +@TH+)KI-'BR M1(K#"3@I!;$RU*DWRK@'BC$XDS, #8+$S!!,1Y #D*K
M0";.M5* 0 3)1/]P:Y5P)Q,$!4(P(4J(H%8&B BB)4#^!/-ZP!"Y9A#L( $,
M@(<*B>,8)0N" $*:IPMD9P3V1!1,P2UP(!!\ .; ZT0ZX!#H@">H#KWV2.PB
M#A#B8 _L8%XP:1YTA0),@6Y2!2&2( >&J 3TP0YPY?_N#B8&:?4H0 3B)"4:
M@%, 0!1R8%#*K@ <8!*+PP"4!4HBC[GN[B(PP!<QR TV"0!F42V&0+\2HL32
M3I6*PUH(,":6P!!'21].,<&T+@V6L1W'"Z720&L P WBL1&EB0>,SR!.K):.
MCQX?;V-0 CB.L0"X)@IF@08&,B;JX0TB[_92X@S P+3F(0O^;\](8A[_M*%R
M1F)E (T&S*PDZN$%Q+%1,.7-FN^-MD4Q%J8N* (J].(,!L&R7C(MYL'^1L(2
M""%)#, 28."D,,']WH;\^J8M%,UN<*!P9L@&"@T 3./\C&(*XJ]#PF<#6'((
M&H#W<  3"DDW% #/5B!(/F()1A(XX@@A"F >"@"F\B)S.$,:_Z\"/@-(EF)H
MD"TF>J!_C","OD"U$B N,4(.U 0NJ(""3,T!CH#7, %[ALUH &&"U&+78.)H
MV, "*, OQ<IM'$!ZLL=Z.D 2  8C!E/)@*!ZHB033@#9ID 'M,]]TB< S"T'
M\<HVV2VN"(C5 *$8S&$- J ?VF D)2[T(N2"__S#G)X0\R*@!6@D!YZC@" $
M$%+  RQ(*]#E"1)@!!1A1/J!$;IS) Q.>,A3+3A./0!A$.[!!^CJ7ZXN1\X@
M/!G!"C+GYD:@"9[ -"%&/!]$+2A@#9HM *S B1X'$L3SXGY%3.B,!OR+$7C.
MWWHH[[;%$IB F@H$!G1 2:++'%Y&/ <AXAP162A!#MAO@'K ZBC% RX%\3!B
M!;P 5)SL".+@60C3%F8H5NPH$#&"$/8!%TGB$;Y+Z!IP+7R@2>Z N0)$!>R.
M$#!)DS#-P1K,.)Y4,< +3_II0 . <=2""!*4$;Q@1*V%0/A% HCS6"S@$13A
M!*X+#&[.H:!3 I"@1_]=S)BNZ#(>84L981$9K03H\P3Z%"1XSS#4( @BTD\%
MX 60QA]T9H\8#66RH,R*P_C*( AL@/.(X Y ! -$H'&^#(3TAJ[R 6SN(0PJ
M#0E,P1SJX44_*@=H@$Y.@#!Q(P*\YDP;PRBXAC[5QPOXA",(QDA2 "WXRUGH
M"E>WCQH#(01&I%=A FH:-1^0( /,(1?:5 +:@-34@BTV!R[DHI\\:BO"H'?\
M95K/X$R+\P@-P WPQBA$Z@VP@$["5)=:;0+$L^7^8@4@I@U0$OV&TU^RXG$J
M02O,SS$"0:LVL'040&_F3)9&*E<'D1JQ $09(=8$TT8CU%8<8#ERE*LT1S;_
M2,HXCJ %_*%XAF@"8XVKX" /1M.73& 4#N!C?Z4#<P0-Z 0)M"L[MF,DDD 1
MTL,_*C:N#& '2%8'<K.O[B,_]L-HEY9IWV<$$D'CFE9JPXV)V'%JKQ9KC8_
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MVT951@.$#@Y@.PFT'^B@^";!"$"(OV(5@0@HMDX #C&O"_V%)@+(3T, N\#
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M!\4 G$@V(LD '@$<SPXFNH,G?@N#B&"/!$E0CL('>@@(F,Y'_Y8"&N #4@P
M#J4H* $&HC8F,M*^/L5*EJ *I$N06H 0C4,.%D&[ZLM\_T9@[#"(5ES$&%6K
M8J+@P*SE( (!D"JL$;%@%U.B2=V$!OR@*GRP U#,%KK[3!YA[6!"NF-C!8P
MG@7&L@"@E::+!LJ @H9 !$0EOL4."M3CR.A;+8!@!UB;\ KU.SZ/)]P !4#(
M\C!H"!09<I?@#O;1. PR)CIB)$H@P=^"+@H\H# B#0RQ8G; LDK "? D*QG
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MQ "A$;3/ 9H@#\+#LOP#GA-B$@X[+>"_. +;/R*KUYN@"#0((&8 >,!D2P(
M" $D^;&A *TNCZ1L &! CCP<"0$X(-3G($*"=CP"P"?%0Q)3=C)V^(&@0,:$
M"PCQ</GR 4>!"5>^L!5!AD!*'!,0?'&P@P@[1*QXR+B@APP+0')LH0BHRU(
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M'5(6#]"%&4%:>R4$SX$B#E0^&((D%W)RWY$--R((#I00/<)F.! D$;(#-P=
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MUF(]UF3M1]1XT$Z]C4W@#Z0$!KTS M=<%G!-4A*A*_2WN/U ![.@"%]0S=N
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M$B 1%T+&Y =3,AL!:@LF#> '2S!U%*2V1!1$BGL"/\ DD;((D'V(;"4!BP0
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MHP<L 8 EMO'!3T9,(%W4R$I:\H.7Q.2*';N)! *P$UC6$BA"(8HMG0(RA9B
M65GKTP@D,22R7*4#*S#CTPC#%Q(DLBG%M$4/VC>2JAAS!?) R0B:D +4540.
M._M(7C; S 2P#32!D$01BF48*VAA-JN1PS2S]H89D*5R9+%#)I!6$BN4P!17
M^0MV:@(3*W@ 5$Q0)W!L%0)Z#M0$QQD!(>X) ^%(Z#J+D5MM*&J+CY3& YDC
M20=VD(?@V (3<I !:!PG(=:YSG,CB0T/D(,[F9+DI1V  11FH1[VP* /"7A
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MQ#$0(?](BD:(8(6I)-*.Z.1!"-)8&#AF!@>N7  @/E!3A5!@% =(Y!8"-M]
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M%E%L70)(@/((-DL2'%S!BL"1@Q<F_^R 3+1AA209@7H'.MT4+F%:'?C$SY'
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MES1&"0DO3*H(+?^\2%CY)2 HBWC!I$?Z(-$S@"$P!18@R()0I'BA'QSHT8I
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M*:.9\@0"14"$+3L:GB$+GWD/ML !3+A#$VB;H?D[D]F I_@I.)4QP5BF,)@
M1S(!X*J,66."(0&$3<"RDOF!J\A 4J6)TA")#MRK8O-6"5G>UWA!$1D"7DN
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MC+Q]425"M+#1F0&97(07EPF1P%<2.SC&4 <@,F1A1""]$(8\$5'20Q\=[*!
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MP 2Y :$*4N"55523"!X$62D=6,$>I)R8"C1 !64*BF*JT(5#+T44(2A0GHD
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M,,.DS8 !#,,:?(&@ 4#_G77!:\1=\ V$*UZ922Q&K&6<@\5=L>6<AF%<!'P
ML*V$S@'"B!W F7T"A5%@&[Q! 2P #<#!&V#"$@Q"QRS $5!!$:#-+E+@^/'%
MZ=W<0=R:S*!9,*(!&&":8IS!EA6 )81 #LC&%/0 %LY:*F;<'9! SIF";&0<
M%FIA&^1*;HP83YQ>)@[$V3&)+0 C<@B$I7G!%F@A&!C9 QR!$EP(#03D0#Q"
M%7!!L.T4?6&'$+G05RU !"Q"S;R)(/HB!<!!%P3!CPD<%AQ?1B2"P'6 G7G
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M(0 >$.:K0)PD4!V8'";83C7IM.G#/NP #SA )H0@#VY""BC  L G>5XJ+)H
M'(@ %'B;HBG 4$I!4<H!PA0 !4 "T:$!)""!#%Q SGV  -H OF$"]*%<NK4!
M@&KHN<&@%[A 1B"HHEW K9D?)*!?+<8='ZC W<G?"\9!EYH$#;I@T;6 S!@
M#<1!_\5I@PAXB.)<@1]P0+U1)@-N0-P]H VD&X6U:)$E!C/\VI7Z0.)Q "'P
MYNE17-%-P-H8()HEW@4F(9J=Y3[.W9^40!5DP&M8)B0L' ?L !2\QAB>@(Z&
MV.-FG^3. -S.3 F4+0PVAB5LH0 N01149&)@ @TL7Q7P 1=0($;"S"8LG+8A
M </D'!<N@3YL&%:A6';<4SZ!U0*XV"8P@@A 1,2%G!=4VT"@PP=H(H8Q+@"<
M7APTHB7HF%"&P!X4Y8_QF66NP<B9P^*^1N:L 2-0&Z]D#B3<@0HT0*MA' :
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K#SJA%[JA'SJB)[JB+SJC-[JC/SJD1[JD3SJE5[JE7SJF9[JF;SJC!P0 .P$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
